Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term:dithiol
go back to main search page
Accession:CHEBI:23853 term browser browse the term
Synonyms:related_synonym: dithiols
 xref_mesh: MESH:C004848


show annotations for term's descendants           Sort by:
dithiol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Alox12 arachidonate 12-lipoxygenase decreases activity ISO dithiol results in decreased activity of ALOX12 protein CTD PMID:3928952 NCBI chr11:70,132,283...70,146,206
Ensembl chr11:70,132,283...70,146,179 		JBrowse link
G Alox5 arachidonate 5-lipoxygenase decreases activity ISO dithiol results in decreased activity of ALOX5 protein CTD PMID:3928952 NCBI chr 6:116,387,030...116,438,139
Ensembl chr 6:116,387,038...116,438,139 		JBrowse link
1,4-dithiothreitol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adora1 adenosine A1 receptor multiple interactions ISO [Dithiothreitol co-treated with Cadmium Chloride] inhibits the reaction [2-chloro-N(6)cyclopentyladenosine binds to ADORA1 protein]; [Dithiothreitol co-treated with Dithionitrobenzoic Acid] inhibits the reaction [2-chloro-N(6)cyclopentyladenosine binds to ADORA1 protein]; Dithiothreitol inhibits the reaction [Cadmium Chloride inhibits the reaction [2-chloro-N(6)cyclopentyladenosine binds to ADORA1 protein]]; Dithiothreitol inhibits the reaction [Dithionitrobenzoic Acid inhibits the reaction [2-chloro-N(6)cyclopentyladenosine binds to ADORA1 protein]] CTD PMID:10413299 NCBI chr 1:134,126,953...134,163,195
Ensembl chr 1:134,126,963...134,163,169 		JBrowse link
G Akt1 thymoma viral proto-oncogene 1 multiple interactions ISO Dithiothreitol inhibits the reaction [sodium arsenite results in increased phosphorylation of AKT1 protein] CTD PMID:12614848 NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318 		JBrowse link
G Alad aminolevulinate, delta-, dehydratase multiple interactions
increases activity		 EXP
ISO		 Dithiothreitol inhibits the reaction [Cadmium Chloride inhibits the reaction [diphenyldiselenide results in decreased activity of ALAD protein]]
Dithiothreitol results in increased activity of ALAD protein
[Zinc co-treated with Dithiothreitol] inhibits the reaction [Lead results in decreased activity of ALAD protein]; Cadmium affects the reaction [[Zinc co-treated with Dithiothreitol] inhibits the reaction [Lead results in decreased activity of ALAD protein]]; lead nitrate inhibits the reaction [Dithiothreitol results in increased activity of ALAD protein]; lead nitrate inhibits the reaction [zinc chloride promotes the reaction [Dithiothreitol results in increased activity of ALAD protein]]; triethyllead acetate inhibits the reaction [Dithiothreitol results in increased activity of ALAD protein]; triethyllead acetate inhibits the reaction [zinc chloride promotes the reaction [Dithiothreitol results in increased activity of ALAD protein]]; zinc chloride promotes the reaction [Dithiothreitol results in increased activity of ALAD protein]
cadmium acetate inhibits the reaction [Dithiothreitol results in increased activity of ALAD protein]; Dithiothreitol inhibits the reaction [2,2'-dithienyl diselenide results in decreased activity of ALAD protein]; Dithiothreitol inhibits the reaction [ebselen results in decreased activity of ALAD protein]; Zinc Acetate inhibits the reaction [Dithiothreitol results in increased activity of ALAD protein]		 CTD PMID:2061546 PMID:20472051 PMID:21360559 PMID:21910133 PMID:22180340 More... NCBI chr 4:62,422,762...62,438,300
Ensembl chr 4:62,427,406...62,438,155 		JBrowse link
G Apex1 apurinic/apyrimidinic endonuclease 1 multiple interactions ISO Dithiothreitol promotes the reaction [MAPK1 protein binds to APEX1 protein] CTD PMID:23370007 NCBI chr14:51,162,406...51,164,645
Ensembl chr14:51,162,425...51,164,596 		JBrowse link
G Ar androgen receptor multiple interactions ISO Dithiothreitol inhibits the reaction [cadmium sulfate inhibits the reaction [Androgens binds to AR protein]]; Dithiothreitol inhibits the reaction [Copper Sulfate inhibits the reaction [Androgens binds to AR protein]]; Dithiothreitol inhibits the reaction [zinc chloride inhibits the reaction [Androgens binds to AR protein]] CTD PMID:6323860 NCBI chr  X:97,192,363...97,366,824
Ensembl chr  X:97,192,375...97,366,821 		JBrowse link
G As3mt arsenite methyltransferase multiple interactions
increases reduction		 ISO Dithiothreitol promotes the reaction [AS3MT protein results in increased methylation of Arsenic]
Dithiothreitol results in increased reduction of AS3MT protein
Dithiothreitol promotes the reaction [AS3MT protein binds to and results in increased methylation of arsenite]		 CTD PMID:15025511 PMID:25349987 NCBI chr19:46,695,124...46,729,538
Ensembl chr19:46,695,897...46,729,538 		JBrowse link
G Atf3 activating transcription factor 3 increases expression ISO Dithiothreitol results in increased expression of ATF3 mRNA CTD PMID:17332266 NCBI chr 1:190,902,493...190,915,530
Ensembl chr 1:190,902,493...190,950,236 		JBrowse link
G Atf4 activating transcription factor 4 increases expression ISO
EXP		 Dithiothreitol results in increased expression of ATF4 mRNA CTD PMID:27226639 NCBI chr15:80,139,385...80,141,746
Ensembl chr15:80,139,385...80,141,742 		JBrowse link
G Atp7a ATPase, Cu++ transporting, alpha polypeptide multiple interactions ISO Dithiothreitol inhibits the reaction [Ethylmaleimide results in increased glutathionylation of ATP7A protein] CTD PMID:20566629 NCBI chr  X:105,070,830...105,171,766
Ensembl chr  X:105,070,882...105,168,532 		JBrowse link
G Bcl2 B cell leukemia/lymphoma 2 multiple interactions ISO Dithiothreitol inhibits the reaction [arsenic trioxide results in increased expression of BCL2 protein] CTD PMID:18022205 NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004 		JBrowse link
G Calu calumenin increases expression ISO Dithiothreitol results in increased expression of CALU protein CTD PMID:21692457 NCBI chr 6:29,348,105...29,376,674
Ensembl chr 6:29,348,068...29,377,109 		JBrowse link
G Casp1 caspase 1 multiple interactions EXP Dithiothreitol inhibits the reaction [Ziram results in decreased expression of and results in increased degradation of CASP1 protein] CTD PMID:25929180 NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290 		JBrowse link
G Casp3 caspase 3 multiple interactions ISO
EXP		 [Dithiothreitol co-treated with Peroxynitrous Acid] results in increased metabolism of CASP3 protein; Dithiothreitol inhibits the reaction [[NOS2 protein results in increased abundance of Nitric Oxide] inhibits the reaction [Lipopolysaccharides results in increased activity of CASP3 protein]]; Dithiothreitol inhibits the reaction [[NOS2 protein results in increased abundance of Nitric Oxide] which results in decreased activity of CASP3 protein]; Dithiothreitol inhibits the reaction [[NOS2 protein results in increased abundance of Nitric Oxide] which results in increased metabolism of CASP3 protein]; Dithiothreitol inhibits the reaction [arsenic trioxide results in increased activity of CASP3 protein]; Dithiothreitol inhibits the reaction [chelerythrine results in increased cleavage of CASP3 protein]; Dithiothreitol inhibits the reaction [Nitric Oxide results in decreased activity of CASP3 protein]; Dithiothreitol promotes the reaction [1-(N-(3-ammoniopropyl)-N-(n-propyl)amino)diazen-1-ium-1,2-diolate results in increased metabolism of CASP3 protein]
Dithiothreitol inhibits the reaction [2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester results in decreased activity of CASP3 protein]; Dithiothreitol inhibits the reaction [Nitric Oxide Donors inhibits the reaction [[TNF protein co-treated with Galactosamine] results in increased activity of CASP3 protein]]
Dithiothreitol inhibits the reaction [1H-(1,2,3)oxadiazolo(4,4-a)quinoxalin-1-one inhibits the reaction [[Nitric Oxide Donors results in increased abundance of Nitric Oxide] which results in decreased activity of CASP3 protein]]		 CTD PMID:9388267 PMID:9441900 PMID:9706149 PMID:9755104 PMID:10673743 More... NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724 		JBrowse link
G Casp8 caspase 8 multiple interactions EXP Dithiothreitol inhibits the reaction [2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester results in decreased activity of CASP8 protein] CTD PMID:11226294 NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662 		JBrowse link
G Casp9 caspase 9 multiple interactions EXP Dithiothreitol inhibits the reaction [2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester results in decreased activity of CASP9 protein] CTD PMID:11226294 NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287 		JBrowse link
G Cat catalase multiple interactions ISO CAT protein inhibits the reaction [[9,10-phenanthrenequinone co-treated with Dithiothreitol] results in decreased activity of and results in increased oxidation of PTPN1 protein]; CAT protein inhibits the reaction [Dithiothreitol results in increased abundance of Hydrogen Peroxide] CTD PMID:7491977 PMID:32493877 NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505 		JBrowse link
G Cbr1 carbonyl reductase 1 multiple interactions ISO Dithiothreitol inhibits the reaction [S-Nitrosoglutathione inhibits the reaction [CBR1 protein results in increased reduction of S-Nitrosoglutathione]] CTD PMID:21256830 NCBI chr16:93,404,752...93,407,226
Ensembl chr16:93,402,741...93,407,393 		JBrowse link
G Ccnd1 cyclin D1 decreases expression ISO Dithiothreitol results in decreased expression of CCND1 mRNA CTD PMID:17332266 NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662 		JBrowse link
G Ccng2 cyclin G2 increases expression ISO Dithiothreitol results in increased expression of CCNG2 mRNA CTD PMID:17332266 NCBI chr 5:93,415,432...93,424,090
Ensembl chr 5:93,415,116...93,424,090 		JBrowse link
G Cdh1 cadherin 1 multiple interactions ISO Dithiothreitol inhibits the reaction [4-cresol sulfate results in decreased expression of CDH1 protein] CTD PMID:31873818 NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878 		JBrowse link
G Cftr cystic fibrosis transmembrane conductance regulator multiple interactions ISO Dithiothreitol inhibits the reaction [Glutathione results in decreased activity of CFTR protein] CTD PMID:15657297 NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767 		JBrowse link
G Chuk conserved helix-loop-helix ubiquitous kinase multiple interactions EXP Dithiothreitol inhibits the reaction [Melitten binds to and results in decreased activity of CHUK protein]; Dithiothreitol inhibits the reaction [Melitten inhibits the reaction [Nitroprusside results in increased activity of CHUK protein]] CTD PMID:17067557 NCBI chr19:44,061,773...44,095,940
Ensembl chr19:44,061,774...44,095,919 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions ISO Dithiothreitol inhibits the reaction [1-nitropyrene results in increased degradation of CYP1A1 protein] CTD PMID:16280210 NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107 		JBrowse link
G Cyp7a1 cytochrome P450, family 7, subfamily a, polypeptide 1 increases activity ISO Dithiothreitol results in increased activity of CYP7A1 protein CTD PMID:1175606 NCBI chr 4:6,265,612...6,275,632
Ensembl chr 4:6,265,612...6,275,633 		JBrowse link
G Ddit3 DNA-damage inducible transcript 3 increases expression
multiple interactions		 ISO
EXP		 Dithiothreitol results in increased expression of DDIT3 mRNA
indolo(3,2-b)carbazole inhibits the reaction [Dithiothreitol results in increased expression of DDIT3 mRNA]		 CTD PMID:17332266 PMID:23123503 PMID:27226639 NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157
Ensembl chr10:127,126,643...127,132,157 		JBrowse link
G Dnajb9 DnaJ heat shock protein family (Hsp40) member B9 increases expression ISO Dithiothreitol results in increased expression of DNAJB9 mRNA CTD PMID:23123503 NCBI chr12:44,252,680...44,256,851
Ensembl chr12:44,252,342...44,257,109 		JBrowse link
G Eif2a eukaryotic translation initiation factor 2A multiple interactions ISO Dithiothreitol results in increased phosphorylation of and results in increased activity of EIF2A protein CTD PMID:12486162 NCBI chr 3:58,433,252...58,464,922
Ensembl chr 3:58,433,242...58,464,922 		JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 multiple interactions
increases phosphorylation		 ISO Dithiothreitol results in increased phosphorylation of and results in increased activity of EIF2AK3 protein
Dithiothreitol results in increased phosphorylation of EIF2AK3 protein		 CTD PMID:12486162 PMID:25321315 NCBI chr 6:70,821,468...70,882,225
Ensembl chr 6:70,821,499...70,882,229 		JBrowse link
G Eif2s1 eukaryotic translation initiation factor 2, subunit 1 alpha increases phosphorylation
multiple interactions		 EXP
ISO		 Dithiothreitol results in increased phosphorylation of EIF2S1 protein
EIF2S1 protein mutant form inhibits the reaction [Dithiothreitol results in increased phosphorylation of EIF2S1 protein]		 CTD PMID:30385349 PMID:34244458 NCBI chr12:78,908,846...78,933,784
Ensembl chr12:78,908,593...78,933,784 		JBrowse link
G Ern1 endoplasmic reticulum to nucleus signalling 1 multiple interactions
increases expression		 ISO Dithiothreitol results in increased phosphorylation of and results in increased activity of ERN1 protein
Dithiothreitol results in increased expression of ERN1 protein		 CTD PMID:12486162 PMID:25321315 NCBI chr11:106,285,474...106,378,701
Ensembl chr11:106,285,476...106,378,678 		JBrowse link
G Esr1 estrogen receptor 1 (alpha) multiple interactions ISO fulvestrant inhibits the reaction [Dithiothreitol results in increased activity of ESR1 protein]; Tamoxifen inhibits the reaction [Dithiothreitol results in increased activity of ESR1 protein] CTD PMID:22403704 NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614 		JBrowse link
G F3 coagulation factor III increases activity ISO Dithiothreitol results in increased activity of F3 protein CTD PMID:17726162 NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697 		JBrowse link
G Fgf21 fibroblast growth factor 21 increases expression
increases secretion
multiple interactions		 ISO
EXP		 Dithiothreitol results in increased expression of FGF21 mRNA
Dithiothreitol results in increased secretion of FGF21 protein
indolo(3,2-b)carbazole inhibits the reaction [Dithiothreitol results in increased expression of FGF21 mRNA]		 CTD PMID:23123503 PMID:27226639 NCBI chr 7:45,263,314...45,264,914
Ensembl chr 7:45,263,310...45,264,914 		JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible 45 alpha increases expression ISO Dithiothreitol results in increased expression of GADD45A mRNA CTD PMID:17332266 NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441 		JBrowse link
G Hif1a hypoxia inducible factor 1, alpha subunit multiple interactions ISO Dithiothreitol inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of HIF1A protein]; Dithiothreitol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of HIF1A protein alternative form] CTD PMID:14695184 PMID:17658243 NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304 		JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions ISO
EXP		 Dithiothreitol inhibits the reaction [diallyl trisulfide results in increased expression of HMOX1 protein]
Dithiothreitol inhibits the reaction [farrerol results in increased expression of HMOX1 protein]; Dithiothreitol inhibits the reaction [hydroquinone results in increased expression of HMOX1 protein]		 CTD PMID:23290930 PMID:24489685 PMID:26111761 NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217 		JBrowse link
G Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 multiple interactions
increases activity		 ISO Dithiothreitol inhibits the reaction [perfluorodecanoic acid results in decreased activity of HSD11B2 protein]; Dithiothreitol inhibits the reaction [Thiram results in decreased activity of HSD11B2 protein]; Dithiothreitol inhibits the reaction [Ziram results in decreased activity of HSD11B2 protein]; perfluorodecanoic acid inhibits the reaction [Dithiothreitol results in increased activity of HSD11B2 protein] CTD PMID:12901862 PMID:26859423 PMID:36878351 NCBI chr 8:106,245,378...106,250,620
Ensembl chr 8:106,245,387...106,250,620 		JBrowse link
G Hsd3b1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 multiple interactions
increases activity		 ISO Dithiothreitol inhibits the reaction [Thiram results in decreased activity of HSD3B1 protein]
Dithiothreitol results in increased activity of HSD3B1 protein		 CTD PMID:36965607 NCBI chr 3:98,749,672...98,767,110
Ensembl chr 3:98,759,510...98,767,110 		JBrowse link
G Hsp90b1 heat shock protein 90, beta (Grp94), member 1 multiple interactions ISO Dactinomycin inhibits the reaction [Dithiothreitol results in increased expression of HSP90B1 mRNA]; Dithiothreitol results in increased expression of and affects the localization of HSP90B1 mRNA CTD PMID:34244458 NCBI chr10:86,526,705...86,541,308
Ensembl chr10:86,526,073...86,541,373 		JBrowse link
G Hspa5 heat shock protein 5 increases expression ISO Dithiothreitol metabolite results in increased expression of HSPA5 protein; Dithiothreitol results in increased expression of HSPA5 mRNA; Dithiothreitol results in increased expression of HSPA5 protein CTD PMID:15710169 PMID:17332266 PMID:17416481 PMID:21692457 PMID:23123503 More... NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559 		JBrowse link
G Ikbkb inhibitor of kappaB kinase beta multiple interactions ISO
EXP		 Dithiothreitol inhibits the reaction [3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of IKBKB protein]]
Dithiothreitol inhibits the reaction [Melitten binds to and results in decreased activity of IKBKB protein]; Dithiothreitol inhibits the reaction [Melitten inhibits the reaction [Nitroprusside results in increased activity of IKBKB protein]]		 CTD PMID:17067557 PMID:20584749 NCBI chr 8:23,149,228...23,196,605
Ensembl chr 8:23,149,228...23,196,605 		JBrowse link
G Il1a interleukin 1 alpha multiple interactions ISO [Dithiothreitol co-treated with IL1A protein] results in increased expression of SOD2 protein; Dithiothreitol promotes the reaction [IL1A protein results in increased expression of SOD2 mRNA] CTD PMID:7476933 NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892 		JBrowse link
G Il1b interleukin 1 beta multiple interactions ISO Dithiothreitol inhibits the reaction [nitroaspirin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IL1B protein] results in increased activity of [NFKB1 protein binds to NFKB1 protein]]] CTD PMID:14762100 NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059 		JBrowse link
G Il5 interleukin 5 multiple interactions ISO Dithiothreitol inhibits the reaction [Thiazoles analog inhibits the reaction [IL5 protein binds to IL5RA protein]] CTD PMID:7957178 NCBI chr11:53,611,621...53,615,930
Ensembl chr11:53,611,621...53,615,933 		JBrowse link
G Il5ra interleukin 5 receptor, alpha multiple interactions ISO Dithiothreitol inhibits the reaction [Thiazoles analog inhibits the reaction [IL5 protein binds to IL5RA protein]] CTD PMID:7957178 NCBI chr 6:106,687,336...106,725,998
Ensembl chr 6:106,687,318...106,725,998 		JBrowse link
G Inhbe inhibin beta-E increases expression ISO Dithiothreitol results in increased expression of INHBE mRNA CTD PMID:22935518 NCBI chr10:127,185,271...127,187,717
Ensembl chr10:127,184,726...127,190,280 		JBrowse link
G Ins1 insulin I decreases activity
multiple interactions		 ISO Dithiothreitol results in decreased activity of INS1 protein
Dithiothreitol affects the reaction [oxophenylarsine results in decreased activity of INS1 protein]; Dithiothreitol inhibits the reaction [INS1 protein results in increased uptake of Glucose]		 CTD PMID:2262933 NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914 		JBrowse link
G Jun jun proto-oncogene multiple interactions EXP Dithiothreitol inhibits the reaction [sodium arsenite results in increased phosphorylation of JUN protein] CTD PMID:11035063 NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459 		JBrowse link
G Kif5a kinesin family member 5A multiple interactions ISO Dithiothreitol inhibits the reaction [cupric chloride results in decreased activity of KIF5A protein] CTD PMID:24853401 NCBI chr10:127,061,564...127,102,217
Ensembl chr10:127,061,565...127,099,217 		JBrowse link
G Map3k5 mitogen-activated protein kinase kinase kinase 5 multiple interactions ISO Dithiothreitol inhibits the reaction [NCX 4040 inhibits the reaction [TXN1 protein binds to MAP3K5 protein]] CTD PMID:18922898 NCBI chr10:19,809,847...20,018,496
Ensembl chr10:19,810,218...20,018,499 		JBrowse link
G Mapk1 mitogen-activated protein kinase 1 multiple interactions EXP
ISO		 Dithiothreitol inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK1 protein]
Dithiothreitol inhibits the reaction [Hydrogen Peroxide results in decreased activity of MAPK1 protein]; Dithiothreitol promotes the reaction [MAPK1 protein binds to APEX1 protein]		 CTD PMID:11035063 PMID:23370007 NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317 		JBrowse link
G Mapk3 mitogen-activated protein kinase 3 multiple interactions EXP Dithiothreitol inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK3 protein] CTD PMID:11035063 NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991 		JBrowse link
G Mapk8 mitogen-activated protein kinase 8 multiple interactions ISO Dithiothreitol inhibits the reaction [Sodium Selenite results in decreased activity of MAPK8 protein] CTD PMID:10644709 NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115 		JBrowse link
G Mgst1 microsomal glutathione S-transferase 1 multiple interactions ISO Dithiothreitol inhibits the reaction [[1-hydroxy-2-oxo-3-(3-aminopropyl)-3-isopropyl-1-triazene results in increased abundance of Nitric Oxide] which results in increased activity of MGST1 protein]; Dithiothreitol inhibits the reaction [[Peroxynitrous Acid co-treated with Glutathione] results in increased activity of MGST1 protein]; Dithiothreitol inhibits the reaction [[S-nitrosocysteine results in increased abundance of Nitric Oxide] which results in increased activity of MGST1 protein]; Dithiothreitol inhibits the reaction [[S-Nitrosoglutathione results in increased abundance of Nitric Oxide] which results in increased activity of MGST1 protein]; Dithiothreitol inhibits the reaction [Gallic Acid results in increased activity of MGST1 protein] CTD PMID:16125204 PMID:16386761 NCBI chr 6:138,117,525...138,133,753
Ensembl chr 6:138,117,314...138,133,753 		JBrowse link
G Msrb2 methionine sulfoxide reductase B2 increases reduction ISO Dithiothreitol results in increased reduction of MSRB2 protein CTD PMID:16735467 NCBI chr 2:19,376,247...19,399,787
Ensembl chr 2:19,376,251...19,399,787 		JBrowse link
G Msrb3 methionine sulfoxide reductase B3 increases reduction ISO Dithiothreitol results in increased reduction of MSRB3 protein CTD PMID:16735467 NCBI chr10:120,617,005...120,735,132
Ensembl chr10:120,617,001...120,735,006 		JBrowse link
G Mt1 metallothionein 1 multiple interactions EXP Dithiothreitol results in increased reduction of [MT1 protein binds to Zinc] CTD PMID:22001350 NCBI chr 8:94,905,214...94,906,955
Ensembl chr 8:94,905,710...94,906,955 		JBrowse link
G Mylk myosin, light polypeptide kinase multiple interactions ISO Dithiothreitol inhibits the reaction [4-cresol sulfate results in increased phosphorylation of MYLK protein] CTD PMID:31873818 NCBI chr16:34,565,569...34,822,806
Ensembl chr16:34,565,580...34,822,790 		JBrowse link
G Nat1 N-acetyl transferase 1 increases activity
multiple interactions		 ISO Dithiothreitol results in increased activity of NAT1 protein
Dithiothreitol inhibits the reaction [Hydrogen Peroxide results in decreased activity of NAT1 protein]		 CTD PMID:22835378 NCBI chr 8:67,943,620...67,945,183
Ensembl chr 8:67,933,573...67,944,756 		JBrowse link
G Nfe2l2 nuclear factor, erythroid derived 2, like 2 multiple interactions ISO Dithiothreitol inhibits the reaction [diallyl trisulfide affects the localization of NFE2L2 protein] CTD PMID:24489685 NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985 		JBrowse link
G Nfkb1 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 multiple interactions ISO
EXP		 Dithiothreitol inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased activity of NFKB1 protein]]; Dithiothreitol inhibits the reaction [nitroaspirin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IL1B protein] results in increased activity of [NFKB1 protein binds to NFKB1 protein]]]
[Pertussis Toxin co-treated with Dithiothreitol] inhibits the reaction [Aspirin inhibits the reaction [Lipopolysaccharides promotes the reaction [[RELA protein co-treated with NFKB1 protein] binds to TNF promoter]]]		 CTD PMID:9281604 PMID:14762100 PMID:16219905 NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308 		JBrowse link
G Nfkbia nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha multiple interactions EXP
ISO		 Dithiothreitol inhibits the reaction [Melitten inhibits the reaction [Nitroprusside results in increased phosphorylation of NFKBIA protein]]
Dithiothreitol inhibits the reaction [ent-1,3,6,11-tetrahydroxykaur-16-ene-15-one 3,11-diacetate results in increased activity of NFKBIA protein]		 CTD PMID:17067557 PMID:19509257 NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432 		JBrowse link
G Nos2 nitric oxide synthase 2, inducible multiple interactions ISO
EXP		 Dithiothreitol inhibits the reaction [[NOS2 protein results in increased abundance of Nitric Oxide] inhibits the reaction [Lipopolysaccharides results in increased activity of CASP3 protein]]; Dithiothreitol inhibits the reaction [[NOS2 protein results in increased abundance of Nitric Oxide] which results in decreased activity of CASP3 protein]; Dithiothreitol inhibits the reaction [[NOS2 protein results in increased abundance of Nitric Oxide] which results in increased metabolism of CASP3 protein]
Dithiothreitol inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA]
Dithiothreitol inhibits the reaction [Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]		 CTD PMID:7532384 PMID:9706149 PMID:9755104 PMID:15907790 NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080 		JBrowse link
G Nqo1 NAD(P)H dehydrogenase, quinone 1 multiple interactions ISO Dithiothreitol inhibits the reaction [diallyl trisulfide results in increased expression of NQO1 protein] CTD PMID:24489685 NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 multiple interactions ISO Dithiothreitol inhibits the reaction [arsenite inhibits the reaction [Dexamethasone binds to NR3C1 protein]]; Dithiothreitol inhibits the reaction [Thiram inhibits the reaction [Dexamethasone binds to NR3C1 protein]]
Dithiothreitol inhibits the reaction [Mercuric Chloride inhibits the reaction [Triamcinolone Acetonide binds to NR3C1 protein]]; Dithiothreitol inhibits the reaction [methyl methanethiosulfonate inhibits the reaction [dexamethasone 21-methanesulfonate binds to NR3C1 protein]]; Dithiothreitol inhibits the reaction [methyl methanethiosulfonate inhibits the reaction [Dexamethasone binds to NR3C1 protein]]; Dithiothreitol inhibits the reaction [sodium arsenite inhibits the reaction [dexamethasone 21-methanesulfonate binds to NR3C1 protein]]; Dithiothreitol inhibits the reaction [sodium arsenite inhibits the reaction [Dexamethasone binds to NR3C1 protein]]		 CTD PMID:2226332 PMID:2298732 PMID:15250541 PMID:16857225 NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474 		JBrowse link
G Nrgn neurogranin multiple interactions ISO Dithiothreitol inhibits the reaction [chloramine-T affects the phosphorylation of NRGN protein] CTD PMID:21241739 NCBI chr 9:37,455,789...37,464,041
Ensembl chr 9:37,455,788...37,464,200 		JBrowse link
G Nudt9 nudix hydrolase 9 multiple interactions ISO Dithiothreitol inhibits the reaction [Hydrogen Peroxide inhibits the reaction [Magnesium Chloride results in increased activity of NUDT9 protein]]; Dithiothreitol inhibits the reaction [Hydrogen Peroxide inhibits the reaction [Magnesium results in increased activity of NUDT9 protein]]; Dithiothreitol inhibits the reaction [Hydrogen Peroxide promotes the reaction [manganese chloride results in increased activity of NUDT9 protein]]; Dithiothreitol inhibits the reaction [Hydrogen Peroxide promotes the reaction [Manganese results in increased activity of NUDT9 protein]] CTD PMID:16860484 NCBI chr 5:104,193,407...104,213,244
Ensembl chr 5:104,194,172...104,213,245 		JBrowse link
G Ogdh oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) multiple interactions ISO Dithiothreitol inhibits the reaction [Hydrogen Peroxide results in decreased activity of OGDH protein]; Dithiothreitol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of OGDH protein] CTD PMID:12680778 NCBI chr11:6,241,597...6,309,094
Ensembl chr11:6,241,633...6,306,642 		JBrowse link
G P2rx2 purinergic receptor P2X, ligand-gated ion channel, 2 multiple interactions ISO Dithiothreitol inhibits the reaction [Hydrogen Peroxide promotes the reaction [Adenosine Triphosphate results in increased activity of P2RX2 protein]] CTD PMID:19793987 NCBI chr 5:110,487,678...110,491,186
Ensembl chr 5:110,487,678...110,491,078 		JBrowse link
G Papss1 3'-phosphoadenosine 5'-phosphosulfate synthase 1 increases activity ISO Dithiothreitol results in increased activity of PAPSS1 protein CTD PMID:15065880 NCBI chr 3:131,270,626...131,349,432
Ensembl chr 3:131,270,529...131,349,432 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase family, member 1 multiple interactions EXP
ISO		 Dithiothreitol inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein]
Dithiothreitol inhibits the reaction [arsenic trioxide results in increased cleavage of PARP1 protein]; Dithiothreitol inhibits the reaction [withaferin A results in increased cleavage of PARP1 protein]		 CTD PMID:11035063 PMID:18022205 PMID:20438634 NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819 		JBrowse link
G Pdcd6ip programmed cell death 6 interacting protein increases expression ISO Dithiothreitol results in increased expression of PDCD6IP protein CTD PMID:21692457 NCBI chr 9:113,480,812...113,537,457
Ensembl chr 9:113,480,812...113,537,327 		JBrowse link
G Plod3 procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 increases expression ISO Dithiothreitol results in increased expression of PLOD3 protein CTD PMID:21692457 NCBI chr 5:137,015,873...137,025,500
Ensembl chr 5:137,015,873...137,025,502 		JBrowse link
G Ppargc1a peroxisome proliferative activated receptor, gamma, coactivator 1 alpha increases expression ISO Dithiothreitol results in increased expression of PPARGC1A mRNA CTD PMID:23056435 NCBI chr 5:51,611,591...52,273,316
Ensembl chr 5:51,611,592...51,725,068 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions ISO Dithiothreitol inhibits the reaction [3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein]] CTD PMID:20584749 NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978 		JBrowse link
G Ptk2 PTK2 protein tyrosine kinase 2 multiple interactions ISO Dithiothreitol affects the reaction [4-cresol sulfate affects the localization of PTK2 protein] CTD PMID:31873818 NCBI chr15:73,076,951...73,297,192
Ensembl chr15:73,076,951...73,295,129 		JBrowse link
G Ptpn1 protein tyrosine phosphatase, non-receptor type 1 multiple interactions ISO Dithiothreitol inhibits the reaction [Hydrogen Peroxide results in increased glutathionylation of PTPN1 protein]
[9,10-phenanthrenequinone co-treated with Dithiothreitol] results in decreased activity of and results in increased oxidation of PTPN1 protein; CAT protein inhibits the reaction [[9,10-phenanthrenequinone co-treated with Dithiothreitol] results in decreased activity of and results in increased oxidation of PTPN1 protein]		 CTD PMID:16781456 PMID:32493877 NCBI chr 2:167,772,670...167,821,305
Ensembl chr 2:167,773,977...167,821,305 		JBrowse link
G Rcn2 reticulocalbin 2 increases expression ISO Dithiothreitol results in increased expression of RCN2 protein CTD PMID:21692457 NCBI chr 9:55,949,129...55,966,367
Ensembl chr 9:55,949,129...55,969,166 		JBrowse link
G Rela v-rel reticuloendotheliosis viral oncogene homolog A (avian) multiple interactions
increases activity		 ISO
EXP		 Dithiothreitol inhibits the reaction [cinnamaldehyde results in increased glutathionylation of RELA protein]; Dithiothreitol inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased activity of RELA protein]]
Dithiothreitol results in increased activity of RELA protein
[Pertussis Toxin co-treated with Dithiothreitol] inhibits the reaction [Aspirin inhibits the reaction [Lipopolysaccharides promotes the reaction [[RELA protein co-treated with NFKB1 protein] binds to TNF promoter]]]		 CTD PMID:7491977 PMID:9281604 PMID:16219905 PMID:20351055 NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158 		JBrowse link
G S100a2 S100 calcium binding protein A2 multiple interactions ISO Dithiothreitol inhibits the reaction [Copper promotes the reaction [S100A2 protein binds to S100A2 protein]]; Dithiothreitol inhibits the reaction [S100A2 protein binds to S100A2 protein] CTD PMID:21924240 NCBI chr 3:90,497,554...90,498,815
Ensembl chr 3:90,467,670...90,498,838 		JBrowse link
G S100a4 S100 calcium binding protein A4 multiple interactions ISO Dithiothreitol inhibits the reaction [Copper promotes the reaction [S100A4 protein binds to S100A4 protein]] CTD PMID:21924240 NCBI chr 3:90,511,077...90,513,349
Ensembl chr 3:90,511,078...90,513,352 		JBrowse link
G Slc16a1 solute carrier family 16 (monocarboxylic acid transporters), member 1 multiple interactions ISO Dithiothreitol inhibits the reaction [SLC16A1 protein results in increased uptake of Lactic Acid] CTD PMID:15804185 NCBI chr 3:104,545,980...104,565,778
Ensembl chr 3:104,545,984...104,565,778 		JBrowse link
G Snai1 snail family zinc finger 1 multiple interactions ISO Dithiothreitol inhibits the reaction [4-cresol sulfate results in increased expression of SNAI1 protein] CTD PMID:31873818 NCBI chr 2:167,380,115...167,384,734
Ensembl chr 2:167,380,115...167,384,734 		JBrowse link
G Snai2 snail family zinc finger 2 multiple interactions ISO Dithiothreitol inhibits the reaction [4-cresol sulfate results in increased expression of SNAI2 protein] CTD PMID:31873818 NCBI chr16:14,523,716...14,527,259
Ensembl chr16:14,523,716...14,527,249 		JBrowse link
G Sod1 superoxide dismutase 1, soluble affects folding
multiple interactions		 ISO
EXP		 Dithiothreitol affects the folding of SOD1 protein
Dithiothreitol inhibits the reaction [SOD1 protein affects the reaction [Asbestos, Serpentine results in increased oxidation of STAT6 protein]]
[Dithiothreitol results in increased reduction of SOD1 protein] promotes the reaction [Hydrogen Peroxide results in increased oxidation of SOD1 protein modified form]; [Dithiothreitol results in increased reduction of SOD1 protein] which results in increased susceptibility to Hydrogen Peroxide; Dithiothreitol results in increased reduction of and results in decreased activity of SOD1 protein; Zinc promotes the reaction [Dithiothreitol affects the folding of SOD1 protein]		 CTD PMID:22867017 PMID:26694608 PMID:26699812 NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217 		JBrowse link
G Sod2 superoxide dismutase 2, mitochondrial multiple interactions
increases expression		 ISO [Dithiothreitol co-treated with IL1A protein] results in increased expression of SOD2 protein; [Dithiothreitol co-treated with TNF protein] results in increased expression of SOD2 protein; Dithiothreitol promotes the reaction [IL1A protein results in increased expression of SOD2 mRNA]; Dithiothreitol promotes the reaction [TNF protein results in increased expression of SOD2 mRNA]; TNF protein promotes the reaction [Dithiothreitol results in increased expression of SOD2 mRNA] CTD PMID:7476933 NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950 		JBrowse link
G Stat6 signal transducer and activator of transcription 6 multiple interactions EXP Dithiothreitol inhibits the reaction [Asbestos, Serpentine promotes the reaction [polyethylene glycol-superoxide dismutase results in increased oxidation of STAT6 protein]]; Dithiothreitol inhibits the reaction [Asbestos, Serpentine promotes the reaction [Polyethylene Glycols results in increased oxidation of STAT6 protein]]; Dithiothreitol inhibits the reaction [Asbestos, Serpentine results in increased oxidation of STAT6 protein]; Dithiothreitol inhibits the reaction [polyethylene glycol-superoxide dismutase results in increased oxidation of STAT6 protein]; Dithiothreitol inhibits the reaction [Polyethylene Glycols results in increased oxidation of STAT6 protein]; Dithiothreitol inhibits the reaction [SOD1 protein affects the reaction [Asbestos, Serpentine results in increased oxidation of STAT6 protein]] CTD PMID:26699812 NCBI chr10:127,478,855...127,496,856
Ensembl chr10:127,478,855...127,496,826 		JBrowse link
G Thy1 thymus cell antigen 1, theta multiple interactions EXP Dithiothreitol inhibits the reaction [sodium arsenite promotes the reaction [THY1 protein binds to THY1 protein]] CTD PMID:11035063 NCBI chr 9:43,954,681...43,959,876
Ensembl chr 9:43,954,681...43,959,876 		JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions EXP Dithiothreitol inhibits the reaction [4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides promotes the reaction [TLR4 protein binds to TLR4 protein]]]; Dithiothreitol inhibits the reaction [4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased activity of TLR4 protein]] CTD PMID:19627980 NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO
EXP		 [Dithiothreitol co-treated with TNF protein] results in increased expression of SOD2 protein; Dithiothreitol inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased activity of NFKB1 protein]]; Dithiothreitol inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased activity of RELA protein]]; Dithiothreitol promotes the reaction [TNF protein results in increased expression of SOD2 mRNA]; TNF protein promotes the reaction [Dithiothreitol results in increased expression of SOD2 mRNA]
Dithiothreitol inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA]
[Pertussis Toxin co-treated with Dithiothreitol] inhibits the reaction [Aspirin inhibits the reaction [Lipopolysaccharides promotes the reaction [[RELA protein co-treated with NFKB1 protein] binds to TNF promoter]]]; [Pertussis Toxin co-treated with Dithiothreitol] inhibits the reaction [Aspirin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; Dithiothreitol inhibits the reaction [Nitric Oxide Donors inhibits the reaction [[TNF protein co-treated with Galactosamine] results in increased activity of CASP3 protein]]		 CTD PMID:7476933 PMID:7532384 PMID:9281604 PMID:9388267 PMID:16219905 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983 		JBrowse link
G Top2a topoisomerase (DNA) II alpha multiple interactions ISO Dithiothreitol inhibits the reaction [Cannabidiol metabolite inhibits the reaction [TOP2A protein results in increased hydrolysis of Adenosine Triphosphate]] CTD PMID:29272108 NCBI chr11:98,883,773...98,915,037
Ensembl chr11:98,883,769...98,915,015 		JBrowse link
G Trp53 transformation related protein 53 multiple interactions ISO Dithiothreitol inhibits the reaction [[Cadmium Chloride results in decreased activity of TP53 protein] inhibits the reaction [TP53 protein binds to TP53 gene]]; Dithiothreitol inhibits the reaction [Glutathione Disulfide results in increased glutathionylation of TP53 protein]; Dithiothreitol inhibits the reaction [Glutathione results in increased glutathionylation of TP53 protein] CTD PMID:17555331 PMID:25446071 NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699 		JBrowse link
G Trpa1 transient receptor potential cation channel, subfamily A, member 1 multiple interactions ISO Dithiothreitol inhibits the reaction [[hydroquinone results in increased activity of TRPA1 protein] which results in increased import of Calcium]; Dithiothreitol inhibits the reaction [hydroquinone results in increased activity of TRPA1 protein] CTD PMID:28790335 NCBI chr 1:14,942,868...14,989,086
Ensembl chr 1:14,942,872...14,989,086 		JBrowse link
G Trpc5 transient receptor potential cation channel, subfamily C, member 5 multiple interactions
increases activity		 ISO Dithiothreitol inhibits the reaction [Mercuric Chloride results in increased activity of TRPC5 protein]
Dithiothreitol results in increased activity of TRPC5 protein		 CTD PMID:21984481 NCBI chr  X:143,160,323...143,471,176
Ensembl chr  X:143,164,667...143,471,176 		JBrowse link
G Trpm4 transient receptor potential cation channel, subfamily M, member 4 multiple interactions ISO Dithiothreitol inhibits the reaction [Hydrogen Peroxide results in increased expression of TRPM4 protein] CTD PMID:28214884 NCBI chr 7:44,952,579...44,983,495
Ensembl chr 7:44,952,056...44,983,204 		JBrowse link
G Txn1 thioredoxin 1 multiple interactions ISO Dithiothreitol inhibits the reaction [NCX 4040 inhibits the reaction [TXN1 protein binds to MAP3K5 protein]] CTD PMID:18922898 NCBI chr 4:57,943,373...57,956,411
Ensembl chr 4:57,943,373...57,956,411 		JBrowse link
G Vim vimentin multiple interactions ISO Dithiothreitol inhibits the reaction [4-cresol sulfate results in increased expression of VIM protein] CTD PMID:31873818 NCBI chr 2:13,579,122...13,587,637
Ensembl chr 2:13,578,738...13,587,637 		JBrowse link
G Xbp1 X-box binding protein 1 increases splicing ISO Dithiothreitol results in increased splicing of XBP1 mRNA CTD PMID:23123503 PMID:34244458 NCBI chr11:5,470,641...5,475,993
Ensembl chr11:5,470,659...5,475,893 		JBrowse link
G Xdh xanthine dehydrogenase multiple interactions ISO Dithiothreitol inhibits the reaction [chloramine affects the activity of XDH protein] CTD PMID:19527742 NCBI chr17:74,190,890...74,257,191
Ensembl chr17:74,190,890...74,257,191 		JBrowse link
dihydrolipoamide term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Akt1 thymoma viral proto-oncogene 1 multiple interactions ISO dihydrolipoamide inhibits the reaction [Doxorubicin results in increased phosphorylation of AKT1 protein] CTD PMID:15613977 NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318 		JBrowse link
dimercaprol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adpgk ADP-dependent glucokinase multiple interactions ISO Dimercaprol inhibits the reaction [4-aminophenylarsenoxide binds to ADPGK protein] CTD PMID:26598702 NCBI chr 9:59,198,855...59,223,483
Ensembl chr 9:59,198,841...59,231,335 		JBrowse link
G Alad aminolevulinate, delta-, dehydratase increases expression
decreases expression		 ISO Dimercaprol results in increased expression of ALAD protein
Dimercaprol results in decreased expression of ALAD protein		 CTD PMID:15755317 NCBI chr 4:62,422,762...62,438,300
Ensembl chr 4:62,427,406...62,438,155 		JBrowse link
G App amyloid beta precursor protein affects binding
multiple interactions		 ISO Dimercaprol binds to APP 5' UTR
[Dimercaprol binds to APP 5' UTR] which results in decreased expression of APP protein; [Dimercaprol binds to APP 5' UTR] which results in decreased secretion of APP protein modified form		 CTD PMID:15681799 NCBI chr16:84,751,236...84,972,187
Ensembl chr16:84,746,573...84,970,654 		JBrowse link
G Clcf1 cardiotrophin-like cytokine factor 1 multiple interactions EXP Dimercaprol inhibits the reaction [Mustard Gas results in increased expression of CLCF1 mRNA] CTD PMID:16377760 NCBI chr19:4,264,479...4,273,548
Ensembl chr19:4,264,292...4,273,544 		JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 multiple interactions EXP Dimercaprol inhibits the reaction [Mustard Gas results in increased expression of CXCL2 mRNA] CTD PMID:16377760 NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797 		JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 multiple interactions EXP Dimercaprol inhibits the reaction [Mustard Gas results in increased expression of CXCL1 mRNA] CTD PMID:16377760 NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459 		JBrowse link
G Fgfr3 fibroblast growth factor receptor 3 multiple interactions EXP Dimercaprol inhibits the reaction [Mustard Gas results in decreased expression of FGFR3 mRNA] CTD PMID:16377760 NCBI chr 5:33,879,068...33,894,412
Ensembl chr 5:33,879,018...33,894,412 		JBrowse link
G Gas1 growth arrest specific 1 multiple interactions EXP Dimercaprol inhibits the reaction [Mustard Gas results in decreased expression of GAS1 mRNA] CTD PMID:16377760 NCBI chr13:60,322,219...60,325,179
Ensembl chr13:60,322,219...60,325,179 		JBrowse link
G Gsta1 glutathione S-transferase, alpha 1 (Ya) increases expression
multiple interactions		 EXP Dimercaprol results in increased expression of GSTA1 mRNA
Tetradecanoylphorbol Acetate promotes the reaction [Dimercaprol results in increased expression of GSTA1 mRNA]		 CTD PMID:7568053 NCBI chr 9:78,137,951...78,149,965
Ensembl chr 9:78,137,938...78,149,966 		JBrowse link
G Hk2 hexokinase 2 multiple interactions ISO Dimercaprol inhibits the reaction [4-aminophenylarsenoxide binds to HK2 protein] CTD PMID:26598702 NCBI chr 6:82,702,004...82,751,437
Ensembl chr 6:82,702,006...82,751,435 		JBrowse link
G Hmox1 heme oxygenase 1 increases expression EXP Dimercaprol results in increased expression of HMOX1 mRNA CTD PMID:8612205 NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217 		JBrowse link
G Ikbkb inhibitor of kappaB kinase beta multiple interactions ISO Dimercaprol inhibits the reaction [arsenite inhibits the reaction [4',5'-bis(1,3,2-dithioarsolan-2-yl)fluorescein binds to IKBKB protein]] CTD PMID:10967126 NCBI chr 8:23,149,228...23,196,605
Ensembl chr 8:23,149,228...23,196,605 		JBrowse link
G Ins1 insulin I multiple interactions EXP Dimercaprol inhibits the reaction [oxophenylarsine inhibits the reaction [INS1 protein results in increased transport of Deoxyglucose]]; Dimercaprol inhibits the reaction [oxophenylarsine inhibits the reaction [INS1 protein results in increased uptake of Deoxyglucose]]; Dimercaprol inhibits the reaction [p-aminophenylarsine oxide inhibits the reaction [INS1 protein results in increased transport of Deoxyglucose]] CTD PMID:2202293 PMID:3882699 NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914 		JBrowse link
G Ins2 insulin II multiple interactions ISO Dimercaprol inhibits the reaction [oxophenylarsine inhibits the reaction [INS protein results in decreased phosphorylation of SLC2A4 protein]] CTD PMID:8048502 NCBI chr 7:142,232,393...142,233,463
Ensembl chr 7:142,232,393...142,297,118 		JBrowse link
G Itgb5 integrin beta 5 multiple interactions EXP Dimercaprol inhibits the reaction [Mustard Gas results in decreased expression of ITGB5 mRNA] CTD PMID:16377760 NCBI chr16:33,650,021...33,769,708
Ensembl chr16:33,650,035...33,769,708 		JBrowse link
G Keap1 kelch-like ECH-associated protein 1 affects binding EXP Dimercaprol binds to KEAP1 protein CTD PMID:19808700 NCBI chr 9:21,141,026...21,150,628
Ensembl chr 9:21,141,026...21,150,657 		JBrowse link
G Kif16b kinesin family member 16B multiple interactions EXP Dimercaprol inhibits the reaction [Mustard Gas results in decreased expression of KIF16B mRNA] CTD PMID:16377760 NCBI chr 2:142,459,399...142,743,535
Ensembl chr 2:142,459,394...142,743,451 		JBrowse link
G Kif1b kinesin family member 1B multiple interactions EXP Dimercaprol inhibits the reaction [Mustard Gas results in decreased expression of KIF1B mRNA] CTD PMID:16377760 NCBI chr 4:149,260,776...149,392,762
Ensembl chr 4:149,260,776...149,392,150 		JBrowse link
G Kifap3 kinesin-associated protein 3 multiple interactions EXP Dimercaprol inhibits the reaction [Mustard Gas results in decreased expression of KIFAP3 mRNA] CTD PMID:16377760 NCBI chr 1:163,589,711...163,744,676
Ensembl chr 1:163,607,152...163,744,678 		JBrowse link
G Krt17 keratin 17 multiple interactions EXP Dimercaprol inhibits the reaction [Mustard Gas results in increased expression of KRT17 mRNA] CTD PMID:16377760 NCBI chr11:100,147,041...100,151,855
Ensembl chr11:100,147,043...100,151,855 		JBrowse link
G Krt18 keratin 18 multiple interactions EXP Dimercaprol inhibits the reaction [Mustard Gas results in increased expression of KRT18 mRNA] CTD PMID:16377760 NCBI chr15:101,936,651...101,940,461
Ensembl chr15:101,936,615...101,940,462 		JBrowse link
G Mafk v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian) multiple interactions EXP Dimercaprol inhibits the reaction [Mustard Gas results in increased expression of MAFK mRNA] CTD PMID:16377760 NCBI chr 5:139,777,291...139,788,409
Ensembl chr 5:139,777,268...139,788,408 		JBrowse link
G Mtor mechanistic target of rapamycin kinase multiple interactions ISO Dimercaprol inhibits the reaction [oxophenylarsine inhibits the reaction [MTOR protein binds to RPTOR protein]] CTD PMID:16183647 NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140 		JBrowse link
G Mycl v-myc avian myelocytomatosis viral oncogene lung carcinoma derived multiple interactions EXP Dimercaprol inhibits the reaction [Mustard Gas results in decreased expression of MYCL mRNA] CTD PMID:16377760 NCBI chr 4:122,889,414...122,896,278
Ensembl chr 4:122,889,445...122,896,278 		JBrowse link
G Nos2 nitric oxide synthase 2, inducible multiple interactions EXP [Dimercaprol co-treated with Mercuric Chloride] inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein]; Dimercaprol inhibits the reaction [Lipopolysaccharides results in increased activity of NOS2 protein] CTD PMID:18838692 NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080 		JBrowse link
G Nqo1 NAD(P)H dehydrogenase, quinone 1 multiple interactions
increases activity		 EXP [Dimercaprol co-treated with Mercuric Chloride] results in increased activity of NQO1 protein
Dimercaprol results in increased activity of NQO1 protein		 CTD PMID:18838692 NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838 		JBrowse link
G Pgk1 phosphoglycerate kinase 1 multiple interactions ISO Dimercaprol inhibits the reaction [4-aminophenylarsenoxide binds to PGK1 protein] CTD PMID:26598702 NCBI chr  X:105,230,706...105,247,305
Ensembl chr  X:105,230,706...105,247,305 		JBrowse link
G Pml promyelocytic leukemia multiple interactions ISO Dimercaprol inhibits the reaction [4-aminophenylarsenoxide binds to PML protein] CTD PMID:26598702 NCBI chr 9:58,125,359...58,157,077
Ensembl chr 9:58,125,359...58,157,069 		JBrowse link
G Ppbp pro-platelet basic protein multiple interactions EXP Dimercaprol inhibits the reaction [Mustard Gas results in increased expression of PPBP mRNA] CTD PMID:16377760 NCBI chr 5:90,916,377...90,917,922
Ensembl chr 5:90,916,377...90,917,922 		JBrowse link
G Ppp2r5c protein phosphatase 2, regulatory subunit B', gamma multiple interactions EXP Dimercaprol inhibits the reaction [Mustard Gas results in decreased expression of PPP2R5C mRNA] CTD PMID:16377760 NCBI chr12:110,413,532...110,549,509
Ensembl chr12:110,413,554...110,549,496 		JBrowse link
G Ppp3ca protein phosphatase 3, catalytic subunit, alpha isoform multiple interactions EXP Dimercaprol inhibits the reaction [Mustard Gas results in decreased expression of PPP3CA mRNA] CTD PMID:16377760 NCBI chr 3:136,375,778...136,643,488
Ensembl chr 3:136,375,885...136,643,488 		JBrowse link
G Rbl2 RB transcriptional corepressor like 2 multiple interactions EXP Dimercaprol inhibits the reaction [Mustard Gas results in decreased expression of RBL2 mRNA] CTD PMID:16377760 NCBI chr 8:91,796,685...91,850,472
Ensembl chr 8:91,796,685...91,850,472 		JBrowse link
G Rps6kb1 ribosomal protein S6 kinase, polypeptide 1 multiple interactions ISO Dimercaprol inhibits the reaction [oxophenylarsine results in increased phosphorylation of RPS6KB1 protein] CTD PMID:16183647 NCBI chr11:86,389,695...86,435,711
Ensembl chr11:86,389,697...86,435,631 		JBrowse link
G Rptor regulatory associated protein of MTOR, complex 1 multiple interactions ISO Dimercaprol inhibits the reaction [oxophenylarsine inhibits the reaction [MTOR protein binds to RPTOR protein]] CTD PMID:16183647 NCBI chr11:119,493,731...119,790,417
Ensembl chr11:119,493,731...119,790,402 		JBrowse link
G Slc2a4 solute carrier family 2 (facilitated glucose transporter), member 4 multiple interactions ISO Dimercaprol inhibits the reaction [oxophenylarsine inhibits the reaction [INS protein results in decreased phosphorylation of SLC2A4 protein]] CTD PMID:8048502 NCBI chr11:69,833,112...69,839,040
Ensembl chr11:69,833,365...69,839,014 		JBrowse link
G Slfn1 schlafen 1 multiple interactions EXP Dimercaprol inhibits the reaction [Mustard Gas results in increased expression of SLFN1 mRNA] CTD PMID:16377760 NCBI chr11:83,007,646...83,013,496
Ensembl chr11:83,007,675...83,013,496 		JBrowse link
G Socs3 suppressor of cytokine signaling 3 multiple interactions EXP Dimercaprol inhibits the reaction [Mustard Gas results in increased expression of SOCS3 mRNA] CTD PMID:16377760 NCBI chr11:117,856,905...117,860,192
Ensembl chr11:117,856,905...117,860,873 		JBrowse link
G Stag1 STAG1 cohesin complex component multiple interactions EXP Dimercaprol inhibits the reaction [Mustard Gas results in decreased expression of STAG1 mRNA] CTD PMID:16377760 NCBI chr 9:100,479,762...100,840,597
Ensembl chr 9:100,479,851...100,841,428 		JBrowse link
G Txnrd1 thioredoxin reductase 1 multiple interactions ISO Dimercaprol inhibits the reaction [Mercuric Chloride results in decreased activity of TXNRD1 protein] CTD PMID:20810785 NCBI chr10:82,669,785...82,733,558
Ensembl chr10:82,669,785...82,733,546 		JBrowse link
G Tyr tyrosinase decreases activity ISO Dimercaprol results in decreased activity of TYR protein CTD PMID:16928136 NCBI chr 7:87,073,979...87,142,637
Ensembl chr 7:87,073,979...87,142,720 		JBrowse link
L-1,4-dithiothreitol term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Adora1 adenosine A1 receptor multiple interactions ISO [Dithiothreitol co-treated with Cadmium Chloride] inhibits the reaction [2-chloro-N(6)cyclopentyladenosine binds to ADORA1 protein]; [Dithiothreitol co-treated with Dithionitrobenzoic Acid] inhibits the reaction [2-chloro-N(6)cyclopentyladenosine binds to ADORA1 protein]; Dithiothreitol inhibits the reaction [Cadmium Chloride inhibits the reaction [2-chloro-N(6)cyclopentyladenosine binds to ADORA1 protein]]; Dithiothreitol inhibits the reaction [Dithionitrobenzoic Acid inhibits the reaction [2-chloro-N(6)cyclopentyladenosine binds to ADORA1 protein]] CTD PMID:10413299 NCBI chr 1:134,126,953...134,163,195
Ensembl chr 1:134,126,963...134,163,169 		JBrowse link
G Akt1 thymoma viral proto-oncogene 1 multiple interactions ISO Dithiothreitol inhibits the reaction [sodium arsenite results in increased phosphorylation of AKT1 protein] CTD PMID:12614848 NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318 		JBrowse link
G Alad aminolevulinate, delta-, dehydratase multiple interactions
increases activity		 EXP
ISO		 Dithiothreitol inhibits the reaction [Cadmium Chloride inhibits the reaction [diphenyldiselenide results in decreased activity of ALAD protein]]
Dithiothreitol results in increased activity of ALAD protein
[Zinc co-treated with Dithiothreitol] inhibits the reaction [Lead results in decreased activity of ALAD protein]; Cadmium affects the reaction [[Zinc co-treated with Dithiothreitol] inhibits the reaction [Lead results in decreased activity of ALAD protein]]; lead nitrate inhibits the reaction [Dithiothreitol results in increased activity of ALAD protein]; lead nitrate inhibits the reaction [zinc chloride promotes the reaction [Dithiothreitol results in increased activity of ALAD protein]]; triethyllead acetate inhibits the reaction [Dithiothreitol results in increased activity of ALAD protein]; triethyllead acetate inhibits the reaction [zinc chloride promotes the reaction [Dithiothreitol results in increased activity of ALAD protein]]; zinc chloride promotes the reaction [Dithiothreitol results in increased activity of ALAD protein]
cadmium acetate inhibits the reaction [Dithiothreitol results in increased activity of ALAD protein]; Dithiothreitol inhibits the reaction [2,2'-dithienyl diselenide results in decreased activity of ALAD protein]; Dithiothreitol inhibits the reaction [ebselen results in decreased activity of ALAD protein]; Zinc Acetate inhibits the reaction [Dithiothreitol results in increased activity of ALAD protein]		 CTD PMID:2061546 PMID:20472051 PMID:21360559 PMID:21910133 PMID:22180340 More... NCBI chr 4:62,422,762...62,438,300
Ensembl chr 4:62,427,406...62,438,155 		JBrowse link
G Apex1 apurinic/apyrimidinic endonuclease 1 multiple interactions ISO Dithiothreitol promotes the reaction [MAPK1 protein binds to APEX1 protein] CTD PMID:23370007 NCBI chr14:51,162,406...51,164,645
Ensembl chr14:51,162,425...51,164,596 		JBrowse link
G Ar androgen receptor multiple interactions ISO Dithiothreitol inhibits the reaction [cadmium sulfate inhibits the reaction [Androgens binds to AR protein]]; Dithiothreitol inhibits the reaction [Copper Sulfate inhibits the reaction [Androgens binds to AR protein]]; Dithiothreitol inhibits the reaction [zinc chloride inhibits the reaction [Androgens binds to AR protein]] CTD PMID:6323860 NCBI chr  X:97,192,363...97,366,824
Ensembl chr  X:97,192,375...97,366,821 		JBrowse link
G As3mt arsenite methyltransferase multiple interactions
increases reduction		 ISO Dithiothreitol promotes the reaction [AS3MT protein results in increased methylation of Arsenic]
Dithiothreitol results in increased reduction of AS3MT protein
Dithiothreitol promotes the reaction [AS3MT protein binds to and results in increased methylation of arsenite]		 CTD PMID:15025511 PMID:25349987 NCBI chr19:46,695,124...46,729,538
Ensembl chr19:46,695,897...46,729,538 		JBrowse link
G Atf3 activating transcription factor 3 increases expression ISO Dithiothreitol results in increased expression of ATF3 mRNA CTD PMID:17332266 NCBI chr 1:190,902,493...190,915,530
Ensembl chr 1:190,902,493...190,950,236 		JBrowse link
G Atf4 activating transcription factor 4 increases expression ISO
EXP		 Dithiothreitol results in increased expression of ATF4 mRNA CTD PMID:27226639 NCBI chr15:80,139,385...80,141,746
Ensembl chr15:80,139,385...80,141,742 		JBrowse link
G Atp7a ATPase, Cu++ transporting, alpha polypeptide multiple interactions ISO Dithiothreitol inhibits the reaction [Ethylmaleimide results in increased glutathionylation of ATP7A protein] CTD PMID:20566629 NCBI chr  X:105,070,830...105,171,766
Ensembl chr  X:105,070,882...105,168,532 		JBrowse link
G Bcl2 B cell leukemia/lymphoma 2 multiple interactions ISO Dithiothreitol inhibits the reaction [arsenic trioxide results in increased expression of BCL2 protein] CTD PMID:18022205 NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004 		JBrowse link
G Calu calumenin increases expression ISO Dithiothreitol results in increased expression of CALU protein CTD PMID:21692457 NCBI chr 6:29,348,105...29,376,674
Ensembl chr 6:29,348,068...29,377,109 		JBrowse link
G Casp1 caspase 1 multiple interactions EXP Dithiothreitol inhibits the reaction [Ziram results in decreased expression of and results in increased degradation of CASP1 protein] CTD PMID:25929180 NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290 		JBrowse link
G Casp3 caspase 3 multiple interactions ISO
EXP		 [Dithiothreitol co-treated with Peroxynitrous Acid] results in increased metabolism of CASP3 protein; Dithiothreitol inhibits the reaction [[NOS2 protein results in increased abundance of Nitric Oxide] inhibits the reaction [Lipopolysaccharides results in increased activity of CASP3 protein]]; Dithiothreitol inhibits the reaction [[NOS2 protein results in increased abundance of Nitric Oxide] which results in decreased activity of CASP3 protein]; Dithiothreitol inhibits the reaction [[NOS2 protein results in increased abundance of Nitric Oxide] which results in increased metabolism of CASP3 protein]; Dithiothreitol inhibits the reaction [arsenic trioxide results in increased activity of CASP3 protein]; Dithiothreitol inhibits the reaction [chelerythrine results in increased cleavage of CASP3 protein]; Dithiothreitol inhibits the reaction [Nitric Oxide results in decreased activity of CASP3 protein]; Dithiothreitol promotes the reaction [1-(N-(3-ammoniopropyl)-N-(n-propyl)amino)diazen-1-ium-1,2-diolate results in increased metabolism of CASP3 protein]
Dithiothreitol inhibits the reaction [1H-(1,2,3)oxadiazolo(4,4-a)quinoxalin-1-one inhibits the reaction [[Nitric Oxide Donors results in increased abundance of Nitric Oxide] which results in decreased activity of CASP3 protein]]
Dithiothreitol inhibits the reaction [2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester results in decreased activity of CASP3 protein]; Dithiothreitol inhibits the reaction [Nitric Oxide Donors inhibits the reaction [[TNF protein co-treated with Galactosamine] results in increased activity of CASP3 protein]]		 CTD PMID:9388267 PMID:9441900 PMID:9706149 PMID:9755104 PMID:10673743 More... NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724 		JBrowse link
G Casp8 caspase 8 multiple interactions EXP Dithiothreitol inhibits the reaction [2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester results in decreased activity of CASP8 protein] CTD PMID:11226294 NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662 		JBrowse link
G Casp9 caspase 9 multiple interactions EXP Dithiothreitol inhibits the reaction [2-methyl-3-(2-((4-nitrooxybutyloxy)carbonyl)vinyl)phenyl ursodeoxycholic acid ester results in decreased activity of CASP9 protein] CTD PMID:11226294 NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287 		JBrowse link
G Cat catalase multiple interactions ISO CAT protein inhibits the reaction [[9,10-phenanthrenequinone co-treated with Dithiothreitol] results in decreased activity of and results in increased oxidation of PTPN1 protein]; CAT protein inhibits the reaction [Dithiothreitol results in increased abundance of Hydrogen Peroxide] CTD PMID:7491977 PMID:32493877 NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505 		JBrowse link
G Cbr1 carbonyl reductase 1 multiple interactions ISO Dithiothreitol inhibits the reaction [S-Nitrosoglutathione inhibits the reaction [CBR1 protein results in increased reduction of S-Nitrosoglutathione]] CTD PMID:21256830 NCBI chr16:93,404,752...93,407,226
Ensembl chr16:93,402,741...93,407,393 		JBrowse link
G Ccnd1 cyclin D1 decreases expression ISO Dithiothreitol results in decreased expression of CCND1 mRNA CTD PMID:17332266 NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662 		JBrowse link
G Ccng2 cyclin G2 increases expression ISO Dithiothreitol results in increased expression of CCNG2 mRNA CTD PMID:17332266 NCBI chr 5:93,415,432...93,424,090
Ensembl chr 5:93,415,116...93,424,090 		JBrowse link
G Cdh1 cadherin 1 multiple interactions ISO Dithiothreitol inhibits the reaction [4-cresol sulfate results in decreased expression of CDH1 protein] CTD PMID:31873818 NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878 		JBrowse link
G Cftr cystic fibrosis transmembrane conductance regulator multiple interactions ISO Dithiothreitol inhibits the reaction [Glutathione results in decreased activity of CFTR protein] CTD PMID:15657297 NCBI chr 6:18,170,686...18,322,769
Ensembl chr 6:18,170,686...18,322,767 		JBrowse link
G Chuk conserved helix-loop-helix ubiquitous kinase multiple interactions EXP Dithiothreitol inhibits the reaction [Melitten binds to and results in decreased activity of CHUK protein]; Dithiothreitol inhibits the reaction [Melitten inhibits the reaction [Nitroprusside results in increased activity of CHUK protein]] CTD PMID:17067557 NCBI chr19:44,061,773...44,095,940
Ensembl chr19:44,061,774...44,095,919 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions ISO Dithiothreitol inhibits the reaction [1-nitropyrene results in increased degradation of CYP1A1 protein] CTD PMID:16280210 NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107 		JBrowse link
G Cyp7a1 cytochrome P450, family 7, subfamily a, polypeptide 1 increases activity ISO Dithiothreitol results in increased activity of CYP7A1 protein CTD PMID:1175606 NCBI chr 4:6,265,612...6,275,632
Ensembl chr 4:6,265,612...6,275,633 		JBrowse link
G Ddit3 DNA-damage inducible transcript 3 increases expression
multiple interactions		 ISO
EXP		 Dithiothreitol results in increased expression of DDIT3 mRNA
indolo(3,2-b)carbazole inhibits the reaction [Dithiothreitol results in increased expression of DDIT3 mRNA]		 CTD PMID:17332266 PMID:23123503 PMID:27226639 NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157
Ensembl chr10:127,126,643...127,132,157 		JBrowse link
G Dnajb9 DnaJ heat shock protein family (Hsp40) member B9 increases expression ISO Dithiothreitol results in increased expression of DNAJB9 mRNA CTD PMID:23123503 NCBI chr12:44,252,680...44,256,851
Ensembl chr12:44,252,342...44,257,109 		JBrowse link
G Eif2a eukaryotic translation initiation factor 2A multiple interactions ISO Dithiothreitol results in increased phosphorylation of and results in increased activity of EIF2A protein CTD PMID:12486162 NCBI chr 3:58,433,252...58,464,922
Ensembl chr 3:58,433,242...58,464,922 		JBrowse link
G Eif2ak3 eukaryotic translation initiation factor 2 alpha kinase 3 multiple interactions
increases phosphorylation		 ISO Dithiothreitol results in increased phosphorylation of and results in increased activity of EIF2AK3 protein
Dithiothreitol results in increased phosphorylation of EIF2AK3 protein		 CTD PMID:12486162 PMID:25321315 NCBI chr 6:70,821,468...70,882,225
Ensembl chr 6:70,821,499...70,882,229 		JBrowse link
G Eif2s1 eukaryotic translation initiation factor 2, subunit 1 alpha increases phosphorylation
multiple interactions		 EXP
ISO		 Dithiothreitol results in increased phosphorylation of EIF2S1 protein
EIF2S1 protein mutant form inhibits the reaction [Dithiothreitol results in increased phosphorylation of EIF2S1 protein]		 CTD PMID:30385349 PMID:34244458 NCBI chr12:78,908,846...78,933,784
Ensembl chr12:78,908,593...78,933,784 		JBrowse link
G Ern1 endoplasmic reticulum to nucleus signalling 1 multiple interactions
increases expression		 ISO Dithiothreitol results in increased phosphorylation of and results in increased activity of ERN1 protein
Dithiothreitol results in increased expression of ERN1 protein		 CTD PMID:12486162 PMID:25321315 NCBI chr11:106,285,474...106,378,701
Ensembl chr11:106,285,476...106,378,678 		JBrowse link
G Esr1 estrogen receptor 1 (alpha) multiple interactions ISO fulvestrant inhibits the reaction [Dithiothreitol results in increased activity of ESR1 protein]; Tamoxifen inhibits the reaction [Dithiothreitol results in increased activity of ESR1 protein] CTD PMID:22403704 NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614 		JBrowse link
G F3 coagulation factor III increases activity ISO Dithiothreitol results in increased activity of F3 protein CTD PMID:17726162 NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697 		JBrowse link
G Fgf21 fibroblast growth factor 21 increases expression
increases secretion
multiple interactions		 ISO
EXP		 Dithiothreitol results in increased expression of FGF21 mRNA
Dithiothreitol results in increased secretion of FGF21 protein
indolo(3,2-b)carbazole inhibits the reaction [Dithiothreitol results in increased expression of FGF21 mRNA]		 CTD PMID:23123503 PMID:27226639 NCBI chr 7:45,263,314...45,264,914
Ensembl chr 7:45,263,310...45,264,914 		JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible 45 alpha increases expression ISO Dithiothreitol results in increased expression of GADD45A mRNA CTD PMID:17332266 NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441 		JBrowse link
G Hif1a hypoxia inducible factor 1, alpha subunit multiple interactions ISO Dithiothreitol inhibits the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of HIF1A protein]; Dithiothreitol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of HIF1A protein alternative form] CTD PMID:14695184 PMID:17658243 NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304 		JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions ISO
EXP		 Dithiothreitol inhibits the reaction [diallyl trisulfide results in increased expression of HMOX1 protein]
Dithiothreitol inhibits the reaction [farrerol results in increased expression of HMOX1 protein]; Dithiothreitol inhibits the reaction [hydroquinone results in increased expression of HMOX1 protein]		 CTD PMID:23290930 PMID:24489685 PMID:26111761 NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217 		JBrowse link
G Hsd11b2 hydroxysteroid 11-beta dehydrogenase 2 multiple interactions
increases activity		 ISO Dithiothreitol inhibits the reaction [perfluorodecanoic acid results in decreased activity of HSD11B2 protein]; Dithiothreitol inhibits the reaction [Thiram results in decreased activity of HSD11B2 protein]; Dithiothreitol inhibits the reaction [Ziram results in decreased activity of HSD11B2 protein]; perfluorodecanoic acid inhibits the reaction [Dithiothreitol results in increased activity of HSD11B2 protein] CTD PMID:12901862 PMID:26859423 PMID:36878351 NCBI chr 8:106,245,378...106,250,620
Ensembl chr 8:106,245,387...106,250,620 		JBrowse link
G Hsd3b1 hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 increases activity
multiple interactions		 ISO Dithiothreitol results in increased activity of HSD3B1 protein
Dithiothreitol inhibits the reaction [Thiram results in decreased activity of HSD3B1 protein]		 CTD PMID:36965607 NCBI chr 3:98,749,672...98,767,110
Ensembl chr 3:98,759,510...98,767,110 		JBrowse link
G Hsp90b1 heat shock protein 90, beta (Grp94), member 1 multiple interactions ISO Dactinomycin inhibits the reaction [Dithiothreitol results in increased expression of HSP90B1 mRNA]; Dithiothreitol results in increased expression of and affects the localization of HSP90B1 mRNA CTD PMID:34244458 NCBI chr10:86,526,705...86,541,308
Ensembl chr10:86,526,073...86,541,373 		JBrowse link
G Hspa5 heat shock protein 5 increases expression ISO Dithiothreitol metabolite results in increased expression of HSPA5 protein; Dithiothreitol results in increased expression of HSPA5 mRNA; Dithiothreitol results in increased expression of HSPA5 protein CTD PMID:15710169 PMID:17332266 PMID:17416481 PMID:21692457 PMID:23123503 More... NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559 		JBrowse link
G Ikbkb inhibitor of kappaB kinase beta multiple interactions ISO
EXP		 Dithiothreitol inhibits the reaction [3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of IKBKB protein]]
Dithiothreitol inhibits the reaction [Melitten binds to and results in decreased activity of IKBKB protein]; Dithiothreitol inhibits the reaction [Melitten inhibits the reaction [Nitroprusside results in increased activity of IKBKB protein]]		 CTD PMID:17067557 PMID:20584749 NCBI chr 8:23,149,228...23,196,605
Ensembl chr 8:23,149,228...23,196,605 		JBrowse link
G Il1a interleukin 1 alpha multiple interactions ISO [Dithiothreitol co-treated with IL1A protein] results in increased expression of SOD2 protein; Dithiothreitol promotes the reaction [IL1A protein results in increased expression of SOD2 mRNA] CTD PMID:7476933 NCBI chr 2:129,141,530...129,151,892
Ensembl chr 2:129,141,530...129,151,892 		JBrowse link
G Il1b interleukin 1 beta multiple interactions ISO Dithiothreitol inhibits the reaction [nitroaspirin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IL1B protein] results in increased activity of [NFKB1 protein binds to NFKB1 protein]]] CTD PMID:14762100 NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059 		JBrowse link
G Il5 interleukin 5 multiple interactions ISO Dithiothreitol inhibits the reaction [Thiazoles analog inhibits the reaction [IL5 protein binds to IL5RA protein]] CTD PMID:7957178 NCBI chr11:53,611,621...53,615,930
Ensembl chr11:53,611,621...53,615,933 		JBrowse link
G Il5ra interleukin 5 receptor, alpha multiple interactions ISO Dithiothreitol inhibits the reaction [Thiazoles analog inhibits the reaction [IL5 protein binds to IL5RA protein]] CTD PMID:7957178 NCBI chr 6:106,687,336...106,725,998
Ensembl chr 6:106,687,318...106,725,998 		JBrowse link
G Inhbe inhibin beta-E increases expression ISO Dithiothreitol results in increased expression of INHBE mRNA CTD PMID:22935518 NCBI chr10:127,185,271...127,187,717
Ensembl chr10:127,184,726...127,190,280 		JBrowse link
G Ins1 insulin I multiple interactions
decreases activity		 ISO Dithiothreitol affects the reaction [oxophenylarsine results in decreased activity of INS1 protein]; Dithiothreitol inhibits the reaction [INS1 protein results in increased uptake of Glucose]
Dithiothreitol results in decreased activity of INS1 protein		 CTD PMID:2262933 NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914 		JBrowse link
G Jun jun proto-oncogene multiple interactions EXP Dithiothreitol inhibits the reaction [sodium arsenite results in increased phosphorylation of JUN protein] CTD PMID:11035063 NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459 		JBrowse link
G Kif5a kinesin family member 5A multiple interactions ISO Dithiothreitol inhibits the reaction [cupric chloride results in decreased activity of KIF5A protein] CTD PMID:24853401 NCBI chr10:127,061,564...127,102,217
Ensembl chr10:127,061,565...127,099,217 		JBrowse link
G Map3k5 mitogen-activated protein kinase kinase kinase 5 multiple interactions ISO Dithiothreitol inhibits the reaction [NCX 4040 inhibits the reaction [TXN1 protein binds to MAP3K5 protein]] CTD PMID:18922898 NCBI chr10:19,809,847...20,018,496
Ensembl chr10:19,810,218...20,018,499 		JBrowse link
G Mapk1 mitogen-activated protein kinase 1 multiple interactions ISO
EXP		 Dithiothreitol inhibits the reaction [Hydrogen Peroxide results in decreased activity of MAPK1 protein]; Dithiothreitol promotes the reaction [MAPK1 protein binds to APEX1 protein]
Dithiothreitol inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK1 protein]		 CTD PMID:11035063 PMID:23370007 NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317 		JBrowse link
G Mapk3 mitogen-activated protein kinase 3 multiple interactions EXP Dithiothreitol inhibits the reaction [sodium arsenite results in increased phosphorylation of MAPK3 protein] CTD PMID:11035063 NCBI chr 7:126,358,798...126,364,988
Ensembl chr 7:126,358,773...126,364,991 		JBrowse link
G Mapk8 mitogen-activated protein kinase 8 multiple interactions ISO Dithiothreitol inhibits the reaction [Sodium Selenite results in decreased activity of MAPK8 protein] CTD PMID:10644709 NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115 		JBrowse link
G Mgst1 microsomal glutathione S-transferase 1 multiple interactions ISO Dithiothreitol inhibits the reaction [[1-hydroxy-2-oxo-3-(3-aminopropyl)-3-isopropyl-1-triazene results in increased abundance of Nitric Oxide] which results in increased activity of MGST1 protein]; Dithiothreitol inhibits the reaction [[Peroxynitrous Acid co-treated with Glutathione] results in increased activity of MGST1 protein]; Dithiothreitol inhibits the reaction [[S-nitrosocysteine results in increased abundance of Nitric Oxide] which results in increased activity of MGST1 protein]; Dithiothreitol inhibits the reaction [[S-Nitrosoglutathione results in increased abundance of Nitric Oxide] which results in increased activity of MGST1 protein]; Dithiothreitol inhibits the reaction [Gallic Acid results in increased activity of MGST1 protein] CTD PMID:16125204 PMID:16386761 NCBI chr 6:138,117,525...138,133,753
Ensembl chr 6:138,117,314...138,133,753 		JBrowse link
G Msrb2 methionine sulfoxide reductase B2 increases reduction ISO Dithiothreitol results in increased reduction of MSRB2 protein CTD PMID:16735467 NCBI chr 2:19,376,247...19,399,787
Ensembl chr 2:19,376,251...19,399,787 		JBrowse link
G Msrb3 methionine sulfoxide reductase B3 increases reduction ISO Dithiothreitol results in increased reduction of MSRB3 protein CTD PMID:16735467 NCBI chr10:120,617,005...120,735,132
Ensembl chr10:120,617,001...120,735,006 		JBrowse link
G Mt1 metallothionein 1 multiple interactions EXP Dithiothreitol results in increased reduction of [MT1 protein binds to Zinc] CTD PMID:22001350 NCBI chr 8:94,905,214...94,906,955
Ensembl chr 8:94,905,710...94,906,955 		JBrowse link
G Mylk myosin, light polypeptide kinase multiple interactions ISO Dithiothreitol inhibits the reaction [4-cresol sulfate results in increased phosphorylation of MYLK protein] CTD PMID:31873818 NCBI chr16:34,565,569...34,822,806
Ensembl chr16:34,565,580...34,822,790 		JBrowse link
G Nat1 N-acetyl transferase 1 multiple interactions
increases activity		 ISO Dithiothreitol inhibits the reaction [Hydrogen Peroxide results in decreased activity of NAT1 protein]
Dithiothreitol results in increased activity of NAT1 protein		 CTD PMID:22835378 NCBI chr 8:67,943,620...67,945,183
Ensembl chr 8:67,933,573...67,944,756 		JBrowse link
G Nfe2l2 nuclear factor, erythroid derived 2, like 2 multiple interactions ISO Dithiothreitol inhibits the reaction [diallyl trisulfide affects the localization of NFE2L2 protein] CTD PMID:24489685 NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985 		JBrowse link
G Nfkb1 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 multiple interactions EXP
ISO		 [Pertussis Toxin co-treated with Dithiothreitol] inhibits the reaction [Aspirin inhibits the reaction [Lipopolysaccharides promotes the reaction [[RELA protein co-treated with NFKB1 protein] binds to TNF promoter]]]
Dithiothreitol inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased activity of NFKB1 protein]]; Dithiothreitol inhibits the reaction [nitroaspirin inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IL1B protein] results in increased activity of [NFKB1 protein binds to NFKB1 protein]]]		 CTD PMID:9281604 PMID:14762100 PMID:16219905 NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308 		JBrowse link
G Nfkbia nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha multiple interactions EXP
ISO		 Dithiothreitol inhibits the reaction [Melitten inhibits the reaction [Nitroprusside results in increased phosphorylation of NFKBIA protein]]
Dithiothreitol inhibits the reaction [ent-1,3,6,11-tetrahydroxykaur-16-ene-15-one 3,11-diacetate results in increased activity of NFKBIA protein]		 CTD PMID:17067557 PMID:19509257 NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432 		JBrowse link
G Nos2 nitric oxide synthase 2, inducible multiple interactions ISO
EXP		 Dithiothreitol inhibits the reaction [[NOS2 protein results in increased abundance of Nitric Oxide] inhibits the reaction [Lipopolysaccharides results in increased activity of CASP3 protein]]; Dithiothreitol inhibits the reaction [[NOS2 protein results in increased abundance of Nitric Oxide] which results in decreased activity of CASP3 protein]; Dithiothreitol inhibits the reaction [[NOS2 protein results in increased abundance of Nitric Oxide] which results in increased metabolism of CASP3 protein]
Dithiothreitol inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA]
Dithiothreitol inhibits the reaction [Carbaryl inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein]]		 CTD PMID:7532384 PMID:9706149 PMID:9755104 PMID:15907790 NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080 		JBrowse link
G Nqo1 NAD(P)H dehydrogenase, quinone 1 multiple interactions ISO Dithiothreitol inhibits the reaction [diallyl trisulfide results in increased expression of NQO1 protein] CTD PMID:24489685 NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 multiple interactions ISO Dithiothreitol inhibits the reaction [arsenite inhibits the reaction [Dexamethasone binds to NR3C1 protein]]; Dithiothreitol inhibits the reaction [Thiram inhibits the reaction [Dexamethasone binds to NR3C1 protein]]
Dithiothreitol inhibits the reaction [Mercuric Chloride inhibits the reaction [Triamcinolone Acetonide binds to NR3C1 protein]]; Dithiothreitol inhibits the reaction [methyl methanethiosulfonate inhibits the reaction [dexamethasone 21-methanesulfonate binds to NR3C1 protein]]; Dithiothreitol inhibits the reaction [methyl methanethiosulfonate inhibits the reaction [Dexamethasone binds to NR3C1 protein]]; Dithiothreitol inhibits the reaction [sodium arsenite inhibits the reaction [dexamethasone 21-methanesulfonate binds to NR3C1 protein]]; Dithiothreitol inhibits the reaction [sodium arsenite inhibits the reaction [Dexamethasone binds to NR3C1 protein]]		 CTD PMID:2226332 PMID:2298732 PMID:15250541 PMID:16857225 NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474 		JBrowse link
G Nrgn neurogranin multiple interactions ISO Dithiothreitol inhibits the reaction [chloramine-T affects the phosphorylation of NRGN protein] CTD PMID:21241739 NCBI chr 9:37,455,789...37,464,041
Ensembl chr 9:37,455,788...37,464,200 		JBrowse link
G Nudt9 nudix hydrolase 9 multiple interactions ISO Dithiothreitol inhibits the reaction [Hydrogen Peroxide inhibits the reaction [Magnesium Chloride results in increased activity of NUDT9 protein]]; Dithiothreitol inhibits the reaction [Hydrogen Peroxide inhibits the reaction [Magnesium results in increased activity of NUDT9 protein]]; Dithiothreitol inhibits the reaction [Hydrogen Peroxide promotes the reaction [manganese chloride results in increased activity of NUDT9 protein]]; Dithiothreitol inhibits the reaction [Hydrogen Peroxide promotes the reaction [Manganese results in increased activity of NUDT9 protein]] CTD PMID:16860484 NCBI chr 5:104,193,407...104,213,244
Ensembl chr 5:104,194,172...104,213,245 		JBrowse link
G Ogdh oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) multiple interactions ISO Dithiothreitol inhibits the reaction [Hydrogen Peroxide results in decreased activity of OGDH protein]; Dithiothreitol inhibits the reaction [tert-Butylhydroperoxide results in decreased activity of OGDH protein] CTD PMID:12680778 NCBI chr11:6,241,597...6,309,094
Ensembl chr11:6,241,633...6,306,642 		JBrowse link
G P2rx2 purinergic receptor P2X, ligand-gated ion channel, 2 multiple interactions ISO Dithiothreitol inhibits the reaction [Hydrogen Peroxide promotes the reaction [Adenosine Triphosphate results in increased activity of P2RX2 protein]] CTD PMID:19793987 NCBI chr 5:110,487,678...110,491,186
Ensembl chr 5:110,487,678...110,491,078 		JBrowse link
G Papss1 3'-phosphoadenosine 5'-phosphosulfate synthase 1 increases activity ISO Dithiothreitol results in increased activity of PAPSS1 protein CTD PMID:15065880 NCBI chr 3:131,270,626...131,349,432
Ensembl chr 3:131,270,529...131,349,432 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase family, member 1 multiple interactions EXP
ISO		 Dithiothreitol inhibits the reaction [sodium arsenite results in increased cleavage of PARP1 protein]
Dithiothreitol inhibits the reaction [arsenic trioxide results in increased cleavage of PARP1 protein]; Dithiothreitol inhibits the reaction [withaferin A results in increased cleavage of PARP1 protein]		 CTD PMID:11035063 PMID:18022205 PMID:20438634 NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819 		JBrowse link
G Pdcd6ip programmed cell death 6 interacting protein increases expression ISO Dithiothreitol results in increased expression of PDCD6IP protein CTD PMID:21692457 NCBI chr 9:113,480,812...113,537,457
Ensembl chr 9:113,480,812...113,537,327 		JBrowse link
G Plod3 procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 increases expression ISO Dithiothreitol results in increased expression of PLOD3 protein CTD PMID:21692457 NCBI chr 5:137,015,873...137,025,500
Ensembl chr 5:137,015,873...137,025,502 		JBrowse link
G Ppargc1a peroxisome proliferative activated receptor, gamma, coactivator 1 alpha increases expression ISO Dithiothreitol results in increased expression of PPARGC1A mRNA CTD PMID:23056435 NCBI chr 5:51,611,591...52,273,316
Ensembl chr 5:51,611,592...51,725,068 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions ISO Dithiothreitol inhibits the reaction [3,3',4,5'-tetrahydroxystilbene inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PTGS2 protein]] CTD PMID:20584749 NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978 		JBrowse link
G Ptk2 PTK2 protein tyrosine kinase 2 multiple interactions ISO Dithiothreitol affects the reaction [4-cresol sulfate affects the localization of PTK2 protein] CTD PMID:31873818 NCBI chr15:73,076,951...73,297,192
Ensembl chr15:73,076,951...73,295,129 		JBrowse link
G Ptpn1 protein tyrosine phosphatase, non-receptor type 1 multiple interactions ISO Dithiothreitol inhibits the reaction [Hydrogen Peroxide results in increased glutathionylation of PTPN1 protein]
[9,10-phenanthrenequinone co-treated with Dithiothreitol] results in decreased activity of and results in increased oxidation of PTPN1 protein; CAT protein inhibits the reaction [[9,10-phenanthrenequinone co-treated with Dithiothreitol] results in decreased activity of and results in increased oxidation of PTPN1 protein]		 CTD PMID:16781456 PMID:32493877 NCBI chr 2:167,772,670...167,821,305
Ensembl chr 2:167,773,977...167,821,305 		JBrowse link
G Rcn2 reticulocalbin 2 increases expression ISO Dithiothreitol results in increased expression of RCN2 protein CTD PMID:21692457 NCBI chr 9:55,949,129...55,966,367
Ensembl chr 9:55,949,129...55,969,166 		JBrowse link
G Rela v-rel reticuloendotheliosis viral oncogene homolog A (avian) multiple interactions
increases activity		 EXP
ISO		 [Pertussis Toxin co-treated with Dithiothreitol] inhibits the reaction [Aspirin inhibits the reaction [Lipopolysaccharides promotes the reaction [[RELA protein co-treated with NFKB1 protein] binds to TNF promoter]]]
Dithiothreitol results in increased activity of RELA protein
Dithiothreitol inhibits the reaction [cinnamaldehyde results in increased glutathionylation of RELA protein]; Dithiothreitol inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased activity of RELA protein]]		 CTD PMID:7491977 PMID:9281604 PMID:16219905 PMID:20351055 NCBI chr19:5,686,993...5,698,162
Ensembl chr19:5,687,511...5,698,158 		JBrowse link
G S100a2 S100 calcium binding protein A2 multiple interactions ISO Dithiothreitol inhibits the reaction [Copper promotes the reaction [S100A2 protein binds to S100A2 protein]]; Dithiothreitol inhibits the reaction [S100A2 protein binds to S100A2 protein] CTD PMID:21924240 NCBI chr 3:90,497,554...90,498,815
Ensembl chr 3:90,467,670...90,498,838 		JBrowse link
G S100a4 S100 calcium binding protein A4 multiple interactions ISO Dithiothreitol inhibits the reaction [Copper promotes the reaction [S100A4 protein binds to S100A4 protein]] CTD PMID:21924240 NCBI chr 3:90,511,077...90,513,349
Ensembl chr 3:90,511,078...90,513,352 		JBrowse link
G Slc16a1 solute carrier family 16 (monocarboxylic acid transporters), member 1 multiple interactions ISO Dithiothreitol inhibits the reaction [SLC16A1 protein results in increased uptake of Lactic Acid] CTD PMID:15804185 NCBI chr 3:104,545,980...104,565,778
Ensembl chr 3:104,545,984...104,565,778 		JBrowse link
G Snai1 snail family zinc finger 1 multiple interactions ISO Dithiothreitol inhibits the reaction [4-cresol sulfate results in increased expression of SNAI1 protein] CTD PMID:31873818 NCBI chr 2:167,380,115...167,384,734
Ensembl chr 2:167,380,115...167,384,734 		JBrowse link
G Snai2 snail family zinc finger 2 multiple interactions ISO Dithiothreitol inhibits the reaction [4-cresol sulfate results in increased expression of SNAI2 protein] CTD PMID:31873818 NCBI chr16:14,523,716...14,527,259
Ensembl chr16:14,523,716...14,527,249 		JBrowse link
G Sod1 superoxide dismutase 1, soluble affects folding
multiple interactions		 ISO
EXP		 Dithiothreitol affects the folding of SOD1 protein
Dithiothreitol inhibits the reaction [SOD1 protein affects the reaction [Asbestos, Serpentine results in increased oxidation of STAT6 protein]]
[Dithiothreitol results in increased reduction of SOD1 protein] promotes the reaction [Hydrogen Peroxide results in increased oxidation of SOD1 protein modified form]; [Dithiothreitol results in increased reduction of SOD1 protein] which results in increased susceptibility to Hydrogen Peroxide; Dithiothreitol results in increased reduction of and results in decreased activity of SOD1 protein; Zinc promotes the reaction [Dithiothreitol affects the folding of SOD1 protein]		 CTD PMID:22867017 PMID:26694608 PMID:26699812 NCBI chr16:90,017,650...90,023,221
Ensembl chr16:90,017,642...90,023,217 		JBrowse link
G Sod2 superoxide dismutase 2, mitochondrial multiple interactions
increases expression		 ISO [Dithiothreitol co-treated with IL1A protein] results in increased expression of SOD2 protein; [Dithiothreitol co-treated with TNF protein] results in increased expression of SOD2 protein; Dithiothreitol promotes the reaction [IL1A protein results in increased expression of SOD2 mRNA]; Dithiothreitol promotes the reaction [TNF protein results in increased expression of SOD2 mRNA]; TNF protein promotes the reaction [Dithiothreitol results in increased expression of SOD2 mRNA] CTD PMID:7476933 NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950 		JBrowse link
G Stat6 signal transducer and activator of transcription 6 multiple interactions EXP Dithiothreitol inhibits the reaction [Asbestos, Serpentine promotes the reaction [polyethylene glycol-superoxide dismutase results in increased oxidation of STAT6 protein]]; Dithiothreitol inhibits the reaction [Asbestos, Serpentine promotes the reaction [Polyethylene Glycols results in increased oxidation of STAT6 protein]]; Dithiothreitol inhibits the reaction [Asbestos, Serpentine results in increased oxidation of STAT6 protein]; Dithiothreitol inhibits the reaction [polyethylene glycol-superoxide dismutase results in increased oxidation of STAT6 protein]; Dithiothreitol inhibits the reaction [Polyethylene Glycols results in increased oxidation of STAT6 protein]; Dithiothreitol inhibits the reaction [SOD1 protein affects the reaction [Asbestos, Serpentine results in increased oxidation of STAT6 protein]] CTD PMID:26699812 NCBI chr10:127,478,855...127,496,856
Ensembl chr10:127,478,855...127,496,826 		JBrowse link
G Thy1 thymus cell antigen 1, theta multiple interactions EXP Dithiothreitol inhibits the reaction [sodium arsenite promotes the reaction [THY1 protein binds to THY1 protein]] CTD PMID:11035063 NCBI chr 9:43,954,681...43,959,876
Ensembl chr 9:43,954,681...43,959,876 		JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions EXP Dithiothreitol inhibits the reaction [4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides promotes the reaction [TLR4 protein binds to TLR4 protein]]]; Dithiothreitol inhibits the reaction [4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased activity of TLR4 protein]] CTD PMID:19627980 NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521 		JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO
EXP		 [Dithiothreitol co-treated with TNF protein] results in increased expression of SOD2 protein; Dithiothreitol inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased activity of NFKB1 protein]]; Dithiothreitol inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased activity of RELA protein]]; Dithiothreitol promotes the reaction [TNF protein results in increased expression of SOD2 mRNA]; TNF protein promotes the reaction [Dithiothreitol results in increased expression of SOD2 mRNA]
Dithiothreitol inhibits the reaction [TNF protein results in increased expression of NOS2 mRNA]
[Pertussis Toxin co-treated with Dithiothreitol] inhibits the reaction [Aspirin inhibits the reaction [Lipopolysaccharides promotes the reaction [[RELA protein co-treated with NFKB1 protein] binds to TNF promoter]]]; [Pertussis Toxin co-treated with Dithiothreitol] inhibits the reaction [Aspirin inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]; Dithiothreitol inhibits the reaction [Nitric Oxide Donors inhibits the reaction [[TNF protein co-treated with Galactosamine] results in increased activity of CASP3 protein]]		 CTD PMID:7476933 PMID:7532384 PMID:9281604 PMID:9388267 PMID:16219905 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983 		JBrowse link
G Top2a topoisomerase (DNA) II alpha multiple interactions ISO Dithiothreitol inhibits the reaction [Cannabidiol metabolite inhibits the reaction [TOP2A protein results in increased hydrolysis of Adenosine Triphosphate]] CTD PMID:29272108 NCBI chr11:98,883,773...98,915,037
Ensembl chr11:98,883,769...98,915,015 		JBrowse link
G Trp53 transformation related protein 53 multiple interactions ISO Dithiothreitol inhibits the reaction [[Cadmium Chloride results in decreased activity of TP53 protein] inhibits the reaction [TP53 protein binds to TP53 gene]]; Dithiothreitol inhibits the reaction [Glutathione Disulfide results in increased glutathionylation of TP53 protein]; Dithiothreitol inhibits the reaction [Glutathione results in increased glutathionylation of TP53 protein] CTD PMID:17555331 PMID:25446071 NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699 		JBrowse link
G Trpa1 transient receptor potential cation channel, subfamily A, member 1 multiple interactions ISO Dithiothreitol inhibits the reaction [[hydroquinone results in increased activity of TRPA1 protein] which results in increased import of Calcium]; Dithiothreitol inhibits the reaction [hydroquinone results in increased activity of TRPA1 protein] CTD PMID:28790335 NCBI chr 1:14,942,868...14,989,086
Ensembl chr 1:14,942,872...14,989,086 		JBrowse link
G Trpc5 transient receptor potential cation channel, subfamily C, member 5 multiple interactions
increases activity		 ISO Dithiothreitol inhibits the reaction [Mercuric Chloride results in increased activity of TRPC5 protein]
Dithiothreitol results in increased activity of TRPC5 protein		 CTD PMID:21984481 NCBI chr  X:143,160,323...143,471,176
Ensembl chr  X:143,164,667...143,471,176 		JBrowse link
G Trpm4 transient receptor potential cation channel, subfamily M, member 4 multiple interactions ISO Dithiothreitol inhibits the reaction [Hydrogen Peroxide results in increased expression of TRPM4 protein] CTD PMID:28214884 NCBI chr 7:44,952,579...44,983,495
Ensembl chr 7:44,952,056...44,983,204 		JBrowse link
G Txn1 thioredoxin 1 multiple interactions ISO Dithiothreitol inhibits the reaction [NCX 4040 inhibits the reaction [TXN1 protein binds to MAP3K5 protein]] CTD PMID:18922898 NCBI chr 4:57,943,373...57,956,411
Ensembl chr 4:57,943,373...57,956,411 		JBrowse link
G Vim vimentin multiple interactions ISO Dithiothreitol inhibits the reaction [4-cresol sulfate results in increased expression of VIM protein] CTD PMID:31873818 NCBI chr 2:13,579,122...13,587,637
Ensembl chr 2:13,578,738...13,587,637 		JBrowse link
G Xbp1 X-box binding protein 1 increases splicing ISO Dithiothreitol results in increased splicing of XBP1 mRNA CTD PMID:23123503 PMID:34244458 NCBI chr11:5,470,641...5,475,993
Ensembl chr11:5,470,659...5,475,893 		JBrowse link
G Xdh xanthine dehydrogenase multiple interactions ISO Dithiothreitol inhibits the reaction [chloramine affects the activity of XDH protein] CTD PMID:19527742 NCBI chr17:74,190,890...74,257,191
Ensembl chr17:74,190,890...74,257,191 		JBrowse link
succimer term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Aasdhppt aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of AASDHPPT mRNA CTD PMID:26378955 NCBI chr 9:4,294,793...4,309,656
Ensembl chr 9:4,294,793...4,309,471 		JBrowse link
G Abcb1a ATP-binding cassette, sub-family B member 1A multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ABCB1 mRNA CTD PMID:26378955 NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575 		JBrowse link
G Abcc2 ATP-binding cassette, sub-family member 2 multiple interactions
increases transport		 ISO ABCC2 protein affects the reaction [Succimer binds to and results in increased secretion of [Mercuric Chloride binds to Cysteine]]; ABCC2 protein binds to and results in increased secretion of [Succimer binds to [Mercuric Chloride binds to Cysteine]]
ABCC2 protein results in increased transport of Succimer metabolite
ABCC2 results in increased transport of Succimer metabolite		 CTD PMID:17940195 PMID:18511429 PMID:19063911 NCBI chr19:43,770,747...43,826,771
Ensembl chr19:43,770,631...43,829,179 		JBrowse link
G Abce1 ATP-binding cassette, sub-family E member 1 multiple interactions ISO
EXP		 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ABCE1 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ABCE1 mRNA		 CTD PMID:26378955 NCBI chr 8:80,410,071...80,438,369
Ensembl chr 8:80,410,091...80,438,369 		JBrowse link
G Abcg1 ATP binding cassette subfamily G member 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ABCG1 mRNA CTD PMID:26378955 NCBI chr17:31,276,668...31,336,958
Ensembl chr17:31,276,649...31,336,962 		JBrowse link
G Ablim1 actin-binding LIM protein 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ABLIM1 mRNA CTD PMID:26378955 NCBI chr19:57,021,165...57,303,776
Ensembl chr19:57,021,165...57,303,351 		JBrowse link
G Abtb2 ankyrin repeat and BTB domain containing 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ABTB2 mRNA CTD PMID:21641980 NCBI chr 2:103,396,655...103,548,768
Ensembl chr 2:103,396,655...103,548,768 		JBrowse link
G Acaa1a acetyl-Coenzyme A acyltransferase 1A multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ACAA1A mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ACAA1A mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 9:119,170,113...119,179,361
Ensembl chr 9:119,168,742...119,179,365 		JBrowse link
G Acap1 ArfGAP with coiled-coil, ankyrin repeat and PH domains 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ACAP1 mRNA CTD PMID:21641980 NCBI chr11:69,772,393...69,786,390
Ensembl chr11:69,772,393...69,786,365 		JBrowse link
G Acod1 aconitate decarboxylase 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ACOD1 mRNA CTD PMID:21641980 NCBI chr14:103,284,448...103,294,009
Ensembl chr14:103,284,413...103,294,009 		JBrowse link
G Acp5 acid phosphatase 5, tartrate resistant multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ACP5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ACP5 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 9:22,038,023...22,047,042
Ensembl chr 9:22,038,023...22,047,007 		JBrowse link
G Acsl4 acyl-CoA synthetase long-chain family member 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ACSL4 mRNA CTD PMID:21641980 NCBI chr  X:141,100,989...141,173,792
Ensembl chr  X:141,100,989...141,173,531 		JBrowse link
G Actc1 actin, alpha, cardiac muscle 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ACTC1 mRNA CTD PMID:26378955 NCBI chr 2:113,877,763...113,883,356
Ensembl chr 2:113,877,763...113,884,029 		JBrowse link
G Actg2 actin, gamma 2, smooth muscle, enteric multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ACTG2 mRNA CTD PMID:26378955 NCBI chr 6:83,489,891...83,513,233
Ensembl chr 6:83,489,887...83,513,247 		JBrowse link
G Acy1 aminoacylase 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ACY1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ACY1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 9:106,310,180...106,315,594
Ensembl chr 9:106,310,180...106,315,518 		JBrowse link
G Acy3 aminoacylase 3 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ACY3 mRNA CTD PMID:26378955 NCBI chr19:4,036,570...4,040,007
Ensembl chr19:4,036,570...4,040,007 		JBrowse link
G Adam28 a disintegrin and metallopeptidase domain 28 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ADAM28 mRNA CTD PMID:26378955 NCBI chr14:68,842,447...68,893,338
Ensembl chr14:68,843,476...68,893,291 		JBrowse link
G Adam8 a disintegrin and metallopeptidase domain 8 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ADAM8 mRNA CTD PMID:26378955 NCBI chr 7:139,558,845...139,573,016
Ensembl chr 7:139,558,845...139,572,475 		JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif 1 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ADAMTS1 mRNA CTD PMID:26378955 NCBI chr16:85,590,715...85,600,001
Ensembl chr16:85,590,715...85,600,001 		JBrowse link
G Adamts10 ADAM metallopeptidase with thrombospondin type 1 motif 10 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ADAMTS10 mRNA CTD PMID:26378955 NCBI chr17:33,742,620...33,772,756
Ensembl chr17:33,743,178...33,772,756 		JBrowse link
G Adamts5 ADAM metallopeptidase with thrombospondin type 1 motif 5 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ADAMTS5 mRNA CTD PMID:26378955 NCBI chr16:85,655,045...85,698,013
Ensembl chr16:85,653,061...85,698,716 		JBrowse link
G Adat1 adenosine deaminase, tRNA-specific 1 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ADAT1 mRNA CTD PMID:26378955 NCBI chr 8:112,685,552...112,718,938
Ensembl chr 8:112,693,540...112,718,934 		JBrowse link
G Add3 adducin 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ADD3 mRNA CTD PMID:21641980 NCBI chr19:53,128,874...53,235,518
Ensembl chr19:53,128,874...53,235,830 		JBrowse link
G Adm adrenomedullin multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ADM mRNA CTD PMID:21641980 NCBI chr 7:110,226,864...110,229,027
Ensembl chr 7:110,226,868...110,229,027 		JBrowse link
G Adora2b adenosine A2b receptor multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ADORA2B mRNA CTD PMID:21641980 NCBI chr11:62,139,810...62,157,278
Ensembl chr11:62,139,810...62,157,279 		JBrowse link
G Aebp2 AE binding protein 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of AEBP2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of AEBP2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 6:140,567,480...140,624,198
Ensembl chr 6:140,546,644...140,713,010 		JBrowse link
G Afp alpha fetoprotein multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of AFP mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of AFP mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 5:90,638,573...90,656,766
Ensembl chr 5:90,638,596...90,656,766 		JBrowse link
G Agap1 ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of AGAP1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of AGAP1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 1:89,382,533...89,823,004
Ensembl chr 1:89,382,528...89,825,339 		JBrowse link
G Agfg2 ArfGAP with FG repeats 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of AGFG2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of AGFG2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 5:137,648,725...137,683,068
Ensembl chr 5:137,648,725...137,682,988 		JBrowse link
G Agmo alkylglycerol monooxygenase multiple interactions
decreases expression		 EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of AGMO mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of AGMO mRNA
Succimer results in decreased expression of AGMO mRNA		 CTD PMID:21641980 PMID:26378955 NCBI chr12:37,291,638...37,632,201
Ensembl chr12:37,291,640...37,632,201 		JBrowse link
G Agt angiotensinogen multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of AGT mRNA CTD PMID:26378955 NCBI chr 8:125,283,326...125,296,445
Ensembl chr 8:125,283,273...125,296,445 		JBrowse link
G Ahnak AHNAK nucleoprotein multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of AHNAK mRNA CTD PMID:21641980 NCBI chr19:8,966,640...9,054,299
Ensembl chr19:8,966,648...9,054,278 		JBrowse link
G Ahnak2 AHNAK nucleoprotein 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of AHNAK2 mRNA CTD PMID:21641980 NCBI chr12:112,738,631...112,766,278
Ensembl chr12:112,738,628...112,766,277 		JBrowse link
G Aif1l allograft inflammatory factor 1-like multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of AIF1L mRNA CTD PMID:26378955 NCBI chr 2:31,840,315...31,863,454
Ensembl chr 2:31,840,151...31,863,454 		JBrowse link
G Airn antisense Igf2r RNA multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of AIRN mRNA CTD PMID:21641980 NCBI chr17:12,960,198...13,078,771
Ensembl chr17:12,960,198...13,079,023 		JBrowse link
G Akap9 A kinase anchor protein 9 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of AKAP9 mRNA CTD PMID:21641980 NCBI chr 5:3,977,410...4,130,204
Ensembl chr 5:3,978,054...4,131,310 		JBrowse link
G Akt1 thymoma viral proto-oncogene 1 multiple interactions ISO Succimer inhibits the reaction [sodium arsenite results in decreased expression of AKT1 protein] CTD PMID:31163222 NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318 		JBrowse link
G Aktip AKT interacting protein multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of AKTIP mRNA CTD PMID:26378955 NCBI chr 8:91,834,267...91,862,122
Ensembl chr 8:91,838,412...91,926,604 		JBrowse link
G Alad aminolevulinate, delta-, dehydratase multiple interactions
increases activity		 EXP
ISO		 [diphenyldiselenide co-treated with Succimer] inhibits the reaction [Cadmium Chloride results in decreased activity of ALAD protein]; Succimer inhibits the reaction [Cadmium Chloride results in decreased activity of ALAD protein]
Succimer results in increased activity of ALAD protein
Succimer inhibits the reaction [arsenite results in decreased activity of ALAD protein]; Succimer inhibits the reaction [sodium arsenite results in decreased activity of ALAD protein]		 CTD PMID:9559101 PMID:15202869 PMID:15331134 PMID:17188940 NCBI chr 4:62,422,762...62,438,300
Ensembl chr 4:62,427,406...62,438,155 		JBrowse link
G Alcam activated leukocyte cell adhesion molecule multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ALCAM mRNA CTD PMID:21641980 NCBI chr16:52,069,359...52,273,444
Ensembl chr16:52,069,359...52,274,437 		JBrowse link
G Aldh1l1 aldehyde dehydrogenase 1 family, member L1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ALDH1L1 mRNA CTD PMID:21641980 NCBI chr 6:90,527,751...90,576,153
Ensembl chr 6:90,463,409...90,577,185 		JBrowse link
G Alg6 ALG6 alpha-1,3-glucosyltransferase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ALG6 mRNA CTD PMID:21641980 NCBI chr 4:99,603,833...99,651,697
Ensembl chr 4:99,603,901...99,651,697 		JBrowse link
G Alkbh8 alkB homolog 8, tRNA methyltransferase multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ALKBH8 mRNA CTD PMID:26378955 NCBI chr 9:3,335,151...3,391,154
Ensembl chr 9:3,335,140...3,391,154 		JBrowse link
G Alppl2 alkaline phosphatase, placental-like 2 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ALPG mRNA CTD PMID:26378955 NCBI chr 1:87,014,412...87,023,656
Ensembl chr 1:87,014,416...87,017,650 		JBrowse link
G Ampd3 adenosine monophosphate deaminase 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of AMPD3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of AMPD3 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 7:110,367,291...110,411,612
Ensembl chr 7:110,367,413...110,411,612 		JBrowse link
G Amz1 archaelysin family metallopeptidase 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of AMZ1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of AMZ1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 5:140,709,882...140,739,067
Ensembl chr 5:140,709,882...140,747,194 		JBrowse link
G Anapc1 anaphase promoting complex subunit 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ANAPC1 mRNA CTD PMID:21641980 NCBI chr 2:128,452,003...128,529,558
Ensembl chr 2:128,452,024...128,529,311 		JBrowse link
G Angpt2 angiopoietin 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ANGPT2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ANGPT2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 8:18,740,279...18,791,578
Ensembl chr 8:18,740,279...18,791,578 		JBrowse link
G Angptl2 angiopoietin-like 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ANGPTL2 mRNA CTD PMID:21641980 NCBI chr 2:33,105,963...33,137,737
Ensembl chr 2:33,106,081...33,137,729 		JBrowse link
G Ank3 ankyrin 3, epithelial multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ANK3 mRNA CTD PMID:26378955 NCBI chr10:69,234,608...69,863,266
Ensembl chr10:69,234,603...69,863,268 		JBrowse link
G Ankmy1 ankyrin repeat and MYND domain containing 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ANKMY1 mRNA CTD PMID:26378955 NCBI chr 1:92,787,541...92,830,708
Ensembl chr 1:92,787,525...92,830,628 		JBrowse link
G Ankrd12 ankyrin repeat domain 12 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ANKRD12 mRNA CTD PMID:21641980 NCBI chr17:66,272,698...66,386,242
Ensembl chr17:66,272,693...66,384,084 		JBrowse link
G Ankrd26 ankyrin repeat domain 26 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ANKRD26 mRNA CTD PMID:21641980 NCBI chr 6:118,478,261...118,539,244
Ensembl chr 6:118,478,269...118,539,187 		JBrowse link
G Ankrd37 ankyrin repeat domain 37 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ANKRD37 mRNA CTD PMID:21641980 NCBI chr 8:46,449,945...46,452,904
Ensembl chr 8:46,449,939...46,458,744 		JBrowse link
G Ankrd44 ankyrin repeat domain 44 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ANKRD44 mRNA CTD PMID:21641980 NCBI chr 1:54,684,499...54,968,142
Ensembl chr 1:54,684,499...54,965,546 		JBrowse link
G Anpep alanyl aminopeptidase, membrane multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ANPEP mRNA CTD PMID:26378955 NCBI chr 7:79,471,551...79,497,958
Ensembl chr 7:79,471,551...79,510,807 		JBrowse link
G Aox1 aldehyde oxidase 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of AOX1 mRNA CTD PMID:26378955 NCBI chr 1:58,068,963...58,145,569
Ensembl chr 1:58,069,090...58,145,572 		JBrowse link
G Apobec1 apolipoprotein B mRNA editing enzyme, catalytic polypeptide 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of APOBEC1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of APOBEC1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 6:122,554,755...122,580,068
Ensembl chr 6:122,554,751...122,579,403 		JBrowse link
G Apoc2 apolipoprotein C2 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of APOC2 mRNA CTD PMID:26378955 NCBI chr 7:19,405,504...19,411,866
Ensembl chr 7:19,405,504...19,411,866 		JBrowse link
G Apoh apolipoprotein H multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of APOH mRNA CTD PMID:21641980 NCBI chr11:108,286,123...108,305,222
Ensembl chr11:108,234,180...108,305,222 		JBrowse link
G Apol9a apolipoprotein L 9a multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of APOL9A mRNA CTD PMID:21641980 NCBI chr15:77,287,989...77,295,280
Ensembl chr15:77,287,989...77,295,335 		JBrowse link
G Aqp11 aquaporin 11 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of AQP11 mRNA CTD PMID:21641980 NCBI chr 7:97,375,586...97,387,454
Ensembl chr 7:97,373,213...97,387,496 		JBrowse link
G Arap3 ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 3 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ARAP3 mRNA CTD PMID:26378955 NCBI chr18:38,105,676...38,132,583
Ensembl chr18:38,105,681...38,132,022 		JBrowse link
G Arf2 ADP-ribosylation factor 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ARF2 mRNA CTD PMID:21641980 NCBI chr11:103,857,551...103,876,176
Ensembl chr11:103,857,565...103,876,163 		JBrowse link
G Arfgef3 ARFGEF family member 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ARFGEF3 mRNA CTD PMID:21641980 NCBI chr10:18,463,759...18,619,506
Ensembl chr10:18,457,587...18,619,697 		JBrowse link
G Arg2 arginase type II multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ARG2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ARG2 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ARG2 mRNA		 CTD PMID:21641980 PMID:26378955 NCBI chr12:79,177,562...79,203,075
Ensembl chr12:79,177,551...79,203,075 		JBrowse link
G Arhgap18 Rho GTPase activating protein 18 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ARHGAP18 mRNA CTD PMID:21641980 NCBI chr10:26,648,363...26,794,644
Ensembl chr10:26,629,417...26,794,644 		JBrowse link
G Arhgef6 Rac/Cdc42 guanine nucleotide exchange factor 6 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ARHGEF6 mRNA CTD PMID:21641980 NCBI chr  X:56,276,845...56,384,119
Ensembl chr  X:56,276,845...56,384,089 		JBrowse link
G Arpc2 actin related protein 2/3 complex, subunit 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ARPC2 mRNA CTD PMID:21641980 NCBI chr 1:74,275,656...74,307,368
Ensembl chr 1:74,275,243...74,307,368 		JBrowse link
G Arpp19 cAMP-regulated phosphoprotein 19 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ARPP19 mRNA CTD PMID:21641980 NCBI chr 9:74,944,896...74,967,595
Ensembl chr 9:74,944,896...74,967,595 		JBrowse link
G Arrdc4 arrestin domain containing 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ARRDC4 mRNA CTD PMID:21641980 NCBI chr 7:68,386,742...68,398,986
Ensembl chr 7:68,386,743...68,398,989 		JBrowse link
G Ash1l ASH1 like histone lysine methyltransferase multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ASH1L mRNA CTD PMID:26378955 NCBI chr 3:88,857,721...88,986,682
Ensembl chr 3:88,857,929...88,986,682 		JBrowse link
G Asph aspartate-beta-hydroxylase multiple interactions EXP
ISO		 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ASPH mRNA CTD PMID:26378955 NCBI chr 4:9,449,085...9,669,344
Ensembl chr 4:9,448,069...9,669,344 		JBrowse link
G Atad2 ATPase family, AAA domain containing 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ATAD2 mRNA CTD PMID:21641980 NCBI chr15:57,957,440...57,998,516
Ensembl chr15:57,957,440...57,998,478 		JBrowse link
G Atad5 ATPase family, AAA domain containing 5 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ATAD5 mRNA CTD PMID:21641980 NCBI chr11:79,980,205...80,026,623
Ensembl chr11:79,980,226...80,026,620 		JBrowse link
G Atf2 activating transcription factor 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ATF2 mRNA CTD PMID:26378955 NCBI chr 2:73,646,853...73,723,094
Ensembl chr 2:73,646,853...73,722,983 		JBrowse link
G Atp11c ATPase, class VI, type 11C multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ATP11C mRNA CTD PMID:26378955 NCBI chr  X:59,268,643...59,450,041
Ensembl chr  X:59,268,650...59,636,304 		JBrowse link
G Atp13a3 ATPase type 13A3 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ATP13A3 mRNA CTD PMID:26378955 NCBI chr16:30,131,241...30,207,674
Ensembl chr16:30,131,241...30,224,793 		JBrowse link
G Atp1b1 ATPase, Na+/K+ transporting, beta 1 polypeptide multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ATP1B1 mRNA CTD PMID:26378955 NCBI chr 1:164,264,668...164,285,924
Ensembl chr 1:164,264,678...164,285,924 		JBrowse link
G Atp2b1 ATPase, Ca++ transporting, plasma membrane 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ATP2B1 mRNA CTD PMID:21641980 NCBI chr10:98,750,243...98,862,005
Ensembl chr10:98,750,268...98,862,005 		JBrowse link
G Atp6v0d2 ATPase, H+ transporting, lysosomal V0 subunit D2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ATP6V0D2 mRNA CTD PMID:21641980 NCBI chr 4:19,876,838...19,922,566
Ensembl chr 4:19,876,841...19,922,605 		JBrowse link
G Atp7a ATPase, Cu++ transporting, alpha polypeptide multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ATP7A mRNA CTD PMID:26378955 NCBI chr  X:105,070,830...105,171,766
Ensembl chr  X:105,070,882...105,168,532 		JBrowse link
G Atp8a1 ATPase phospholipid transporting 8A1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ATP8A1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ATP8A1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 5:67,775,482...68,004,822
Ensembl chr 5:67,775,483...68,004,777 		JBrowse link
G Atrx ATRX, chromatin remodeler multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ATRX mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of ATRX mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ATRX mRNA		 CTD PMID:21641980 PMID:26378955 NCBI chr  X:104,841,221...104,972,978
Ensembl chr  X:104,841,221...104,973,009 		JBrowse link
G Atxn1 ataxin 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ATXN1 mRNA CTD PMID:21641980 NCBI chr13:45,703,231...46,118,467
Ensembl chr13:45,703,231...46,118,484 		JBrowse link
G Atxn3 ataxin 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ATXN3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ATXN3 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr12:101,885,160...101,928,139
Ensembl chr12:101,885,160...101,924,505 		JBrowse link
G B3galt4 UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of B3GALT4 mRNA CTD PMID:21641980 NCBI chr17:34,168,886...34,170,462
Ensembl chr17:34,168,883...34,170,462 		JBrowse link
G B4galt5 UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 5 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of B4GALT5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of B4GALT5 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 2:167,140,364...167,191,155
Ensembl chr 2:167,140,364...167,191,103 		JBrowse link
G Bak1 BCL2-antagonist/killer 1 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BAK1 mRNA CTD PMID:26378955 NCBI chr17:27,238,786...27,247,601
Ensembl chr17:27,238,784...27,247,983 		JBrowse link
G Bambi-ps1 BMP and activin membrane-bound inhibitor, pseudogene (Xenopus laevis) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of BAMBI-PS1 mRNA CTD PMID:21641980 NCBI chr 2:122,297,064...122,298,278
Ensembl chr 2:122,297,416...122,298,007 		JBrowse link
G Bax BCL2-associated X protein multiple interactions ISO Succimer inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of BAX mRNA]; Succimer inhibits the reaction [sodium arsenite results in increased expression of BAX mRNA] CTD PMID:31163222 PMID:32402895 NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322 		JBrowse link
G Baz1a bromodomain adjacent to zinc finger domain 1A multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BAZ1A mRNA CTD PMID:26378955 NCBI chr12:54,939,774...55,061,155
Ensembl chr12:54,940,336...55,061,133 		JBrowse link
G Baz2b bromodomain adjacent to zinc finger domain, 2B multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BAZ2B mRNA CTD PMID:26378955 NCBI chr 2:59,729,707...60,040,243
Ensembl chr 2:59,729,707...60,040,183 		JBrowse link
G Bbox1 gamma-butyrobetaine hydroxylase 1 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BBOX1 mRNA CTD PMID:26378955 NCBI chr 2:110,094,401...110,145,158
Ensembl chr 2:110,093,042...110,144,905 		JBrowse link
G Bbs9 Bardet-Biedl syndrome 9 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of BBS9 mRNA CTD PMID:21641980 NCBI chr 9:22,386,819...22,799,579
Ensembl chr 9:22,387,011...22,799,576 		JBrowse link
G Bcl2 B cell leukemia/lymphoma 2 multiple interactions ISO Succimer inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of BCL2 mRNA] CTD PMID:32402895 NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004 		JBrowse link
G Bcl2l1 BCL2-like 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of BCL2L1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of BCL2L1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648 		JBrowse link
G Bcl2l11 BCL2 like 11 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of BCL2L11 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of BCL2L11 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BCL2L11 mRNA		 CTD PMID:21641980 PMID:26378955 NCBI chr 2:127,967,958...128,004,467
Ensembl chr 2:127,967,958...128,004,467 		JBrowse link
G Bcl6b B cell CLL/lymphoma 6, member B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of BCL6B mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of BCL6B mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:70,114,953...70,120,624
Ensembl chr11:70,114,954...70,120,624 		JBrowse link
G Bcl7a B cell CLL/lymphoma 7A multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of BCL7A mRNA CTD PMID:21641980 NCBI chr 5:123,482,511...123,512,146
Ensembl chr 5:123,481,897...123,513,055 		JBrowse link
G Bclaf1 BCL2-associated transcription factor 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of BCLAF1 mRNA CTD PMID:21641980 NCBI chr10:20,187,897...20,218,390
Ensembl chr10:20,188,215...20,220,359 		JBrowse link
G Bco2 beta-carotene oxygenase 2 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BCO2 mRNA CTD PMID:26378955 NCBI chr 9:50,444,387...50,466,513
Ensembl chr 9:50,444,387...50,466,481 		JBrowse link
G Birc3 baculoviral IAP repeat-containing 3 multiple interactions EXP
ISO		 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BIRC3 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of BIRC3 mRNA		 CTD PMID:26378955 NCBI chr 9:7,848,698...7,873,199
Ensembl chr 9:7,848,700...7,873,187 		JBrowse link
G Blm Bloom syndrome, RecQ like helicase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of BLM mRNA CTD PMID:21641980 NCBI chr 7:80,104,839...80,184,896
Ensembl chr 7:80,104,481...80,184,867 		JBrowse link
G Blvrb biliverdin reductase B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of BLVRB mRNA CTD PMID:21641980 NCBI chr 7:27,147,403...27,165,406
Ensembl chr 7:27,147,403...27,165,569 		JBrowse link
G Bpnt2 3'(2'), 5'-bisphosphate nucleotidase 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BPNT2 mRNA CTD PMID:26378955 NCBI chr 4:4,762,484...4,793,306
Ensembl chr 4:4,762,484...4,793,355 		JBrowse link
G Braf Braf transforming gene multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BRAF mRNA CTD PMID:26378955 NCBI chr 6:39,580,171...39,702,592
Ensembl chr 6:39,580,171...39,702,397 		JBrowse link
G Brca1 breast cancer 1, early onset multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of BRCA1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of BRCA1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:101,379,587...101,442,808
Ensembl chr11:101,379,590...101,442,781 		JBrowse link
G Brca2 breast cancer 2, early onset multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of BRCA2 mRNA CTD PMID:26378955 NCBI chr 5:150,445,759...150,493,612
Ensembl chr 5:150,446,095...150,493,794 		JBrowse link
G Brd8 bromodomain containing 8 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of BRD8 mRNA CTD PMID:21641980 NCBI chr18:34,731,668...34,757,916
Ensembl chr18:34,731,668...34,757,654 		JBrowse link
G Brwd1 bromodomain and WD repeat domain containing 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of BRWD1 mRNA CTD PMID:21641980 NCBI chr16:95,793,289...95,883,905
Ensembl chr16:95,793,292...95,883,726 		JBrowse link
G Btg1 BTG anti-proliferation factor 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of BTG1 mRNA CTD PMID:21641980 NCBI chr10:96,452,863...96,458,675
Ensembl chr10:96,452,868...96,458,671 		JBrowse link
G Btg2 BTG anti-proliferation factor 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of BTG2 mRNA CTD PMID:21641980 NCBI chr 1:134,002,603...134,006,893
Ensembl chr 1:134,002,908...134,006,858 		JBrowse link
G Btg3 BTG anti-proliferation factor 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of BTG3 mRNA CTD PMID:21641980 NCBI chr16:78,156,748...78,174,069
Ensembl chr16:78,129,525...78,174,080 		JBrowse link
G C1galt1 core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of C1GALT1 mRNA CTD PMID:26378955 NCBI chr 6:7,845,224...7,872,042
Ensembl chr 6:7,844,842...7,875,687 		JBrowse link
G C3 complement component 3 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of C3 mRNA CTD PMID:26378955 NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136 		JBrowse link
G C78513 EST C78513 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of C78513 mRNA CTD PMID:21641980
G C80258 expressed sequence C80258 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of C80258 mRNA CTD PMID:21641980
G Cacna1a calcium channel, voltage-dependent, P/Q type, alpha 1A subunit multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CACNA1A mRNA CTD PMID:26378955 NCBI chr 8:85,065,257...85,366,880
Ensembl chr 8:85,065,268...85,366,875 		JBrowse link
G Cacna1b calcium channel, voltage-dependent, N type, alpha 1B subunit multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CACNA1B mRNA CTD PMID:26378955 NCBI chr 2:24,493,872...24,653,210
Ensembl chr 2:24,493,899...24,653,164 		JBrowse link
G Cadps Ca2+-dependent secretion activator multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CADPS mRNA CTD PMID:26378955 NCBI chr14:9,646,424...10,097,203
Ensembl chr14:9,646,684...10,097,200 		JBrowse link
G Camk1d calcium/calmodulin-dependent protein kinase ID multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CAMK1D mRNA CTD PMID:21641980 NCBI chr 2:5,298,268...5,719,665
Ensembl chr 2:5,298,268...5,719,326 		JBrowse link
G Camk2d calcium/calmodulin-dependent protein kinase II, delta multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CAMK2D mRNA CTD PMID:21641980 NCBI chr 3:126,389,136...126,639,975
Ensembl chr 3:126,389,951...126,639,975 		JBrowse link
G Cand1 cullin associated and neddylation disassociated 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CAND1 mRNA CTD PMID:21641980 NCBI chr10:119,034,717...119,075,960
Ensembl chr10:119,035,160...119,075,960 		JBrowse link
G Canx calnexin multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CANX mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CANX mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:50,184,784...50,216,500
Ensembl chr11:50,184,788...50,216,500 		JBrowse link
G Capn3 calpain 3 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CAPN3 mRNA CTD PMID:26378955 NCBI chr 2:120,294,074...120,335,400
Ensembl chr 2:120,294,053...120,335,399 		JBrowse link
G Capn7 calpain 7 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CAPN7 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CAPN7 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr14:31,058,582...31,093,944
Ensembl chr14:31,058,595...31,093,943 		JBrowse link
G Car13 carbonic anhydrase 13 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CAR13 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CAR13 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 3:14,706,787...14,728,062
Ensembl chr 3:14,706,787...14,728,062 		JBrowse link
G Cask calcium/calmodulin dependent serine protein kinase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CASK mRNA CTD PMID:21641980 NCBI chr  X:13,383,319...13,713,020
Ensembl chr  X:13,383,319...13,717,606 		JBrowse link
G Casp1 caspase 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CASP1 mRNA CTD PMID:26378955 NCBI chr 9:5,298,517...5,307,281
Ensembl chr 9:5,298,508...5,307,290 		JBrowse link
G Casp12 caspase 12 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CASP12 mRNA CTD PMID:26378955 NCBI chr 9:5,345,419...5,373,034
Ensembl chr 9:5,345,430...5,373,032 		JBrowse link
G Casp3 caspase 3 multiple interactions ISO Succimer inhibits the reaction [sodium arsenite results in increased expression of CASP3 protein] CTD PMID:31163222 NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724 		JBrowse link
G Casp4 caspase 4, apoptosis-related cysteine peptidase multiple interactions EXP
ISO		 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CASP4 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CASP4 mRNA		 CTD PMID:26378955 NCBI chr 9:5,308,816...5,336,791
Ensembl chr 9:5,308,828...5,336,783 		JBrowse link
G Casp8ap2 caspase 8 associated protein 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CASP8AP2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CASP8AP2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 4:32,615,462...32,653,271
Ensembl chr 4:32,615,451...32,653,265 		JBrowse link
G Cast calpastatin multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CAST mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CAST mRNA CTD PMID:21641980 PMID:26378955 NCBI chr13:74,840,485...74,956,993
Ensembl chr13:74,840,487...74,956,929 		JBrowse link
G Cat catalase multiple interactions ISO Succimer inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased activity of CAT protein]; Succimer inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]; Succimer promotes the reaction [Thioctic Acid inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]]; Thioctic Acid promotes the reaction [Succimer inhibits the reaction [sodium arsenite results in decreased activity of CAT protein]] CTD PMID:15998567 PMID:31163222 PMID:32402895 NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505 		JBrowse link
G Cbfa2t2 CBFA2/RUNX1 translocation partner 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CBFA2T2 mRNA CTD PMID:26378955 NCBI chr 2:154,278,018...154,381,276
Ensembl chr 2:154,278,401...154,381,276 		JBrowse link
G Cblb Casitas B-lineage lymphoma b multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] affects the expression of CBLB mRNA CTD PMID:26378955 NCBI chr16:51,851,593...52,028,410
Ensembl chr16:51,851,588...52,028,411 		JBrowse link
G Ccdc117 coiled-coil domain containing 117 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CCDC117 mRNA CTD PMID:21641980 NCBI chr11:5,478,887...5,492,217
Ensembl chr11:5,478,887...5,492,187 		JBrowse link
G Ccdc88a coiled coil domain containing 88A multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CCDC88A mRNA CTD PMID:21641980 NCBI chr11:29,323,521...29,460,808
Ensembl chr11:29,323,658...29,460,808 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279 		JBrowse link
G Ccl22 C-C motif chemokine ligand 22 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL22 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL22 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 8:95,472,312...95,478,016
Ensembl chr 8:95,472,218...95,478,327 		JBrowse link
G Ccl3 C-C motif chemokine ligand 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL3 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181 		JBrowse link
G Ccl4 C-C motif chemokine ligand 4 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL4 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:83,553,410...83,555,509
Ensembl chr11:83,553,410...83,555,509 		JBrowse link
G Ccl5 C-C motif chemokine ligand 5 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL5 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344 		JBrowse link
G Ccl6 C-C motif chemokine ligand 6 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL6 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL6 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:83,478,712...83,483,913
Ensembl chr11:83,478,708...83,483,913 		JBrowse link
G Ccl7 C-C motif chemokine ligand 7 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCL7 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCL7 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:81,936,538...81,938,351
Ensembl chr11:81,936,538...81,938,351 		JBrowse link
G Ccn1 cellular communication network factor 1 multiple interactions EXP
ISO		 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CCN1 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CCN1 mRNA		 CTD PMID:26378955 NCBI chr 3:145,352,726...145,355,740
Ensembl chr 3:145,352,731...145,355,736 		JBrowse link
G Ccn2 cellular communication network factor 2 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CCN2 mRNA CTD PMID:26378955 NCBI chr10:24,471,340...24,474,581
Ensembl chr10:24,471,340...24,474,581 		JBrowse link
G Ccng2 cyclin G2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CCNG2 mRNA CTD PMID:21641980 NCBI chr 5:93,415,432...93,424,090
Ensembl chr 5:93,415,116...93,424,090 		JBrowse link
G Ccnt2 cyclin T2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CCNT2 mRNA CTD PMID:21641980 NCBI chr 1:127,701,901...127,732,574
Ensembl chr 1:127,701,901...127,735,798 		JBrowse link
G Ccny cyclin Y multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CCNY mRNA CTD PMID:21641980 NCBI chr18:9,312,304...9,450,188
Ensembl chr18:9,312,304...9,450,154 		JBrowse link
G Ccr1 C-C motif chemokine receptor 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCR1 mRNA CTD PMID:21641980 NCBI chr 9:123,762,163...123,768,729
Ensembl chr 9:123,762,161...123,768,729 		JBrowse link
G Ccrl2 C-C motif chemokine receptor-like 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CCRL2 mRNA CTD PMID:21641980 NCBI chr 9:110,883,902...110,886,586
Ensembl chr 9:110,883,554...110,886,587 		JBrowse link
G Cd109 CD109 antigen multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CD109 mRNA CTD PMID:21641980 NCBI chr 9:78,522,828...78,623,542
Ensembl chr 9:78,522,828...78,623,535 		JBrowse link
G Cd200r4 CD200 receptor 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CD200R4 mRNA CTD PMID:21641980 NCBI chr16:44,632,036...44,659,497
Ensembl chr16:44,632,096...44,659,513 		JBrowse link
G Cd24a CD24a antigen multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CD24A mRNA CTD PMID:21641980 NCBI chr10:43,454,433...43,460,261
Ensembl chr10:43,454,280...43,460,261 		JBrowse link
G Cd274 CD274 antigen multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CD274 mRNA CTD PMID:21641980 NCBI chr19:29,339,428...29,365,495
Ensembl chr19:29,344,855...29,365,495 		JBrowse link
G Cd276 CD276 antigen multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CD276 mRNA CTD PMID:21641980 NCBI chr 9:58,431,581...58,463,437
Ensembl chr 9:58,431,581...58,462,720 		JBrowse link
G Cd36 CD36 molecule multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CD36 mRNA CTD PMID:26378955 NCBI chr 5:17,986,680...18,093,828
Ensembl chr 5:17,986,688...18,093,799 		JBrowse link
G Cd40 CD40 antigen multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CD40 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CD40 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 2:164,897,535...164,913,574
Ensembl chr 2:164,897,547...164,914,868 		JBrowse link
G Cd44 CD44 antigen multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CD44 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CD44 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 2:102,641,486...102,732,014
Ensembl chr 2:102,641,486...102,732,010 		JBrowse link
G Cd5l CD5 antigen-like multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CD5L mRNA CTD PMID:21641980 NCBI chr 3:87,265,188...87,278,381
Ensembl chr 3:87,265,188...87,278,380 		JBrowse link
G Cd74 CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CD74 mRNA CTD PMID:26378955 NCBI chr18:60,936,921...60,945,724
Ensembl chr18:60,936,920...60,945,724 		JBrowse link
G Cd80 CD80 antigen multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CD80 mRNA CTD PMID:21641980 NCBI chr16:38,277,793...38,316,682
Ensembl chr16:38,275,923...38,316,697 		JBrowse link
G Cd83 CD83 antigen multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CD83 mRNA CTD PMID:21641980 NCBI chr13:43,938,661...43,956,608
Ensembl chr13:43,938,251...43,956,608 		JBrowse link
G Cd86 CD86 antigen multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CD86 mRNA CTD PMID:26378955 NCBI chr16:36,389,318...36,486,439
Ensembl chr16:36,424,231...36,486,443 		JBrowse link
G Cd93 CD93 antigen multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CD93 mRNA CTD PMID:21641980 NCBI chr 2:148,278,571...148,285,455
Ensembl chr 2:148,278,560...148,285,483 		JBrowse link
G Cda cytidine deaminase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CDA mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CDA mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 4:138,065,839...138,095,623
Ensembl chr 4:138,065,735...138,095,303 		JBrowse link
G Cdadc1 cytidine and dCMP deaminase domain containing 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CDADC1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CDADC1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr14:59,796,837...59,835,433
Ensembl chr14:59,796,837...59,835,408 		JBrowse link
G Cdc42bpa CDC42 binding protein kinase alpha multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CDC42BPA mRNA CTD PMID:26378955 NCBI chr 1:179,787,058...179,993,171
Ensembl chr 1:179,788,037...179,993,168 		JBrowse link
G Cdc42ep2 CDC42 effector protein 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CDC42EP2 mRNA CTD PMID:21641980 NCBI chr19:5,967,584...5,974,844
Ensembl chr19:5,965,664...5,974,844 		JBrowse link
G Cdc6 cell division cycle 6 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CDC6 mRNA CTD PMID:21641980 NCBI chr11:98,798,627...98,814,768
Ensembl chr11:98,798,627...98,814,766 		JBrowse link
G Cdc7 cell division cycle 7 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CDC7 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CDC7 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 5:107,112,201...107,132,298
Ensembl chr 5:107,112,188...107,132,298 		JBrowse link
G Cdh10 cadherin 10 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CDH10 mRNA CTD PMID:26378955 NCBI chr15:18,818,763...19,014,883
Ensembl chr15:18,819,033...19,014,322 		JBrowse link
G Cdk12 cyclin dependent kinase 12 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CDK12 mRNA CTD PMID:21641980 NCBI chr11:98,093,259...98,171,941
Ensembl chr11:98,093,885...98,169,330 		JBrowse link
G Cdkn1a cyclin dependent kinase inhibitor 1A multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CDKN1A mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CDKN1A mRNA CTD PMID:21641980 PMID:26378955 NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701 		JBrowse link
G Cdo1 cysteine dioxygenase 1, cytosolic multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CDO1 mRNA CTD PMID:26378955 NCBI chr18:46,846,260...46,861,569
Ensembl chr18:46,846,260...46,861,462 		JBrowse link
G Cds2 CDP-diacylglycerol synthase 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CDS2 mRNA CTD PMID:21641980 NCBI chr 2:132,105,068...132,153,970
Ensembl chr 2:132,105,068...132,153,970 		JBrowse link
G Cebpd CCAAT/enhancer binding protein delta multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CEBPD mRNA CTD PMID:21641980 NCBI chr16:15,705,150...15,707,409
Ensembl chr16:15,705,150...15,708,895 		JBrowse link
G Celf2 CUGBP, Elav-like family member 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CELF2 mRNA CTD PMID:21641980 NCBI chr 2:6,544,505...7,401,345
Ensembl chr 2:6,544,505...7,514,374 		JBrowse link
G Cenpe centromere protein E multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CENPE mRNA CTD PMID:21641980 NCBI chr 3:134,918,324...134,979,301
Ensembl chr 3:134,918,298...134,979,372 		JBrowse link
G Cenpj centromere protein J multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CENPJ mRNA CTD PMID:21641980 NCBI chr14:56,764,218...56,812,950
Ensembl chr14:56,764,218...56,812,882 		JBrowse link
G Cep170 centrosomal protein 170 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CEP170 mRNA CTD PMID:21641980 NCBI chr 1:176,556,638...176,641,545
Ensembl chr 1:176,561,219...176,641,633 		JBrowse link
G Cept1 choline/ethanolaminephosphotransferase 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CEPT1 mRNA CTD PMID:26378955 NCBI chr 3:106,409,576...106,455,118
Ensembl chr 3:106,409,576...106,455,118 		JBrowse link
G Cerk ceramide kinase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CERK mRNA CTD PMID:21641980 NCBI chr15:86,023,302...86,070,537
Ensembl chr15:86,023,329...86,070,342 		JBrowse link
G Cers4 ceramide synthase 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CERS4 mRNA CTD PMID:21641980 NCBI chr 8:4,542,863...4,579,603
Ensembl chr 8:4,543,026...4,581,680 		JBrowse link
G Cflar CASP8 and FADD-like apoptosis regulator multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CFLAR mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CFLAR mRNA		 CTD PMID:21641980 PMID:26378955 NCBI chr 1:58,750,353...58,798,043
Ensembl chr 1:58,750,667...58,798,043 		JBrowse link
G Chd4 chromodomain helicase DNA binding protein 4 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CHD4 mRNA CTD PMID:26378955 NCBI chr 6:125,073,144...125,107,554
Ensembl chr 6:125,072,944...125,107,554 		JBrowse link
G Chd9 chromodomain helicase DNA binding protein 9 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CHD9 mRNA CTD PMID:21641980 NCBI chr 8:91,554,930...91,781,144
Ensembl chr 8:91,554,980...91,781,144 		JBrowse link
G Chek1 checkpoint kinase 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CHEK1 mRNA CTD PMID:21641980 NCBI chr 9:36,619,935...36,637,897
Ensembl chr 9:36,619,778...36,638,361 		JBrowse link
G Chit1 chitinase 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CHIT1 mRNA CTD PMID:21641980 NCBI chr 1:134,038,980...134,079,279
Ensembl chr 1:134,038,980...134,079,278 		JBrowse link
G Chka choline kinase alpha multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CHKA mRNA CTD PMID:21641980 NCBI chr19:3,901,585...3,944,368
Ensembl chr19:3,901,773...3,944,369 		JBrowse link
G Chn1 chimerin 1 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CHN1 mRNA CTD PMID:26378955 NCBI chr 2:73,441,004...73,605,723
Ensembl chr 2:73,441,004...73,605,690 		JBrowse link
G Chuk conserved helix-loop-helix ubiquitous kinase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CHUK mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CHUK mRNA CTD PMID:21641980 PMID:26378955 NCBI chr19:44,061,773...44,095,940
Ensembl chr19:44,061,774...44,095,919 		JBrowse link
G Cldn12 claudin 12 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CLDN12 mRNA CTD PMID:21641980 NCBI chr 5:5,555,109...5,564,953
Ensembl chr 5:5,539,537...5,564,958 		JBrowse link
G Clec10a C-type lectin domain family 10, member A multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CLEC10A mRNA CTD PMID:21641980 NCBI chr11:70,057,449...70,061,662
Ensembl chr11:70,047,023...70,061,660 		JBrowse link
G Clec2h C-type lectin domain family 2, member h multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CLEC2D mRNA CTD PMID:21641980 NCBI chr 6:128,639,348...128,654,337
Ensembl chr 6:128,639,348...128,654,337 		JBrowse link
G Clec4a3 C-type lectin domain family 4, member a3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CLEC4A3 mRNA CTD PMID:21641980 NCBI chr 6:122,929,474...122,946,837
Ensembl chr 6:122,929,474...122,946,834 		JBrowse link
G Clec4e C-type lectin domain family 4, member e multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CLEC4E mRNA CTD PMID:21641980 NCBI chr 6:123,258,748...123,266,830
Ensembl chr 6:123,258,748...123,266,829 		JBrowse link
G Clec4n C-type lectin domain family 4, member n multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CLEC4N mRNA CTD PMID:21641980 NCBI chr 6:123,206,802...123,223,983
Ensembl chr 6:123,206,802...123,223,980 		JBrowse link
G Clec7a C-type lectin domain family 7, member a multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CLEC7A mRNA CTD PMID:26378955 NCBI chr 6:129,438,554...129,449,748
Ensembl chr 6:129,438,554...129,449,742 		JBrowse link
G Clk1 CDC-like kinase 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CLK1 mRNA CTD PMID:21641980 NCBI chr 1:58,451,147...58,463,247
Ensembl chr 1:58,449,348...58,463,225 		JBrowse link
G Clmn calmin multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CLMN mRNA CTD PMID:21641980 NCBI chr12:104,729,373...104,831,335
Ensembl chr12:104,729,376...104,831,335 		JBrowse link
G Clpx caseinolytic mitochondrial matrix peptidase chaperone subunit multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CLPX mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CLPX mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 9:65,201,533...65,237,940
Ensembl chr 9:65,201,542...65,237,940 		JBrowse link
G Clspn claspin multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CLSPN mRNA CTD PMID:21641980 NCBI chr 4:126,450,738...126,488,326
Ensembl chr 4:126,450,728...126,487,696 		JBrowse link
G Clta clathrin light chain A multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CLTA mRNA CTD PMID:21641980 NCBI chr 4:44,003,816...44,032,846
Ensembl chr 4:44,004,452...44,032,846 		JBrowse link
G Cltc clathrin heavy chain multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CLTC mRNA CTD PMID:21641980 NCBI chr11:86,585,178...86,648,637
Ensembl chr11:86,585,177...86,648,391 		JBrowse link
G Clu clusterin multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CLU mRNA CTD PMID:21641980 NCBI chr14:66,206,093...66,218,992
Ensembl chr14:66,205,932...66,218,996 		JBrowse link
G Cmpk2 cytidine/uridine monophosphate kinase 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CMPK2 mRNA CTD PMID:21641980 NCBI chr12:26,519,121...26,529,836
Ensembl chr12:26,519,203...26,529,836 		JBrowse link
G Cnnm3 cyclin M3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CNNM3 mRNA CTD PMID:21641980 NCBI chr 1:36,550,948...36,567,318
Ensembl chr 1:36,550,948...36,567,318 		JBrowse link
G Cnot4 CCR4-NOT transcription complex, subunit 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CNOT4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CNOT4 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 6:34,999,000...35,110,646
Ensembl chr 6:34,999,000...35,110,659 		JBrowse link
G Cnot7 CCR4-NOT transcription complex, subunit 7 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CNOT7 mRNA CTD PMID:26378955 NCBI chr 8:40,945,579...40,968,888
Ensembl chr 8:40,945,581...40,968,888 		JBrowse link
G Col14a1 collagen, type XIV, alpha 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of COL14A1 mRNA CTD PMID:21641980 NCBI chr15:55,171,040...55,384,199
Ensembl chr15:55,171,146...55,384,199 		JBrowse link
G Col18a1 collagen, type XVIII, alpha 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of COL18A1 mRNA CTD PMID:26378955 NCBI chr10:76,888,013...77,002,351
Ensembl chr10:76,888,012...77,002,382 		JBrowse link
G Col3a1 collagen, type III, alpha 1 multiple interactions EXP
ISO		 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of COL3A1 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of COL3A1 mRNA		 CTD PMID:26378955 NCBI chr 1:45,350,698...45,388,866
Ensembl chr 1:45,350,698...45,388,866 		JBrowse link
G Col5a1 collagen, type V, alpha 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of COL5A1 mRNA CTD PMID:26378955 NCBI chr 2:27,776,393...27,929,522
Ensembl chr 2:27,776,437...27,929,526 		JBrowse link
G Col7a1 collagen, type VII, alpha 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of COL7A1 mRNA CTD PMID:21641980 NCBI chr 9:108,782,654...108,813,943
Ensembl chr 9:108,782,654...108,813,943 		JBrowse link
G Col8a1 collagen, type VIII, alpha 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of COL8A1 mRNA CTD PMID:21641980 NCBI chr16:57,444,619...57,575,100
Ensembl chr16:57,444,621...57,575,100 		JBrowse link
G Colec12 collectin sub-family member 12 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of COLEC12 mRNA CTD PMID:26378955 NCBI chr18:9,707,648...9,877,995
Ensembl chr18:9,707,595...9,882,644 		JBrowse link
G Cox5b cytochrome c oxidase subunit 5B multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of COX5B mRNA CTD PMID:26378955 NCBI chr 1:36,730,568...36,732,469
Ensembl chr 1:36,730,530...36,732,762 		JBrowse link
G Cp ceruloplasmin multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CP mRNA CTD PMID:26378955 NCBI chr 3:20,011,097...20,063,914
Ensembl chr 3:20,011,218...20,063,309 		JBrowse link
G Cpa4 carboxypeptidase A4 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CPA4 mRNA CTD PMID:26378955 NCBI chr 6:30,568,368...30,592,417
Ensembl chr 6:30,568,368...30,592,417 		JBrowse link
G Cpd carboxypeptidase D multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CPD mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CPD mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:76,668,034...76,737,834
Ensembl chr11:76,669,250...76,737,844 		JBrowse link
G Cpn1 carboxypeptidase N, polypeptide 1 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CPN1 mRNA CTD PMID:26378955 NCBI chr19:43,944,746...43,974,990
Ensembl chr19:43,944,746...43,974,995 		JBrowse link
G Cpne2 copine II multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CPNE2 mRNA CTD PMID:21641980 NCBI chr 8:95,259,299...95,297,157
Ensembl chr 8:95,259,618...95,297,159 		JBrowse link
G Crebbp CREB binding protein multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CREBBP mRNA CTD PMID:26378955 NCBI chr16:3,899,198...4,031,864
Ensembl chr16:3,899,192...4,031,861 		JBrowse link
G Crim1 cysteine rich transmembrane BMP regulator 1 multiple interactions EXP
ISO		 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CRIM1 mRNA CTD PMID:26378955 NCBI chr17:78,507,602...78,684,021
Ensembl chr17:78,507,677...78,684,021 		JBrowse link
G Csad cysteine sulfinic acid decarboxylase multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CSAD mRNA CTD PMID:26378955 NCBI chr15:102,085,432...102,112,685
Ensembl chr15:102,085,434...102,113,159 		JBrowse link
G Csf1 colony stimulating factor 1 (macrophage) multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CSF1 mRNA CTD PMID:26378955 NCBI chr 3:107,648,364...107,668,048
Ensembl chr 3:107,648,364...107,667,785 		JBrowse link
G Csf3 colony stimulating factor 3 (granulocyte) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CSF3 mRNA CTD PMID:21641980 NCBI chr11:98,591,287...98,594,457
Ensembl chr11:98,592,089...98,594,455 		JBrowse link
G Csgalnact1 chondroitin sulfate N-acetylgalactosaminyltransferase 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CSGALNACT1 mRNA CTD PMID:26378955 NCBI chr 8:68,809,433...69,188,270
Ensembl chr 8:68,809,433...69,187,798 		JBrowse link
G Csgalnact2 chondroitin sulfate N-acetylgalactosaminyltransferase 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CSGALNACT2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CSGALNACT2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 6:118,084,413...118,116,132
Ensembl chr 6:118,084,413...118,116,101 		JBrowse link
G Csn3 casein kappa multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CSN3 mRNA CTD PMID:21641980 NCBI chr 5:88,073,438...88,080,409
Ensembl chr 5:88,073,438...88,080,524 		JBrowse link
G Csprs component of Sp100-rs multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CSPRS mRNA CTD PMID:21641980
G Csrp2 cysteine and glycine-rich protein 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CSRP2 mRNA CTD PMID:26378955 NCBI chr10:110,756,037...110,775,375
Ensembl chr10:110,755,650...110,775,483 		JBrowse link
G Cst3 cystatin C multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CST3 mRNA CTD PMID:26378955 NCBI chr 2:148,713,642...148,717,432
Ensembl chr 2:148,713,642...148,717,612 		JBrowse link
G Cst7 cystatin F (leukocystatin) multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CST7 mRNA CTD PMID:26378955 NCBI chr 2:150,412,335...150,420,864
Ensembl chr 2:150,412,335...150,420,864 		JBrowse link
G Cstf3 cleavage stimulation factor, 3' pre-RNA, subunit 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CSTF3 mRNA CTD PMID:21641980 NCBI chr 2:104,420,829...104,495,770
Ensembl chr 2:104,420,868...104,495,774 		JBrowse link
G Ctcf CCCTC-binding factor multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CTCF mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of CTCF mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 8:106,351,135...106,409,554
Ensembl chr 8:106,363,200...106,409,554 		JBrowse link
G Ctdspl2 CTD small phosphatase like 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CTDSPL2 mRNA CTD PMID:21641980 NCBI chr 2:121,785,879...121,845,807
Ensembl chr 2:121,786,482...121,844,123 		JBrowse link
G Cth cystathionine gamma lyase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CTH mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CTH mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 3:157,599,885...157,630,718
Ensembl chr 3:157,599,885...157,630,714 		JBrowse link
G Ctla2a cytotoxic T lymphocyte-associated protein 2 alpha multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CTLA2A mRNA CTD PMID:26378955 NCBI chr13:61,081,969...61,084,439
Ensembl chr13:61,081,969...61,084,439 		JBrowse link
G Ctla2b cytotoxic T lymphocyte-associated protein 2 beta multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CTLA2B mRNA CTD PMID:26378955 NCBI chr13:61,043,165...61,045,269
Ensembl chr13:61,043,164...61,045,261 		JBrowse link
G Ctsb cathepsin B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CTSB mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of CTSB mRNA CTD PMID:21641980 PMID:26378955 NCBI chr14:63,359,911...63,383,372
Ensembl chr14:63,359,911...63,383,372 		JBrowse link
G Ctsf cathepsin F multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CTSF mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CTSF mRNA CTD PMID:21641980 PMID:26378955 NCBI chr19:4,905,153...4,910,946
Ensembl chr19:4,905,158...4,910,946 		JBrowse link
G Ctsh cathepsin H multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CTSH mRNA CTD PMID:26378955 NCBI chr 9:89,936,320...89,958,148
Ensembl chr 9:89,936,205...89,958,142 		JBrowse link
G Ctsk cathepsin K multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CTSK mRNA CTD PMID:26378955 NCBI chr 3:95,406,521...95,416,698
Ensembl chr 3:95,406,567...95,416,673 		JBrowse link
G Ctss cathepsin S multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CTSS mRNA CTD PMID:26378955 NCBI chr 3:95,434,097...95,463,716
Ensembl chr 3:95,434,097...95,463,714 		JBrowse link
G Cttnbp2nl CTTNBP2 N-terminal like multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CTTNBP2NL mRNA CTD PMID:21641980 NCBI chr 3:104,909,231...104,960,462
Ensembl chr 3:104,909,231...104,960,462 		JBrowse link
G Cul3 cullin 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CUL3 mRNA CTD PMID:21641980 NCBI chr 1:80,242,640...80,318,426
Ensembl chr 1:80,242,640...80,318,197 		JBrowse link
G Cux1 cut-like homeobox 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CUX1 mRNA CTD PMID:21641980 NCBI chr 5:136,276,989...136,596,429
Ensembl chr 5:136,276,989...136,596,344 		JBrowse link
G Cwc22 CWC22 spliceosome-associated protein multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CWC22 mRNA CTD PMID:21641980 NCBI chr 2:77,706,312...77,776,705
Ensembl chr 2:77,711,503...77,776,719 		JBrowse link
G Cx3cr1 C-X3-C motif chemokine receptor 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CX3CR1 mRNA CTD PMID:21641980 NCBI chr 9:119,877,749...119,897,362
Ensembl chr 9:119,877,749...119,898,945 		JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CXCL10 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CXCL10 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748 		JBrowse link
G Cxcl11 chemokine (C-X-C motif) ligand 11 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CXCL11 mRNA CTD PMID:26378955 NCBI chr 5:92,507,403...92,511,155
Ensembl chr 5:92,507,403...92,513,344 		JBrowse link
G Cxcl13 C-X-C motif chemokine ligand 13 multiple interactions ISO
EXP		 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CXCL13 mRNA CTD PMID:26378955 NCBI chr 5:96,104,785...96,108,927
Ensembl chr 5:96,104,810...96,108,927 		JBrowse link
G Cxcl15 C-X-C motif chemokine ligand 15 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CXCL15 mRNA CTD PMID:26378955 NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926 		JBrowse link
G Cxcl16 C-X-C motif chemokine ligand 16 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CXCL16 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of CXCL16 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:70,345,215...70,350,810
Ensembl chr11:70,344,809...70,350,810 		JBrowse link
G Cxcl2 C-X-C motif chemokine ligand 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CXCL2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CXCL2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 5:91,051,758...91,053,797
Ensembl chr 5:91,051,730...91,053,797 		JBrowse link
G Cxcl3 C-X-C motif chemokine ligand 3 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CXCL1 mRNA CTD PMID:26378955 NCBI chr 5:90,933,960...90,935,952
Ensembl chr 5:90,933,962...90,937,459 		JBrowse link
G Cxcl5 C-X-C motif chemokine ligand 5 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CXCL5 mRNA CTD PMID:26378955 NCBI chr 5:90,907,157...90,909,484
Ensembl chr 5:90,907,219...90,909,483 		JBrowse link
G Cyb5r4 cytochrome b5 reductase 4 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYB5R4 mRNA CTD PMID:26378955 NCBI chr 9:86,904,082...86,959,827
Ensembl chr 9:86,904,067...86,959,827 		JBrowse link
G Cybb cytochrome b-245, beta polypeptide multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYBB mRNA CTD PMID:26378955 NCBI chr  X:9,301,493...9,354,005
Ensembl chr  X:9,301,491...9,354,010 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CYP1A1 mRNA CTD PMID:26378955 NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107 		JBrowse link
G Cyp1b1 cytochrome P450, family 1, subfamily b, polypeptide 1 decreases activity ISO Succimer results in decreased activity of CYP1B1 protein CTD PMID:33814510 NCBI chr17:80,014,369...80,022,490
Ensembl chr17:80,008,966...80,022,490 		JBrowse link
G Cyp20a1 cytochrome P450, family 20, subfamily a, polypeptide 1 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CYP20A1 mRNA CTD PMID:26378955 NCBI chr 1:60,382,459...60,427,219
Ensembl chr 1:60,382,482...60,427,219 		JBrowse link
G Cyp2b10 cytochrome P450, family 2, subfamily b, polypeptide 10 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CYP2B10 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYP2B10 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049 		JBrowse link
G Cyp2c55 cytochrome P450, family 2, subfamily c, polypeptide 55 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CYP2C55 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYP2C55 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr19:38,995,384...39,031,134
Ensembl chr19:38,995,463...39,031,137 		JBrowse link
G Cyp2c68 cytochrome P450, family 2, subfamily c, polypeptide 68 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CYP2C68 mRNA CTD PMID:26378955 NCBI chr19:39,677,280...39,729,545
Ensembl chr19:39,677,278...39,729,498 		JBrowse link
G Cyp2s1 cytochrome P450, family 2, subfamily s, polypeptide 1 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYP2S1 mRNA CTD PMID:26378955 NCBI chr 7:25,501,894...25,515,950
Ensembl chr 7:25,501,900...25,516,338 		JBrowse link
G Cyp4b1 cytochrome P450, family 4, subfamily b, polypeptide 1 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYP4B1 mRNA CTD PMID:26378955 NCBI chr 4:115,481,895...115,504,918
Ensembl chr 4:115,481,922...115,504,920 		JBrowse link
G Cyp4f39 cytochrome P450, family 4, subfamily f, polypeptide 39 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CYP4F39 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYP4F39 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr17:32,671,670...32,712,294
Ensembl chr17:32,671,697...32,712,294 		JBrowse link
G Cyp4v3 cytochrome P450, family 4, subfamily v, polypeptide 3 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CYP4V3 mRNA CTD PMID:26378955 NCBI chr 8:45,758,838...45,786,200
Ensembl chr 8:45,757,981...45,786,253 		JBrowse link
G Cyp51 cytochrome P450, family 51 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CYP51 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CYP51 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 5:4,130,674...4,154,697
Ensembl chr 5:4,131,145...4,154,746 		JBrowse link
G Cyp7b1 cytochrome P450, family 7, subfamily b, polypeptide 1 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of CYP7B1 mRNA CTD PMID:26378955 NCBI chr 3:18,126,108...18,298,054
Ensembl chr 3:18,126,114...18,297,502 		JBrowse link
G Cyrib CYFIP related Rac1 interactor B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of CYRIB mRNA CTD PMID:21641980 NCBI chr15:63,800,943...63,932,627
Ensembl chr15:63,800,946...63,932,327 		JBrowse link
G D10Ertd709e DNA segment, Chr 10, ERATO Doi 709, expressed multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of D10ERTD709E mRNA CTD PMID:21641980
G D13Ertd666e DNA segment, Chr 13, ERATO Doi 666, expressed multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of D13ERTD666E mRNA CTD PMID:21641980
G D13Ertd787e DNA segment, Chr 13, ERATO Doi 787, expressed multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of D13ERTD787E mRNA CTD PMID:21641980
G D3Wsu106e DNA segment, Chr 3, Wayne State University 106, expressed multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of D3WSU106E mRNA CTD PMID:21641980
G Daam1 dishevelled associated activator of morphogenesis 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of DAAM1 mRNA CTD PMID:21641980 NCBI chr12:71,877,834...72,039,150
Ensembl chr12:71,877,852...72,039,107 		JBrowse link
G Dab2 disabled 2, mitogen-responsive phosphoprotein multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DAB2 mRNA CTD PMID:21641980 NCBI chr15:6,329,269...6,470,196
Ensembl chr15:6,329,269...6,470,193 		JBrowse link
G Dcbld2 discoidin, CUB and LCCL domain containing 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of DCBLD2 mRNA CTD PMID:21641980 NCBI chr16:58,228,789...58,304,013
Ensembl chr16:58,228,806...58,290,090 		JBrowse link
G Dcstamp dendrocyte expressed seven transmembrane protein multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of DCSTAMP mRNA CTD PMID:21641980 NCBI chr15:39,609,326...39,624,334
Ensembl chr15:39,609,326...39,624,334 		JBrowse link
G Ddhd1 DDHD domain containing 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DDHD1 mRNA CTD PMID:26378955 NCBI chr14:45,830,628...45,895,600
Ensembl chr14:45,825,924...45,895,600 		JBrowse link
G Ddit3 DNA-damage inducible transcript 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DDIT3 mRNA CTD PMID:21641980 NCBI chr10:127,126,662...127,132,160
Ensembl chr10:127,126,643...127,132,157
Ensembl chr10:127,126,643...127,132,157 		JBrowse link
G Ddx46 DEAD box helicase 46 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DDX46 mRNA CTD PMID:21641980 NCBI chr13:55,782,790...55,829,080
Ensembl chr13:55,782,841...55,829,069 		JBrowse link
G Ddx50 DExD box helicase 50 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DDX50 mRNA CTD PMID:21641980 NCBI chr10:62,451,571...62,487,260
Ensembl chr10:62,451,674...62,486,997 		JBrowse link
G Deptor DEP domain containing MTOR-interacting protein multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DEPTOR mRNA CTD PMID:21641980 NCBI chr15:54,975,824...55,122,667
Ensembl chr15:54,975,713...55,122,667 		JBrowse link
G Dhcr24 24-dehydrocholesterol reductase multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of DHCR24 mRNA CTD PMID:26378955 NCBI chr 4:106,418,279...106,446,310
Ensembl chr 4:106,418,235...106,446,310 		JBrowse link
G Dhx58 DExH-box helicase 58 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of DHX58 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DHX58 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:100,585,710...100,595,165
Ensembl chr11:100,585,710...100,595,097 		JBrowse link
G Dhx9 DExH-box helicase 9 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DHX9 mRNA CTD PMID:21641980 NCBI chr 1:153,331,506...153,363,464
Ensembl chr 1:153,331,504...153,363,406 		JBrowse link
G Dkc1 dyskeratosis congenita 1, dyskerin multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DKC1 mRNA CTD PMID:21641980 NCBI chr  X:74,139,460...74,153,382
Ensembl chr  X:74,139,460...74,153,383 		JBrowse link
G Dlat dihydrolipoamide S-acetyltransferase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DLAT mRNA CTD PMID:21641980 NCBI chr 9:50,545,933...50,571,080
Ensembl chr 9:50,545,933...50,571,080 		JBrowse link
G Dmpk dystrophia myotonica-protein kinase multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of DMPK mRNA CTD PMID:26378955 NCBI chr 7:18,817,571...18,827,746
Ensembl chr 7:18,817,774...18,827,746 		JBrowse link
G Dnaja1 DnaJ heat shock protein family (Hsp40) member A1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DNAJA1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of DNAJA1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 4:40,722,468...40,734,965
Ensembl chr 4:40,722,150...40,737,149 		JBrowse link
G Dnajc2 DnaJ heat shock protein family (Hsp40) member C2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DNAJC2 mRNA CTD PMID:21641980 NCBI chr 5:21,962,279...21,990,183
Ensembl chr 5:21,962,265...21,990,249 		JBrowse link
G Dnajc21 DnaJ heat shock protein family (Hsp40) member C21 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of DNAJC21 mRNA CTD PMID:26378955 NCBI chr15:10,446,849...10,470,685
Ensembl chr15:10,446,842...10,470,602 		JBrowse link
G Dnajc3 DnaJ heat shock protein family (Hsp40) member C3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DNAJC3 mRNA CTD PMID:21641980 NCBI chr14:119,175,371...119,219,114
Ensembl chr14:119,175,388...119,219,109 		JBrowse link
G Dnajc5 DnaJ heat shock protein family (Hsp40) member C5 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of DNAJC5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DNAJC5 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 2:181,162,141...181,194,679
Ensembl chr 2:181,162,278...181,196,926 		JBrowse link
G Dnajc5b DnaJ heat shock protein family (Hsp40) member C5 beta multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of DNAJC5B mRNA CTD PMID:26378955 NCBI chr 3:19,562,755...19,665,026
Ensembl chr 3:19,562,759...19,665,026 		JBrowse link
G Dnmt3l DNA methyltransferase 3-like multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of DNMT3L mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DNMT3L mRNA CTD PMID:21641980 PMID:26378955 NCBI chr10:77,878,121...77,899,456
Ensembl chr10:77,877,781...77,899,456 		JBrowse link
G Dock10 dedicator of cytokinesis 10 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DOCK10 mRNA CTD PMID:21641980 NCBI chr 1:80,478,785...80,736,482
Ensembl chr 1:80,478,790...80,736,244 		JBrowse link
G Dph3 diphthamine biosynthesis 3 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of DPH3 mRNA CTD PMID:26378955 NCBI chr14:31,802,474...31,807,649
Ensembl chr14:31,802,523...31,807,686 		JBrowse link
G Dph5 diphthamide biosynthesis 5 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DPH5 mRNA CTD PMID:21641980 NCBI chr 3:115,681,785...115,728,010
Ensembl chr 3:115,681,486...115,728,010 		JBrowse link
G Dpyd dihydropyrimidine dehydrogenase multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of DPYD mRNA CTD PMID:26378955 NCBI chr 3:118,355,758...119,226,573
Ensembl chr 3:118,355,778...119,226,573 		JBrowse link
G Dpys dihydropyrimidinase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of DPYS mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DPYS mRNA CTD PMID:21641980 PMID:26378955 NCBI chr15:39,631,881...39,720,866
Ensembl chr15:39,631,883...39,720,866 		JBrowse link
G Dsc2 desmocollin 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DSC2 mRNA CTD PMID:26378955 NCBI chr18:20,163,690...20,192,611
Ensembl chr18:20,163,690...20,192,611 		JBrowse link
G Dscc1 DNA replication and sister chromatid cohesion 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DSCC1 mRNA CTD PMID:21641980 NCBI chr15:54,939,497...54,953,887
Ensembl chr15:54,939,495...54,953,887 		JBrowse link
G Dsg2 desmoglein 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DSG2 mRNA CTD PMID:26378955 NCBI chr18:20,691,247...20,737,583
Ensembl chr18:20,691,131...20,737,578 		JBrowse link
G Dtl denticleless E3 ubiquitin protein ligase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DTL mRNA CTD PMID:21641980 NCBI chr 1:191,269,468...191,307,656
Ensembl chr 1:191,269,468...191,307,656 		JBrowse link
G Dtx1 deltex 1, E3 ubiquitin ligase multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DTX1 mRNA CTD PMID:26378955 NCBI chr 5:120,818,268...120,850,879
Ensembl chr 5:120,818,267...120,849,992 		JBrowse link
G Dtx4 deltex 4, E3 ubiquitin ligase multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of DTX4 mRNA CTD PMID:26378955 NCBI chr19:12,443,700...12,479,509
Ensembl chr19:12,443,702...12,478,818 		JBrowse link
G Dusp1 dual specificity phosphatase 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of DUSP1 mRNA CTD PMID:21641980 NCBI chr17:26,724,565...26,727,446
Ensembl chr17:26,724,564...26,781,102 		JBrowse link
G Dusp14 dual specificity phosphatase 14 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of DUSP14 mRNA CTD PMID:21641980 NCBI chr11:83,938,859...83,960,016
Ensembl chr11:83,938,867...83,960,087 		JBrowse link
G Dusp6 dual specificity phosphatase 6 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of DUSP6 mRNA CTD PMID:21641980 NCBI chr10:99,098,676...99,103,351
Ensembl chr10:99,099,093...99,103,351 		JBrowse link
G Dzip3 DAZ interacting protein 3, zinc finger multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of DZIP3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of DZIP3 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr16:48,744,591...48,814,505
Ensembl chr16:48,744,595...48,814,528 		JBrowse link
G E2f2 E2F transcription factor 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of E2F2 mRNA CTD PMID:21641980 NCBI chr 4:135,899,585...135,923,368
Ensembl chr 4:135,899,705...135,923,368 		JBrowse link
G E2f7 E2F transcription factor 7 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of E2F7 mRNA CTD PMID:21641980 NCBI chr10:110,580,799...110,623,245
Ensembl chr10:110,581,300...110,623,245 		JBrowse link
G E2f8 E2F transcription factor 8 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of E2F8 mRNA CTD PMID:21641980 NCBI chr 7:48,516,177...48,531,821
Ensembl chr 7:48,516,177...48,531,344 		JBrowse link
G Ect2 ect2 oncogene multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ECT2 mRNA CTD PMID:21641980 NCBI chr 3:27,151,371...27,207,971
Ensembl chr 3:27,151,371...27,208,027 		JBrowse link
G Edil3 EGF-like repeats and discoidin I-like domains 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of EDIL3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of EDIL3 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr13:88,969,591...89,471,344
Ensembl chr13:88,969,591...89,471,342 		JBrowse link
G Eef1d eukaryotic translation elongation factor 1 delta multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of EEF1D mRNA CTD PMID:21641980 NCBI chr15:75,766,643...75,781,425
Ensembl chr15:75,766,054...75,781,405 		JBrowse link
G Eeig2 EEIG family member 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EEIG2 mRNA CTD PMID:21641980 NCBI chr 3:108,878,313...108,935,588
Ensembl chr 3:108,878,313...108,934,923 		JBrowse link
G Efcab7 EF-hand calcium binding domain 7 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EFCAB7 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of EFCAB7 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 4:99,717,440...99,769,985
Ensembl chr 4:99,717,435...99,769,985 		JBrowse link
G Egfr epidermal growth factor receptor multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of EGFR mRNA CTD PMID:26378955 NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158 		JBrowse link
G Egln3 egl-9 family hypoxia-inducible factor 3 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of EGLN3 mRNA CTD PMID:26378955 NCBI chr12:54,225,767...54,250,660
Ensembl chr12:54,225,767...54,250,646 		JBrowse link
G Egr1 early growth response 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] affects the expression of EGR1 mRNA CTD PMID:26378955 NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037 		JBrowse link
G Egr2 early growth response 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EGR2 mRNA; [Succimer binds to Magnetite Nanoparticles] which results in increased expression of EGR2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of EGR2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr10:67,370,334...67,383,354
Ensembl chr10:67,371,305...67,378,018 		JBrowse link
G Egr3 early growth response 3 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of EGR3 mRNA CTD PMID:26378955 NCBI chr14:70,314,766...70,320,062
Ensembl chr14:70,314,652...70,320,063 		JBrowse link
G Ehd1 EH-domain containing 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of EHD1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of EHD1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr19:6,326,926...6,350,126
Ensembl chr19:6,326,755...6,350,126 		JBrowse link
G Ehd2 EH-domain containing 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of EHD2 mRNA CTD PMID:26378955 NCBI chr 7:15,680,883...15,701,402
Ensembl chr 7:15,680,883...15,701,492 		JBrowse link
G Eif2ak2 eukaryotic translation initiation factor 2-alpha kinase 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of EIF2AK2 mRNA CTD PMID:26378955 NCBI chr17:79,157,933...79,190,001
Ensembl chr17:79,159,993...79,190,002 		JBrowse link
G Eif2s1 eukaryotic translation initiation factor 2, subunit 1 alpha multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EIF2S1 mRNA CTD PMID:21641980 NCBI chr12:78,908,846...78,933,784
Ensembl chr12:78,908,593...78,933,784 		JBrowse link
G Eif2s3y eukaryotic translation initiation factor 2, subunit 3, structural gene Y-linked multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EIF2S3Y mRNA CTD PMID:21641980 NCBI chr  Y:1,010,562...1,049,136
Ensembl chr  Y:1,010,543...1,028,847 		JBrowse link
G Eif3a eukaryotic translation initiation factor 3, subunit A multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EIF3A mRNA CTD PMID:21641980 NCBI chr19:60,749,554...60,779,131
Ensembl chr19:60,749,555...60,779,096 		JBrowse link
G Ell2 elongation factor for RNA polymerase II 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ELL2 mRNA CTD PMID:21641980 NCBI chr13:75,855,603...75,920,480
Ensembl chr13:75,854,876...75,920,483 		JBrowse link
G Eloc elongin C multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ELOC mRNA CTD PMID:21641980 NCBI chr 1:16,711,949...16,727,652
Ensembl chr 1:16,711,949...16,727,266 		JBrowse link
G Elovl6 ELOVL fatty acid elongase 6 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ELOVL6 mRNA CTD PMID:21641980 NCBI chr 3:129,326,035...129,432,144
Ensembl chr 3:129,326,004...129,432,144 		JBrowse link
G Endod1 endonuclease domain containing 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ENDOD1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of ENDOD1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 9:14,265,286...14,292,538
Ensembl chr 9:14,265,286...14,292,803 		JBrowse link
G Eno2 enolase 2, gamma neuronal multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ENO2 mRNA CTD PMID:26378955 NCBI chr 6:124,737,018...124,746,489
Ensembl chr 6:124,737,016...124,746,636 		JBrowse link
G Enpp2 ectonucleotide pyrophosphatase/phosphodiesterase 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ENPP2 mRNA CTD PMID:26378955 NCBI chr15:54,702,297...54,816,284
Ensembl chr15:54,702,297...54,816,288 		JBrowse link
G Epb41l2 erythrocyte membrane protein band 4.1 like 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EPB41L2 mRNA CTD PMID:21641980 NCBI chr10:25,235,680...25,399,413
Ensembl chr10:25,235,696...25,399,417 		JBrowse link
G Epha8 Eph receptor A8 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of EPHA8 mRNA CTD PMID:21641980 NCBI chr 4:136,656,729...136,684,170
Ensembl chr 4:136,656,730...136,684,127 		JBrowse link
G Eps15 epidermal growth factor receptor pathway substrate 15 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of EPS15 mRNA CTD PMID:26378955 NCBI chr 4:109,137,372...109,245,014
Ensembl chr 4:109,137,465...109,245,014 		JBrowse link
G Epsti1 epithelial stromal interaction 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of EPSTI1 mRNA CTD PMID:21641980 NCBI chr14:78,141,679...78,240,096
Ensembl chr14:78,141,679...78,240,097 		JBrowse link
G Erap1 endoplasmic reticulum aminopeptidase 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ERAP1 mRNA CTD PMID:26378955 NCBI chr13:74,787,692...74,841,321
Ensembl chr13:74,787,687...74,841,320 		JBrowse link
G Erbb4 erb-b2 receptor tyrosine kinase 4 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ERBB4 mRNA CTD PMID:26378955 NCBI chr 1:68,071,063...69,147,756
Ensembl chr 1:68,071,345...69,147,218 		JBrowse link
G Ern1 endoplasmic reticulum to nucleus signalling 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ERN1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ERN1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:106,285,474...106,378,701
Ensembl chr11:106,285,476...106,378,678 		JBrowse link
G Ero1a endoplasmic reticulum oxidoreductase 1 alpha multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ERO1A mRNA CTD PMID:26378955 NCBI chr14:45,520,544...45,556,029
Ensembl chr14:45,520,544...45,556,228 		JBrowse link
G Esco2 establishment of sister chromatid cohesion N-acetyltransferase 2 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ESCO2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ESCO2 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ESCO2 mRNA		 CTD PMID:21641980 PMID:26378955 NCBI chr14:66,056,476...66,071,418
Ensembl chr14:66,056,487...66,071,443 		JBrowse link
G Esd esterase D/formylglutathione hydrolase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ESD mRNA CTD PMID:21641980 NCBI chr14:74,969,591...74,988,205
Ensembl chr14:74,969,737...74,988,205 		JBrowse link
G Esr1 estrogen receptor 1 (alpha) multiple interactions ISO Succimer inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ESR1 protein]; Succimer inhibits the reaction [sodium arsenite results in decreased expression of ESR1 protein] CTD PMID:31163222 PMID:32402895 NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614 		JBrowse link
G Ets2 E26 avian leukemia oncogene 2, 3' domain multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ETS2 mRNA CTD PMID:21641980 NCBI chr16:95,503,274...95,522,093
Ensembl chr16:95,502,942...95,522,095 		JBrowse link
G Eva1b eva-1 homolog B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of EVA1B mRNA CTD PMID:21641980 NCBI chr 4:126,039,502...126,043,668
Ensembl chr 4:126,041,537...126,043,668 		JBrowse link
G Evi5 ecotropic viral integration site 5 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EVI5 mRNA CTD PMID:21641980 NCBI chr 5:107,892,661...108,022,973
Ensembl chr 5:107,892,661...108,022,973 		JBrowse link
G Exo1 exonuclease 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EXO1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of EXO1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 1:175,708,334...175,738,962
Ensembl chr 1:175,708,147...175,741,055 		JBrowse link
G Exosc1 exosome component 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EXOSC1 mRNA CTD PMID:21641980 NCBI chr19:41,911,417...41,921,836
Ensembl chr19:41,910,731...41,921,862 		JBrowse link
G Eya4 EYA transcriptional coactivator and phosphatase 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of EYA4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of EYA4 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr10:22,978,861...23,226,785
Ensembl chr10:22,978,862...23,226,684 		JBrowse link
G F13a1 coagulation factor XIII, A1 subunit multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of F13A1 mRNA CTD PMID:26378955 NCBI chr13:37,051,150...37,234,220
Ensembl chr13:37,051,152...37,234,220 		JBrowse link
G F3 coagulation factor III multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of F3 mRNA CTD PMID:26378955 NCBI chr 3:121,517,186...121,528,701
Ensembl chr 3:121,517,186...121,528,697 		JBrowse link
G Fabp4 fatty acid binding protein 4, adipocyte multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of FABP4 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FABP4 mRNA		 CTD PMID:21641980 PMID:26378955 NCBI chr 3:10,269,406...10,273,653
Ensembl chr 3:10,269,148...10,273,636 		JBrowse link
G Fahd2a fumarylacetoacetate hydrolase domain containing 2A multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FAHD2A mRNA CTD PMID:26378955 NCBI chr 2:127,278,135...127,286,491
Ensembl chr 2:127,278,135...127,286,485 		JBrowse link
G Fam13b family with sequence similarity 13, member B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FAM13B mRNA CTD PMID:21641980 NCBI chr18:34,573,624...34,656,096
Ensembl chr18:34,575,404...34,639,884 		JBrowse link
G Fam13c family with sequence similarity 13, member C multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FAM13C mRNA CTD PMID:21641980 NCBI chr10:70,274,981...70,394,566
Ensembl chr10:70,276,311...70,394,566 		JBrowse link
G Fam162a family with sequence similarity 162, member A multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FAM162A mRNA CTD PMID:26378955 NCBI chr16:35,864,214...35,891,931
Ensembl chr16:35,864,131...35,891,964 		JBrowse link
G Fam199x family with sequence similarity 199, X-linked multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FAM199X mRNA CTD PMID:21641980 NCBI chr  X:135,950,343...135,983,252
Ensembl chr  X:135,950,343...135,983,252 		JBrowse link
G Fam20c FAM20C, golgi associated secretory pathway kinase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of FAM20C mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of FAM20C mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 5:138,740,836...138,795,818
Ensembl chr 5:138,740,269...138,795,832 		JBrowse link
G Fam76b family with sequence similarity 76, member B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FAM76B mRNA CTD PMID:21641980 NCBI chr 9:13,738,490...13,766,033
Ensembl chr 9:13,739,012...13,766,283 		JBrowse link
G Fancb Fanconi anemia, complementation group B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FANCB mRNA CTD PMID:21641980 NCBI chr  X:163,763,678...163,780,266
Ensembl chr  X:163,763,588...163,780,268 		JBrowse link
G Far1 fatty acyl CoA reductase 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FAR1 mRNA CTD PMID:21641980 NCBI chr 7:113,113,008...113,170,713
Ensembl chr 7:113,113,041...113,170,718 		JBrowse link
G Fas Fas cell surface death receptor multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of FAS mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of FAS mRNA CTD PMID:21641980 PMID:26378955 NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172 		JBrowse link
G Fbp1 fructose bisphosphatase 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FBP1 mRNA CTD PMID:26378955 NCBI chr13:63,012,567...63,036,112
Ensembl chr13:63,012,567...63,036,096 		JBrowse link
G Fbxo15 F-box protein 15 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of FBXO15 mRNA CTD PMID:21641980 NCBI chr18:84,952,677...84,999,601
Ensembl chr18:84,952,907...84,999,598 		JBrowse link
G Fcgr4 Fc receptor, IgG, low affinity IV multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of FCGR4 mRNA CTD PMID:21641980 NCBI chr 1:170,846,495...170,857,330
Ensembl chr 1:170,846,489...170,857,330 		JBrowse link
G Fez1 fasciculation and elongation protein zeta 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of FEZ1 mRNA CTD PMID:26378955 NCBI chr 9:36,732,694...36,790,220
Ensembl chr 9:36,733,160...36,790,220 		JBrowse link
G Fgd2 FYVE, RhoGEF and PH domain containing 2 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FGD2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FGD2 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of FGD2 mRNA		 CTD PMID:21641980 PMID:26378955 NCBI chr17:29,579,878...29,598,509
Ensembl chr17:29,579,888...29,598,635 		JBrowse link
G Fgd3 FYVE, RhoGEF and PH domain containing 3 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of FGD3 mRNA CTD PMID:26378955 NCBI chr13:49,415,030...49,473,783
Ensembl chr13:49,415,030...49,473,787 		JBrowse link
G Fgd4 FYVE, RhoGEF and PH domain containing 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FGD4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FGD4 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr16:16,234,774...16,418,400
Ensembl chr16:16,234,781...16,418,413 		JBrowse link
G Fgf1 fibroblast growth factor 1 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FGF1 mRNA CTD PMID:26378955 NCBI chr18:38,971,725...39,062,532
Ensembl chr18:38,971,726...39,062,525 		JBrowse link
G Fhit fragile histidine triad gene multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FHIT mRNA CTD PMID:26378955 NCBI chr14:11,307,718...12,919,681
Ensembl chr14:11,307,738...12,919,681 		JBrowse link
G Fip1l1 factor interacting with PAPOLA and CPSF1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FIP1L1 mRNA CTD PMID:21641980 NCBI chr 5:74,695,774...74,759,451
Ensembl chr 5:74,696,110...74,759,461 		JBrowse link
G Fli1 Friend leukemia integration 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FLI1 mRNA CTD PMID:21641980 NCBI chr 9:32,333,500...32,454,292
Ensembl chr 9:32,333,500...32,454,157 		JBrowse link
G Fmn1 formin 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FMN1 mRNA CTD PMID:21641980 NCBI chr 2:113,158,029...113,547,113
Ensembl chr 2:113,158,081...113,547,112 		JBrowse link
G Fn1 fibronectin 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FN1 mRNA CTD PMID:26378955 NCBI chr 1:71,624,632...71,692,439
Ensembl chr 1:71,624,679...71,692,359 		JBrowse link
G Fosl1 fos-like antigen 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of FOSL1 mRNA CTD PMID:21641980 NCBI chr19:5,497,726...5,505,966
Ensembl chr19:5,497,575...5,505,974 		JBrowse link
G Fosl2 fos-like antigen 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of FOSL2 mRNA CTD PMID:21641980 NCBI chr 5:32,292,599...32,315,184
Ensembl chr 5:32,293,145...32,315,186 		JBrowse link
G Foxp1 forkhead box P1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FOXP1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FOXP1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 6:98,902,303...99,510,587
Ensembl chr 6:98,902,299...99,499,682 		JBrowse link
G Frmd4b FERM domain containing 4B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FRMD4B mRNA CTD PMID:21641980 NCBI chr 6:97,263,828...97,594,618
Ensembl chr 6:97,263,828...97,594,502 		JBrowse link
G Fscn1 fascin actin-bundling protein 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of FSCN1 mRNA CTD PMID:21641980 NCBI chr 5:142,946,110...142,958,944
Ensembl chr 5:142,946,098...142,958,940 		JBrowse link
G Fshb follicle stimulating hormone beta multiple interactions ISO Succimer inhibits the reaction [sodium arsenite results in decreased expression of FSHB protein] CTD PMID:31163222 NCBI chr 2:106,886,331...106,889,996
Ensembl chr 2:106,886,485...106,890,001 		JBrowse link
G Fth1 ferritin heavy polypeptide 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of FTH1 mRNA CTD PMID:26378955 NCBI chr19:9,957,964...9,962,475
Ensembl chr19:9,957,962...9,962,462 		JBrowse link
G Fubp1 far upstream element (FUSE) binding protein 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FUBP1 mRNA CTD PMID:21641980 NCBI chr 3:151,916,059...151,942,467
Ensembl chr 3:151,916,059...151,942,463 		JBrowse link
G Fus fused in sarcoma multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FUS mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FUS mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 7:127,565,276...127,581,204
Ensembl chr 7:127,566,629...127,584,873 		JBrowse link
G Fut11 fucosyltransferase 11 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FUT11 mRNA CTD PMID:21641980 NCBI chr14:20,745,036...20,750,265
Ensembl chr14:20,745,036...20,751,084 		JBrowse link
G Fxyd2 FXYD domain-containing ion transport regulator 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FXYD2 mRNA CTD PMID:21641980 NCBI chr 9:45,311,007...45,321,576
Ensembl chr 9:45,310,967...45,321,576 		JBrowse link
G Fyco1 FYVE and coiled-coil domain containing 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of FYCO1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of FYCO1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 9:123,618,565...123,681,110
Ensembl chr 9:123,618,565...123,680,964 		JBrowse link
G Fyn Fyn proto-oncogene multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FYN mRNA CTD PMID:26378955 NCBI chr10:39,245,735...39,441,377
Ensembl chr10:39,244,851...39,441,377 		JBrowse link
G Fzd10 frizzled class receptor 10 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FZD10 mRNA CTD PMID:26378955 NCBI chr 5:128,678,170...128,681,157
Ensembl chr 5:128,677,908...128,681,157 		JBrowse link
G Fzd7 frizzled class receptor 7 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of FZD7 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of FZD7 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 1:59,521,306...59,526,114
Ensembl chr 1:59,521,583...59,526,114 		JBrowse link
G G2e3 G2/M-phase specific E3 ubiquitin ligase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of G2E3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of G2E3 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr12:51,395,013...51,423,769
Ensembl chr12:51,394,844...51,423,769 		JBrowse link
G Gabpb1 GA repeat binding protein, beta 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GABPB1 mRNA CTD PMID:21641980 NCBI chr 2:126,470,832...126,527,184
Ensembl chr 2:126,469,362...126,518,257 		JBrowse link
G Gadd45a growth arrest and DNA-damage-inducible 45 alpha multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GADD45A mRNA CTD PMID:21641980 NCBI chr 6:67,012,080...67,014,391
Ensembl chr 6:67,012,080...67,014,441 		JBrowse link
G Gadd45b growth arrest and DNA-damage-inducible 45 beta multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GADD45B mRNA CTD PMID:21641980 NCBI chr10:80,765,925...80,768,038
Ensembl chr10:80,765,907...80,768,038 		JBrowse link
G Galnt1 polypeptide N-acetylgalactosaminyltransferase 1 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] affects the expression of GALNT1 mRNA CTD PMID:26378955 NCBI chr18:24,338,401...24,419,873
Ensembl chr18:24,338,401...24,419,875 		JBrowse link
G Galnt7 polypeptide N-acetylgalactosaminyltransferase 7 multiple interactions EXP
ISO		 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GALNT7 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GALNT7 mRNA		 CTD PMID:26378955 NCBI chr 8:57,976,859...58,106,089
Ensembl chr 8:57,976,862...58,106,066 		JBrowse link
G Garin5a golgi associated RAB2 interactor 5A multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GARIN5A mRNA CTD PMID:21641980 NCBI chr 7:44,145,923...44,153,690
Ensembl chr 7:44,146,005...44,150,910 		JBrowse link
G Gas5 growth arrest specific 5 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GAS5 mRNA CTD PMID:21641980 NCBI chr 1:160,862,171...160,866,109
Ensembl chr 1:160,861,992...160,866,116 		JBrowse link
G Gas6 growth arrest specific 6 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GAS6 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GAS6 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 8:13,515,374...13,544,535
Ensembl chr 8:13,515,374...13,544,490 		JBrowse link
G Gask1b golgi associated kinase 1B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GASK1B mRNA CTD PMID:21641980 NCBI chr 3:79,791,795...79,853,585
Ensembl chr 3:79,791,840...79,853,587 		JBrowse link
G Gbp2b guanylate binding protein 2b multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GBP1 mRNA CTD PMID:21641980 NCBI chr 3:142,300,577...142,324,940
Ensembl chr 3:142,300,608...142,324,940 		JBrowse link
G Gbp9 guanylate-binding protein 9 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GBP6 mRNA CTD PMID:21641980 NCBI chr 5:105,224,331...105,258,255
Ensembl chr 5:105,225,496...105,287,405 		JBrowse link
G Gca grancalcin multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GCA mRNA CTD PMID:26378955 NCBI chr 2:62,494,671...62,524,453
Ensembl chr 2:62,494,629...62,524,453 		JBrowse link
G Gch1 GTP cyclohydrolase 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GCH1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GCH1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr14:47,391,352...47,426,870
Ensembl chr14:47,391,352...47,426,870 		JBrowse link
G Gclc glutamate-cysteine ligase, catalytic subunit multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GCLC mRNA CTD PMID:26378955 NCBI chr 9:77,661,817...77,701,771
Ensembl chr 9:77,661,817...77,701,767 		JBrowse link
G Gclm glutamate-cysteine ligase, modifier subunit multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GCLM mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GCLM mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 3:122,039,206...122,060,864
Ensembl chr 3:122,039,206...122,064,381 		JBrowse link
G Gda guanine deaminase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GDA mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GDA mRNA CTD PMID:21641980 PMID:26378955 NCBI chr19:21,368,671...21,450,025
Ensembl chr19:21,368,671...21,450,809 		JBrowse link
G Gfod1 glucose-fructose oxidoreductase domain containing 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GFOD1 mRNA CTD PMID:21641980 NCBI chr13:43,348,716...43,457,648
Ensembl chr13:43,348,721...43,457,648 		JBrowse link
G Ggt1 gamma-glutamyltransferase 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GGT1 mRNA CTD PMID:26378955 NCBI chr10:75,396,910...75,422,027
Ensembl chr10:75,397,438...75,422,034 		JBrowse link
G Gigyf2 GRB10 interacting GYF protein 2 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GIGYF2 mRNA CTD PMID:26378955 NCBI chr 1:87,254,653...87,378,532
Ensembl chr 1:87,254,720...87,378,518 		JBrowse link
G Gja1 gap junction protein, alpha 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GJA1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of GJA1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr10:56,253,297...56,266,519
Ensembl chr10:56,253,426...56,278,609 		JBrowse link
G Glg1 golgi apparatus protein 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GLG1 mRNA CTD PMID:26378955 NCBI chr 8:111,879,916...111,985,842
Ensembl chr 8:111,881,053...111,985,848 		JBrowse link
G Gli3 GLI-Kruppel family member GLI3 multiple interactions ISO
EXP		 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GLI3 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GLI3 mRNA		 CTD PMID:26378955 NCBI chr13:15,638,308...15,904,611
Ensembl chr13:15,637,820...15,904,611 		JBrowse link
G Glipr1 GLI pathogenesis related 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GLIPR1 mRNA CTD PMID:26378955 NCBI chr10:111,821,353...111,838,539
Ensembl chr10:111,821,353...111,838,536 		JBrowse link
G Glrx glutaredoxin multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GLRX mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GLRX mRNA CTD PMID:21641980 PMID:26378955 NCBI chr13:75,988,004...75,998,270
Ensembl chr13:75,987,987...75,998,273 		JBrowse link
G Gmnn geminin multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GMNN mRNA CTD PMID:21641980 NCBI chr13:24,935,828...24,954,222
Ensembl chr13:24,935,828...24,945,906 		JBrowse link
G Gmps guanine monophosphate synthetase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GMPS mRNA CTD PMID:21641980 NCBI chr 3:63,871,054...63,928,975
Ensembl chr 3:63,883,527...63,930,000 		JBrowse link
G Gna13 guanine nucleotide binding protein, alpha 13 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GNA13 mRNA CTD PMID:26378955 NCBI chr11:109,253,620...109,292,195
Ensembl chr11:109,253,657...109,292,195 		JBrowse link
G Gnai2 G protein subunit alpha i2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GNAI2 mRNA CTD PMID:26378955 NCBI chr 9:107,491,324...107,512,542
Ensembl chr 9:107,491,324...107,512,566 		JBrowse link
G Gnaq guanine nucleotide binding protein, alpha q polypeptide multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GNAQ mRNA CTD PMID:26378955 NCBI chr19:16,110,048...16,365,884
Ensembl chr19:16,110,195...16,364,827 		JBrowse link
G Gng4 guanine nucleotide binding protein (G protein), gamma 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GNG4 mRNA CTD PMID:21641980 NCBI chr13:13,958,644...14,002,480
Ensembl chr13:13,958,644...14,002,481 		JBrowse link
G Golga4 golgin A4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GOLGA4 mRNA CTD PMID:21641980 NCBI chr 9:118,335,280...118,411,587
Ensembl chr 9:118,335,335...118,411,587 		JBrowse link
G Gpatch4 G patch domain containing 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GPATCH4 mRNA CTD PMID:21641980 NCBI chr 3:87,950,413...87,963,301
Ensembl chr 3:87,950,415...87,963,300 		JBrowse link
G Gpbp1 GC-rich promoter binding protein 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GPBP1 mRNA CTD PMID:21641980 NCBI chr13:111,562,214...111,626,658
Ensembl chr13:111,562,214...111,626,645 		JBrowse link
G Gpd2 glycerol phosphate dehydrogenase 2, mitochondrial multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of GPD2 mRNA CTD PMID:26378955 NCBI chr 2:57,127,690...57,260,731
Ensembl chr 2:57,127,647...57,260,731 		JBrowse link
G Gpr150 G protein-coupled receptor 150 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GPR150 mRNA CTD PMID:21641980 NCBI chr13:76,202,970...76,205,115
Ensembl chr13:76,202,970...76,205,115 		JBrowse link
G Gpr155 G protein-coupled receptor 155 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GPR155 mRNA CTD PMID:21641980 NCBI chr 2:73,171,850...73,216,842
Ensembl chr 2:73,171,850...73,216,916 		JBrowse link
G Gpr84 G protein-coupled receptor 84 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GPR84 mRNA CTD PMID:21641980 NCBI chr15:103,216,660...103,219,050
Ensembl chr15:103,216,662...103,219,039 		JBrowse link
G Gpr85 G protein-coupled receptor 85 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GPR85 mRNA CTD PMID:21641980 NCBI chr 6:13,834,405...13,839,951
Ensembl chr 6:13,834,457...13,839,941 		JBrowse link
G Gpt glutamic pyruvic transaminase, soluble multiple interactions ISO Succimer inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased activity of GPT protein] CTD PMID:32402895 NCBI chr15:76,580,926...76,583,875
Ensembl chr15:76,579,916...76,583,886 		JBrowse link
G Gramd1b GRAM domain containing 1B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GRAMD1B mRNA CTD PMID:21641980 NCBI chr 9:40,204,529...40,443,656
Ensembl chr 9:40,204,529...40,442,679 		JBrowse link
G Grap GRB2-related adaptor protein multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GRAP mRNA CTD PMID:21641980 NCBI chr11:61,544,081...61,563,610
Ensembl chr11:61,544,091...61,563,610 		JBrowse link
G Grcc10 gene rich cluster, C10 gene multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GRCC10 mRNA CTD PMID:21641980 NCBI chr 6:124,716,146...124,718,032
Ensembl chr 6:124,716,146...124,718,337 		JBrowse link
G Gsap gamma-secretase activating protein multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GSAP mRNA CTD PMID:21641980 NCBI chr 5:21,380,767...21,518,423
Ensembl chr 5:21,391,253...21,520,130 		JBrowse link
G Gsg1 germ cell associated 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GSG1 mRNA CTD PMID:21641980 NCBI chr 6:135,214,327...135,231,334
Ensembl chr 6:135,214,324...135,231,349
Ensembl chr 6:135,214,324...135,231,349 		JBrowse link
G Gsk3b glycogen synthase kinase 3 beta multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GSK3B mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of GSK3B mRNA CTD PMID:21641980 PMID:26378955 NCBI chr16:37,909,363...38,066,446
Ensembl chr16:37,909,363...38,066,446 		JBrowse link
G Gsn gelsolin multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GSN mRNA CTD PMID:26378955 NCBI chr 2:35,146,371...35,197,914
Ensembl chr 2:35,146,392...35,197,904 		JBrowse link
G Gsta1 glutathione S-transferase, alpha 1 (Ya) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GSTA1 mRNA CTD PMID:21641980 NCBI chr 9:78,137,951...78,149,965
Ensembl chr 9:78,137,938...78,149,966 		JBrowse link
G Gsta2 glutathione S-transferase, alpha 2 (Yc2) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of GSTA2 mRNA CTD PMID:21641980 NCBI chr 9:78,238,300...78,254,474
Ensembl chr 9:78,238,300...78,263,070 		JBrowse link
G Gtf3c2 general transcription factor IIIC, polypeptide 2, beta multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of GTF3C2 mRNA CTD PMID:21641980 NCBI chr 5:31,313,350...31,337,488
Ensembl chr 5:31,313,349...31,337,488 		JBrowse link
G Gucy1b1 guanylate cyclase 1, soluble, beta 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of GUCY1B1 mRNA CTD PMID:26378955 NCBI chr 3:81,939,311...81,982,018
Ensembl chr 3:81,939,313...81,981,996 		JBrowse link
G H1f2 H1.2 linker histone, cluster member multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of H1F2 mRNA CTD PMID:21641980 NCBI chr13:23,922,790...23,923,514
Ensembl chr13:23,922,791...23,924,350 		JBrowse link
G H2-Eb1 histocompatibility 2, class II antigen E beta multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of H2-EB1 mRNA CTD PMID:21641980 NCBI chr17:34,524,841...34,535,648
Ensembl chr17:34,524,841...34,535,648 		JBrowse link
G H2-T23 histocompatibility 2, T region locus 23 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of H2-T23 mRNA CTD PMID:21641980 NCBI chr17:36,340,869...36,343,593
Ensembl chr17:36,340,665...36,343,747 		JBrowse link
G H2-T24 histocompatibility 2, T region locus 24 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of H2-T24 mRNA CTD PMID:21641980 NCBI chr17:36,314,363...36,331,689
Ensembl chr17:36,316,587...36,331,452 		JBrowse link
G H2ac7 H2A clustered histone 7 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of H2AC7 mRNA CTD PMID:21641980 NCBI chr13:23,758,555...23,759,089
Ensembl chr13:23,758,555...23,759,126 		JBrowse link
G H2bc4 H2B clustered histone 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of H2BC4 mRNA CTD PMID:21641980 NCBI chr13:23,868,182...23,876,805
Ensembl chr13:23,868,182...23,876,891 		JBrowse link
G H3c7 H3 clustered histone 7 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of H3C15 mRNA CTD PMID:21641980 NCBI chr13:23,728,222...23,729,124
Ensembl chr13:23,728,222...23,729,482 		JBrowse link
G H3f3b H3.3 histone B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of H3F3B mRNA CTD PMID:21641980 NCBI chr11:115,912,787...115,921,313
Ensembl chr11:115,912,738...115,918,788 		JBrowse link
G H4c1 H4 clustered histone 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of H4C1 mRNA CTD PMID:21641980 NCBI chr13:23,944,778...23,945,232
Ensembl chr13:23,944,675...23,945,213 		JBrowse link
G H60a histocompatibility 60a multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of H60A mRNA CTD PMID:21641980
G Haghl hydroxyacylglutathione hydrolase-like multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HAGHL mRNA CTD PMID:26378955 NCBI chr17:25,998,817...26,004,560
Ensembl chr17:25,998,817...26,004,647 		JBrowse link
G Hao1 hydroxyacid oxidase 1, liver multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of HAO1 mRNA CTD PMID:21641980 NCBI chr 2:134,339,281...134,396,272
Ensembl chr 2:134,339,281...134,396,288 		JBrowse link
G Haus6 HAUS augmin-like complex, subunit 6 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HAUS6 mRNA CTD PMID:21641980 NCBI chr 4:86,497,092...86,530,317
Ensembl chr 4:86,497,092...86,530,292 		JBrowse link
G Havcr2 hepatitis A virus cellular receptor 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HAVCR2 mRNA CTD PMID:21641980 NCBI chr11:46,345,758...46,372,082
Ensembl chr11:46,345,762...46,372,082 		JBrowse link
G Hbb-y hemoglobin Y, beta-like embryonic chain multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HBB-Y mRNA CTD PMID:26378955 NCBI chr 7:103,500,961...103,502,414
Ensembl chr 7:103,500,956...103,502,423 		JBrowse link
G Hbegf heparin-binding EGF-like growth factor multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of HBEGF mRNA CTD PMID:21641980 NCBI chr18:36,637,980...36,648,858
Ensembl chr18:36,637,980...36,648,858 		JBrowse link
G Hdac9 histone deacetylase 9 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HDAC9 mRNA CTD PMID:26378955 NCBI chr12:34,097,579...34,967,094
Ensembl chr12:34,097,579...34,967,094 		JBrowse link
G Hdc histidine decarboxylase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of HDC mRNA CTD PMID:21641980 NCBI chr 2:126,435,579...126,465,942
Ensembl chr 2:126,435,587...126,461,219 		JBrowse link
G Hectd1 HECT domain E3 ubiquitin protein ligase 1 multiple interactions EXP
ISO		 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HECTD1 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of HECTD1 mRNA		 CTD PMID:26378955 NCBI chr12:51,790,504...51,876,540
Ensembl chr12:51,790,505...51,876,319 		JBrowse link
G Hells helicase, lymphoid specific multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HELLS mRNA CTD PMID:21641980 NCBI chr19:38,913,282...38,958,914
Ensembl chr19:38,919,359...38,959,495 		JBrowse link
G Helz helicase with zinc finger domain multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HELZ mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HELZ mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:107,437,789...107,584,652
Ensembl chr11:107,438,756...107,584,652 		JBrowse link
G Herpud1 homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HERPUD1 mRNA CTD PMID:26378955 NCBI chr 8:95,113,057...95,121,999
Ensembl chr 8:95,113,066...95,122,005 		JBrowse link
G Hfe homeostatic iron regulator multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HFE mRNA CTD PMID:26378955 NCBI chr13:23,886,017...23,894,837
Ensembl chr13:23,886,017...23,894,837 		JBrowse link
G Hip1 huntingtin interacting protein 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HIP1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HIP1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 5:135,435,350...135,574,167
Ensembl chr 5:135,435,385...135,573,974 		JBrowse link
G Hivep1 human immunodeficiency virus type I enhancer binding protein 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HIVEP1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HIVEP1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr13:42,205,304...42,338,504
Ensembl chr13:42,205,497...42,346,013 		JBrowse link
G Hivep3 human immunodeficiency virus type I enhancer binding protein 3 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of HIVEP3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of HIVEP3 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 4:119,590,982...119,992,608
Ensembl chr 4:119,590,981...119,995,242 		JBrowse link
G Hk3 hexokinase 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of HK3 mRNA CTD PMID:21641980 NCBI chr13:55,153,798...55,169,233
Ensembl chr13:55,153,798...55,169,198 		JBrowse link
G Hmgb1-ps7 high-mobility group high mobility group box 1, pseudogene 7 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HMGB1-PS7 mRNA CTD PMID:21641980 NCBI chr 7:41,670,149...41,671,427
Ensembl chr 7:41,670,260...41,670,907 		JBrowse link
G Hmgb2 high mobility group box 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HMGB2 mRNA CTD PMID:21641980 NCBI chr 8:57,964,877...57,969,033
Ensembl chr 8:57,964,941...57,969,033 		JBrowse link
G Hmgcs1 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HMGCS1 mRNA CTD PMID:21641980 NCBI chr13:120,151,887...120,169,796
Ensembl chr13:120,151,915...120,169,796 		JBrowse link
G Hmmr hyaluronan mediated motility receptor (RHAMM) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HMMR mRNA CTD PMID:21641980 NCBI chr11:40,592,215...40,624,290
Ensembl chr11:40,592,222...40,624,249 		JBrowse link
G Hmox1 heme oxygenase 1 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of HMOX1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of HMOX1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 8:75,820,246...75,827,221
Ensembl chr 8:75,820,249...75,827,217 		JBrowse link
G Hmx2 H6 homeobox 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of HMX2 mRNA CTD PMID:21641980 NCBI chr 7:131,150,486...131,159,743
Ensembl chr 7:131,150,502...131,159,743 		JBrowse link
G Hnrnpa2b1 heterogeneous nuclear ribonucleoprotein A2/B1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HNRNPA2B1 mRNA CTD PMID:21641980 NCBI chr 6:51,437,414...51,448,054
Ensembl chr 6:51,437,912...51,446,874 		JBrowse link
G Hnrnpa3 heterogeneous nuclear ribonucleoprotein A3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HNRNPA3 mRNA CTD PMID:21641980 NCBI chr 2:75,489,416...75,499,751
Ensembl chr 2:75,489,605...75,499,751 		JBrowse link
G Hnrnpdl heterogeneous nuclear ribonucleoprotein D-like multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HNRNPDL mRNA CTD PMID:21641980 NCBI chr 5:100,181,436...100,187,769
Ensembl chr 5:100,181,436...100,187,523 		JBrowse link
G Hnrnph1 heterogeneous nuclear ribonucleoprotein H1 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HNRNPH1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HNRNPH1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:50,266,084...50,277,355
Ensembl chr11:50,267,817...50,277,355 		JBrowse link
G Hnrnph3 heterogeneous nuclear ribonucleoprotein H3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HNRNPH3 mRNA CTD PMID:21641980 NCBI chr10:62,850,443...62,859,764
Ensembl chr10:62,850,443...62,859,996 		JBrowse link
G Hpd 4-hydroxyphenylpyruvic acid dioxygenase multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HPD mRNA CTD PMID:26378955 NCBI chr 5:123,309,870...123,320,786
Ensembl chr 5:123,309,870...123,320,790 		JBrowse link
G Hpgds hematopoietic prostaglandin D synthase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HPGDS mRNA CTD PMID:21641980 NCBI chr 6:65,094,019...65,121,960
Ensembl chr 6:65,094,277...65,121,892 		JBrowse link
G Hsp90b1 heat shock protein 90, beta (Grp94), member 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HSP90B1 mRNA CTD PMID:21641980 NCBI chr10:86,526,705...86,541,308
Ensembl chr10:86,526,073...86,541,373 		JBrowse link
G Hspa1b heat shock protein 1B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HSPA1B mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of HSPA1B mRNA CTD PMID:21641980 PMID:26378955 NCBI chr17:35,175,405...35,178,214
Ensembl chr17:35,175,412...35,178,214 		JBrowse link
G Hspa4 heat shock protein 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HSPA4 mRNA CTD PMID:21641980 NCBI chr11:53,150,641...53,191,306
Ensembl chr11:53,150,641...53,191,284 		JBrowse link
G Hunk hormonally upregulated Neu-associated kinase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of HUNK mRNA CTD PMID:21641980 NCBI chr16:90,182,550...90,296,443
Ensembl chr16:90,182,901...90,296,441 		JBrowse link
G Hycc1 hyccin PI4KA lipid kinase complex subunit 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HYCC1 mRNA CTD PMID:21641980 NCBI chr 5:24,120,274...24,235,694
Ensembl chr 5:24,120,274...24,235,688 		JBrowse link
G Hycc2 hyccin PI4KA lipid kinase complex subunit 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of HYCC2 mRNA CTD PMID:21641980 NCBI chr 1:58,561,965...58,625,492
Ensembl chr 1:58,561,965...58,625,482 		JBrowse link
G Icam1 intercellular adhesion molecule 1 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ICAM1 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ICAM1 mRNA		 CTD PMID:21641980 PMID:26378955 NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113 		JBrowse link
G Id1 inhibitor of DNA binding 1, HLH protein multiple interactions ISO
EXP		 [Magnetite Nanoparticles co-treated with Succimer] results in decreased expression of ID1 mRNA
[Magnetite Nanoparticles co-treated with Succimer] affects the expression of ID1 mRNA		 CTD PMID:25522732 NCBI chr 2:152,578,171...152,579,330
Ensembl chr 2:152,578,171...152,579,330 		JBrowse link
G Id2 inhibitor of DNA binding 2 multiple interactions ISO
EXP		 [Magnetite Nanoparticles co-treated with Succimer] affects the expression of ID2 mRNA CTD PMID:25522732 NCBI chr12:25,143,798...25,146,091
Ensembl chr12:25,143,798...25,147,139 		JBrowse link
G Id3 inhibitor of DNA binding 3 multiple interactions EXP
ISO		 [Magnetite Nanoparticles co-treated with Succimer] results in decreased expression of ID3 mRNA; [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ID3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ID3 mRNA CTD PMID:21641980 PMID:25522732 PMID:26378955 NCBI chr 4:135,871,133...135,872,703
Ensembl chr 4:135,870,808...135,873,066 		JBrowse link
G Id4 inhibitor of DNA binding 4 multiple interactions ISO
EXP		 [Magnetite Nanoparticles co-treated with Succimer] affects the expression of ID4 mRNA CTD PMID:25522732 NCBI chr13:48,414,592...48,419,504
Ensembl chr13:48,414,704...48,419,502 		JBrowse link
G Ide insulin degrading enzyme multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IDE mRNA CTD PMID:26378955 NCBI chr19:37,246,140...37,341,664
Ensembl chr19:37,246,142...37,340,010 		JBrowse link
G Idi1 isopentenyl-diphosphate delta isomerase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IDI1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IDI1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr13:8,935,642...8,942,432
Ensembl chr13:8,935,537...8,942,487 		JBrowse link
G Ier3 immediate early response 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IER3 mRNA CTD PMID:21641980 NCBI chr17:36,132,605...36,133,803
Ensembl chr17:36,132,576...36,133,815 		JBrowse link
G Ifi202b interferon activated gene 202B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IFI202B mRNA CTD PMID:21641980 NCBI chr 1:173,790,135...173,810,410
Ensembl chr 1:173,790,134...173,810,310 		JBrowse link
G Ifi203 interferon activated gene 203 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IFI203 mRNA CTD PMID:21641980 NCBI chr 1:173,747,966...173,770,432
Ensembl chr 1:173,747,973...173,770,238 		JBrowse link
G Ifi204 interferon activated gene 204 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IFI16 mRNA CTD PMID:26378955 NCBI chr 1:173,574,859...173,594,606
Ensembl chr 1:173,574,859...173,594,509 		JBrowse link
G Ifi211 interferon activated gene 211 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MNDA mRNA CTD PMID:21641980 NCBI chr 1:173,723,907...173,740,650
Ensembl chr 1:173,723,911...173,740,612 		JBrowse link
G Ifi213 interferon activated gene 213 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IFI213 mRNA CTD PMID:21641980 NCBI chr 1:173,393,849...173,426,868
Ensembl chr 1:173,393,849...173,426,840 		JBrowse link
G Ifi27 interferon, alpha-inducible protein 27 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IFI27 mRNA CTD PMID:26378955 NCBI chr12:103,400,448...103,406,504
Ensembl chr12:103,400,470...103,406,498 		JBrowse link
G Ifi27l2a interferon, alpha-inducible protein 27 like 2A multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IFI27L2A mRNA CTD PMID:21641980 NCBI chr12:103,400,132...103,409,939
Ensembl chr12:103,408,426...103,409,939 		JBrowse link
G Ifi35 interferon-induced protein 35 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IFI35 mRNA CTD PMID:21641980 NCBI chr11:101,339,238...101,349,527
Ensembl chr11:101,339,233...101,349,524 		JBrowse link
G Ifi44 interferon-induced protein 44 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IFI44 mRNA CTD PMID:21641980 NCBI chr 3:151,436,559...151,455,580
Ensembl chr 3:151,436,559...151,455,597 		JBrowse link
G Ifi44l interferon-induced protein 44 like multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IFI44L mRNA CTD PMID:21641980 NCBI chr 3:151,464,374...151,468,528
Ensembl chr 3:151,464,374...151,468,529 		JBrowse link
G Ifih1 interferon induced with helicase C domain 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IFIH1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IFIH1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 2:62,426,137...62,476,599
Ensembl chr 2:62,426,142...62,476,599 		JBrowse link
G Ifit1 interferon-induced protein with tetratricopeptide repeats 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IFIT1 mRNA CTD PMID:21641980 NCBI chr19:34,618,289...34,627,409
Ensembl chr19:34,618,271...34,627,409 		JBrowse link
G Ifit3 interferon-induced protein with tetratricopeptide repeats 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IFIT3 mRNA CTD PMID:21641980 NCBI chr19:34,560,519...34,566,382
Ensembl chr19:34,560,931...34,566,131 		JBrowse link
G Ifnar2 interferon (alpha and beta) receptor 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IFNAR2 mRNA CTD PMID:21641980 NCBI chr16:91,166,517...91,202,477
Ensembl chr16:91,169,671...91,202,477 		JBrowse link
G Ift57 intraflagellar transport 57 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IFT57 mRNA CTD PMID:26378955 NCBI chr16:49,519,657...49,585,489
Ensembl chr16:49,519,596...49,585,489 		JBrowse link
G Ift74 intraflagellar transport 74 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IFT74 mRNA CTD PMID:21641980 NCBI chr 4:94,491,503...94,581,470
Ensembl chr 4:94,502,728...94,581,466 		JBrowse link
G Ift80 intraflagellar transport 80 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IFT80 mRNA CTD PMID:21641980 NCBI chr 3:68,799,832...68,911,939
Ensembl chr 3:68,799,832...68,911,892 		JBrowse link
G Igf1 insulin-like growth factor 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IGF1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IGF1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904 		JBrowse link
G Igf1r insulin-like growth factor I receptor multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IGF1R mRNA CTD PMID:26378955 NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416 		JBrowse link
G Igf2bp1 insulin-like growth factor 2 mRNA binding protein 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IGF2BP1 mRNA CTD PMID:26378955 NCBI chr11:95,847,989...95,896,770
Ensembl chr11:95,847,989...95,896,766 		JBrowse link
G Igf2bp2 insulin-like growth factor 2 mRNA binding protein 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IGF2BP2 mRNA CTD PMID:21641980 NCBI chr16:21,877,759...21,982,049
Ensembl chr16:21,877,759...21,982,049 		JBrowse link
G Igfbp1 insulin-like growth factor binding protein 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IGFBP1 mRNA CTD PMID:26378955 NCBI chr11:7,147,787...7,152,546
Ensembl chr11:7,147,782...7,152,546 		JBrowse link
G Igfbp3 insulin-like growth factor binding protein 3 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IGFBP3 mRNA CTD PMID:26378955 NCBI chr11:7,156,086...7,165,498
Ensembl chr11:7,156,086...7,163,923 		JBrowse link
G Igfbp4 insulin-like growth factor binding protein 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IGFBP4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IGFBP4 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:98,930,820...98,943,481
Ensembl chr11:98,932,070...98,945,218 		JBrowse link
G Igfbp5 insulin-like growth factor binding protein 5 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IGFBP5 mRNA CTD PMID:26378955 NCBI chr 1:72,897,224...72,914,024
Ensembl chr 1:72,897,091...72,914,043 		JBrowse link
G Igfbp6 insulin-like growth factor binding protein 6 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IGFBP6 mRNA CTD PMID:26378955 NCBI chr15:102,052,621...102,057,947
Ensembl chr15:102,052,797...102,057,946 		JBrowse link
G Iglc2 immunoglobulin lambda constant 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IGLC2 mRNA CTD PMID:21641980 NCBI chr16:19,017,286...19,017,602
Ensembl chr16:19,017,146...19,019,101 		JBrowse link
G Igsf3 immunoglobulin superfamily, member 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IGSF3 mRNA CTD PMID:21641980 NCBI chr 3:101,284,306...101,370,375
Ensembl chr 3:101,284,399...101,370,375 		JBrowse link
G Igsf6 immunoglobulin superfamily, member 6 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IGSF6 mRNA CTD PMID:21641980 NCBI chr 7:120,663,290...120,673,753
Ensembl chr 7:120,663,290...120,673,795 		JBrowse link
G Igtp interferon gamma induced GTPase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IGTP mRNA CTD PMID:21641980 NCBI chr11:58,090,382...58,098,418
Ensembl chr11:58,090,382...58,098,417 		JBrowse link
G Ihh Indian hedgehog multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IHH mRNA CTD PMID:26378955 NCBI chr 1:74,984,474...74,990,831
Ensembl chr 1:74,984,474...74,990,831 		JBrowse link
G Ikbke inhibitor of kappaB kinase epsilon multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IKBKE mRNA CTD PMID:21641980 NCBI chr 1:131,182,337...131,207,339
Ensembl chr 1:131,182,080...131,207,344 		JBrowse link
G Ikbkg inhibitor of kappaB kinase gamma multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IKBKG mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IKBKG mRNA CTD PMID:21641980 PMID:26378955 NCBI chr  X:73,436,883...73,498,013
Ensembl chr  X:73,436,896...73,497,460 		JBrowse link
G Ikzf1 IKAROS family zinc finger 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IKZF1 mRNA CTD PMID:26378955 NCBI chr11:11,634,970...11,722,930
Ensembl chr11:11,634,980...11,722,926 		JBrowse link
G Ikzf5 IKAROS family zinc finger 5 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of IKZF5 mRNA CTD PMID:26378955 NCBI chr 7:130,990,378...131,012,243
Ensembl chr 7:130,990,381...131,012,250 		JBrowse link
G Il13ra1 interleukin 13 receptor, alpha 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IL13RA1 mRNA CTD PMID:21641980 NCBI chr  X:35,375,761...35,434,915
Ensembl chr  X:35,375,763...35,434,912 		JBrowse link
G Il13ra2 interleukin 13 receptor, alpha 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IL13RA2 mRNA CTD PMID:21641980 NCBI chr  X:146,166,474...146,214,982
Ensembl chr  X:146,166,472...146,212,188 		JBrowse link
G Il18rap interleukin 18 receptor accessory protein multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IL18RAP mRNA CTD PMID:21641980 NCBI chr 1:40,554,548...40,590,867
Ensembl chr 1:40,554,522...40,590,865 		JBrowse link
G Il1b interleukin 1 beta multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IL1B mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IL1B mRNA		 CTD PMID:21641980 PMID:26378955 NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059 		JBrowse link
G Il1rl1 interleukin 1 receptor-like 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IL1RL1 mRNA CTD PMID:21641980 NCBI chr 1:40,444,105...40,504,575
Ensembl chr 1:40,468,730...40,504,575 		JBrowse link
G Il1rn interleukin 1 receptor antagonist multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IL1RN mRNA CTD PMID:21641980 NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506 		JBrowse link
G Il4i1 interleukin 4 induced 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IL4I1 mRNA CTD PMID:21641980 NCBI chr 7:44,485,712...44,490,233
Ensembl chr 7:44,465,811...44,490,233 		JBrowse link
G Il6 interleukin 6 multiple interactions ISO Succimer inhibits the reaction [sodium arsenite results in increased secretion of IL6 protein] CTD PMID:31163222 NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979 		JBrowse link
G Il6ra interleukin 6 receptor, alpha multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IL6RA mRNA CTD PMID:21641980 NCBI chr 3:89,776,631...89,820,503
Ensembl chr 3:89,771,366...89,820,503 		JBrowse link
G Il6st interleukin 6 signal transducer multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of IL6ST mRNA CTD PMID:21641980 NCBI chr13:112,600,604...112,643,394
Ensembl chr13:112,600,604...112,646,620 		JBrowse link
G Inpp5d inositol polyphosphate-5-phosphatase D multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of INPP5D mRNA CTD PMID:21641980 NCBI chr 1:87,548,034...87,648,232
Ensembl chr 1:87,548,034...87,648,229 		JBrowse link
G Insig1 insulin induced gene 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of INSIG1 mRNA CTD PMID:21641980 NCBI chr 5:28,276,410...28,283,660
Ensembl chr 5:28,276,361...28,283,660 		JBrowse link
G Irak2 interleukin-1 receptor-associated kinase 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IRAK2 mRNA CTD PMID:21641980 NCBI chr 6:113,615,428...113,671,987
Ensembl chr 6:113,615,428...113,671,987 		JBrowse link
G Irf4 interferon regulatory factor 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IRF4 mRNA CTD PMID:21641980 NCBI chr13:30,933,191...30,950,965
Ensembl chr13:30,933,209...30,950,959 		JBrowse link
G Irf7 interferon regulatory factor 7 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IRF7 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of IRF7 mRNA		 CTD PMID:21641980 PMID:26378955 NCBI chr 7:140,843,096...140,846,412
Ensembl chr 7:140,842,619...140,846,394 		JBrowse link
G Irf9 interferon regulatory factor 9 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IRF9 mRNA CTD PMID:21641980 NCBI chr14:55,841,442...55,847,487
Ensembl chr14:55,841,028...55,847,487 		JBrowse link
G Irgm1 immunity-related GTPase family M member 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IRGM1 mRNA CTD PMID:21641980 NCBI chr11:48,756,072...48,762,247
Ensembl chr11:48,752,795...48,762,510 		JBrowse link
G Irgm2 immunity-related GTPase family M member 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of IRGM2 mRNA CTD PMID:21641980 NCBI chr11:58,105,803...58,113,609
Ensembl chr11:58,090,444...58,113,608 		JBrowse link
G Isg15 ISG15 ubiquitin-like modifier multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ISG15 mRNA CTD PMID:21641980 NCBI chr 4:156,283,881...156,285,275
Ensembl chr 4:156,283,912...156,285,253 		JBrowse link
G Isg20 interferon-stimulated protein multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ISG20 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ISG20 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 7:78,561,136...78,570,144
Ensembl chr 7:78,563,172...78,570,144 		JBrowse link
G Itga4 integrin alpha 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ITGA4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ITGA4 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 2:79,084,767...79,163,458
Ensembl chr 2:79,085,770...79,163,467 		JBrowse link
G Itgam integrin alpha M multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ITGAM mRNA CTD PMID:26378955 NCBI chr 7:127,661,812...127,717,663
Ensembl chr 7:127,661,812...127,717,663 		JBrowse link
G Itgav integrin alpha V multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ITGAV mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ITGAV mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 2:83,554,796...83,637,261
Ensembl chr 2:83,554,741...83,637,260 		JBrowse link
G Itgax integrin alpha X multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ITGAX mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ITGAX mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 7:127,728,697...127,749,829
Ensembl chr 7:127,728,719...127,749,829 		JBrowse link
G Itgb5 integrin beta 5 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ITGB5 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ITGB5 mRNA		 CTD PMID:21641980 PMID:26378955 NCBI chr16:33,650,021...33,769,708
Ensembl chr16:33,650,035...33,769,708 		JBrowse link
G Itgb7 integrin beta 7 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ITGB7 mRNA CTD PMID:21641980 NCBI chr15:102,124,429...102,141,840
Ensembl chr15:102,124,430...102,140,379 		JBrowse link
G Itpr1 inositol 1,4,5-trisphosphate receptor 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ITPR1 mRNA CTD PMID:26378955 NCBI chr 6:108,190,044...108,528,077
Ensembl chr 6:108,190,057...108,528,070 		JBrowse link
G Itpr2 inositol 1,4,5-triphosphate receptor 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ITPR2 mRNA CTD PMID:26378955 NCBI chr 6:146,009,797...146,403,757
Ensembl chr 6:146,009,797...146,403,721 		JBrowse link
G Itsn2 intersectin 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ITSN2 mRNA CTD PMID:26378955 NCBI chr12:4,642,792...4,763,952
Ensembl chr12:4,642,638...4,763,962 		JBrowse link
G Jade1 jade family PHD finger 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of JADE1 mRNA CTD PMID:21641980 NCBI chr 3:41,510,169...41,571,299
Ensembl chr 3:41,510,166...41,571,299 		JBrowse link
G Jade2 jade family PHD finger 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of JADE2 mRNA CTD PMID:21641980 NCBI chr11:51,704,278...51,749,835
Ensembl chr11:51,704,282...51,748,480 		JBrowse link
G Jag1 jagged 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of JAG1 mRNA CTD PMID:26378955 NCBI chr 2:136,923,371...136,958,440
Ensembl chr 2:136,923,376...136,958,564 		JBrowse link
G Jak2 Janus kinase 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of JAK2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of JAK2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480 		JBrowse link
G Jazf1 JAZF zinc finger 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of JAZF1 mRNA CTD PMID:26378955 NCBI chr 6:52,745,050...53,045,613
Ensembl chr 6:52,745,782...53,045,616 		JBrowse link
G Jdp2 Jun dimerization protein 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of JDP2 mRNA CTD PMID:21641980 NCBI chr12:85,645,190...85,686,652
Ensembl chr12:85,645,801...85,686,652 		JBrowse link
G Jmjd1c jumonji domain containing 1C multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of JMJD1C mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of JMJD1C mRNA CTD PMID:21641980 PMID:26378955 NCBI chr10:66,932,189...67,092,105
Ensembl chr10:66,931,904...67,092,105 		JBrowse link
G Kank2 KN motif and ankyrin repeat domains 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KANK2 mRNA CTD PMID:21641980 NCBI chr 9:21,678,069...21,709,842
Ensembl chr 9:21,678,080...21,710,040 		JBrowse link
G Kat14 lysine acetyltransferase 14 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of KAT14 mRNA CTD PMID:26378955 NCBI chr 2:144,210,952...144,249,595
Ensembl chr 2:144,210,903...144,249,596 		JBrowse link
G Kat7 K(lysine) acetyltransferase 7 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KAT7 mRNA CTD PMID:21641980 NCBI chr11:95,162,683...95,201,030
Ensembl chr11:95,165,085...95,201,072 		JBrowse link
G Kbtbd11 kelch repeat and BTB (POZ) domain containing 11 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KBTBD11 mRNA CTD PMID:21641980 NCBI chr 8:15,059,408...15,083,333
Ensembl chr 8:15,061,025...15,083,333 		JBrowse link
G Kbtbd7 kelch repeat and BTB (POZ) domain containing 7 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KBTBD7 mRNA CTD PMID:21641980 NCBI chr14:79,663,951...79,668,479
Ensembl chr14:79,663,951...79,668,476 		JBrowse link
G Kcnq1ot1 KCNQ1 overlapping transcript 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KCNQ1OT1 mRNA CTD PMID:21641980 NCBI chr 7:142,766,848...142,850,284
Ensembl chr 7:142,731,562...142,850,286 		JBrowse link
G Kctd12 potassium channel tetramerisation domain containing 12 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of KCTD12 mRNA CTD PMID:21641980 NCBI chr14:103,214,017...103,220,073
Ensembl chr14:103,214,017...103,220,073 		JBrowse link
G Kdm4c lysine (K)-specific demethylase 4C multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of KDM4C mRNA CTD PMID:26378955 NCBI chr 4:74,160,734...74,324,101
Ensembl chr 4:74,160,734...74,324,097 		JBrowse link
G Kdm5a lysine demethylase 5A multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] affects the expression of KDM5A mRNA CTD PMID:26378955 NCBI chr 6:120,341,060...120,421,535
Ensembl chr 6:120,341,085...120,421,535 		JBrowse link
G Kdm7a lysine (K)-specific demethylase 7A multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KDM7A mRNA CTD PMID:21641980 NCBI chr 6:39,113,554...39,183,707
Ensembl chr 6:39,113,557...39,183,723 		JBrowse link
G Kif11 kinesin family member 11 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KIF11 mRNA CTD PMID:21641980 NCBI chr19:37,364,830...37,410,311
Ensembl chr19:37,364,851...37,410,307 		JBrowse link
G Kif20b kinesin family member 20B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KIF20B mRNA CTD PMID:21641980 NCBI chr19:34,899,735...34,953,150
Ensembl chr19:34,899,761...34,953,145 		JBrowse link
G Kif21b kinesin family member 21B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KIF21B mRNA CTD PMID:21641980 NCBI chr 1:136,059,128...136,105,739
Ensembl chr 1:136,059,127...136,105,736 		JBrowse link
G Kif3c kinesin family member 3C multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of KIF3C mRNA CTD PMID:21641980 NCBI chr12:3,415,132...3,456,494
Ensembl chr12:3,415,132...3,456,494 		JBrowse link
G Kif5b kinesin family member 5B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KIF5B mRNA CTD PMID:21641980 NCBI chr18:6,201,005...6,241,524
Ensembl chr18:6,201,002...6,242,174 		JBrowse link
G Kifc3 kinesin family member C3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KIFC3 mRNA CTD PMID:21641980 NCBI chr 8:95,826,456...95,929,454
Ensembl chr 8:95,826,456...95,929,440 		JBrowse link
G Kit KIT proto-oncogene receptor tyrosine kinase multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of KIT mRNA CTD PMID:26378955 NCBI chr 5:75,735,647...75,817,382
Ensembl chr 5:75,735,576...75,817,382 		JBrowse link
G Klf4 Kruppel-like transcription factor 4 (gut) multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KLF4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of KLF4 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of KLF4 mRNA		 CTD PMID:21641980 PMID:26378955 NCBI chr 4:55,527,137...55,536,984
Ensembl chr 4:55,527,143...55,532,466 		JBrowse link
G Klf6 Kruppel-like transcription factor 6 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] affects the expression of KLF6 mRNA CTD PMID:26378955 NCBI chr13:5,911,488...5,920,392
Ensembl chr13:5,911,481...5,920,393 		JBrowse link
G Klf7 Kruppel-like transcription factor 7 (ubiquitous) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KLF7 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of KLF7 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 1:64,068,607...64,161,504
Ensembl chr 1:64,068,606...64,161,441 		JBrowse link
G Kmt2e lysine (K)-specific methyltransferase 2E multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KMT2E mRNA CTD PMID:21641980 NCBI chr 5:23,638,034...23,709,233
Ensembl chr 5:23,639,439...23,709,233 		JBrowse link
G Krr1 KRR1, small subunit (SSU) processome component, homolog (yeast) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of KRR1 mRNA CTD PMID:21641980 NCBI chr10:111,808,600...111,824,335
Ensembl chr10:111,808,569...111,824,337 		JBrowse link
G Krtap19-9b keratin associated protein 19-9B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of KRTAP19-9B mRNA CTD PMID:21641980 NCBI chr16:88,728,692...88,729,152
Ensembl chr16:88,728,692...88,729,153 		JBrowse link
G Layn layilin multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of LAYN mRNA CTD PMID:21641980 NCBI chr 9:50,966,323...50,988,501
Ensembl chr 9:50,965,940...50,988,394 		JBrowse link
G Lck lymphocyte protein tyrosine kinase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of LCK mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LCK mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 4:129,442,142...129,467,415
Ensembl chr 4:129,442,137...129,467,434 		JBrowse link
G Lcn2 lipocalin 2 multiple interactions EXP [Magnetite Nanoparticles co-treated with Succimer] results in increased expression of LCN2 mRNA; [Succimer binds to Magnetite Nanoparticles] which results in increased expression of LCN2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LCN2 mRNA CTD PMID:21641980 PMID:23086747 PMID:25522732 PMID:26378955 NCBI chr 2:32,274,649...32,277,751
Ensembl chr 2:32,274,645...32,278,264 		JBrowse link
G Ldlrad3 low density lipoprotein receptor class A domain containing 3 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of LDLRAD3 mRNA CTD PMID:26378955 NCBI chr 2:101,780,546...102,016,805
Ensembl chr 2:101,780,548...102,016,730 		JBrowse link
G Lemd3 LEM domain containing 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LEMD3 mRNA CTD PMID:21641980 NCBI chr10:120,759,316...120,815,491
Ensembl chr10:120,759,318...120,815,237 		JBrowse link
G Lfng LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase multiple interactions EXP
ISO		 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LFNG mRNA CTD PMID:26378955 NCBI chr 5:140,593,096...140,601,300
Ensembl chr 5:140,593,075...140,601,300 		JBrowse link
G Lgals9 lectin, galactose binding, soluble 9 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of LGALS9 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LGALS9 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:78,853,805...78,875,750
Ensembl chr11:78,853,800...78,875,772 		JBrowse link
G Lhb luteinizing hormone beta multiple interactions ISO Succimer inhibits the reaction [sodium arsenite results in decreased expression of LHB protein] CTD PMID:31163222 NCBI chr 7:45,070,370...45,071,278
Ensembl chr 7:45,070,244...45,071,321 		JBrowse link
G Lhx2 LIM homeobox protein 2 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LHX2 mRNA CTD PMID:26378955 NCBI chr 2:38,229,282...38,259,747
Ensembl chr 2:38,229,293...38,259,745 		JBrowse link
G Lif leukemia inhibitory factor multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of LIF mRNA CTD PMID:21641980 NCBI chr11:4,207,587...4,222,514
Ensembl chr11:4,207,557...4,222,514 		JBrowse link
G Lig4 ligase IV, DNA, ATP-dependent multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LIG4 mRNA CTD PMID:26378955 NCBI chr 8:10,020,020...10,027,680
Ensembl chr 8:10,019,049...10,027,686 		JBrowse link
G Lims1 LIM and senescent cell antigen-like domains 1 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of LIMS1 mRNA CTD PMID:26378955 NCBI chr10:58,159,164...58,260,513
Ensembl chr10:58,159,288...58,260,513 		JBrowse link
G Lims2 LIM and senescent cell antigen like domains 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of LIMS2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LIMS2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr18:32,055,346...32,091,673
Ensembl chr18:32,055,343...32,091,672 		JBrowse link
G Lmcd1 LIM and cysteine-rich domains 1 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LMCD1 mRNA CTD PMID:26378955 NCBI chr 6:112,250,747...112,307,384
Ensembl chr 6:112,250,719...112,307,386 		JBrowse link
G Lmln leishmanolysin-like (metallopeptidase M8 family) multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LMLN mRNA CTD PMID:26378955 NCBI chr16:32,881,974...32,948,065
Ensembl chr16:32,882,891...32,948,065 		JBrowse link
G Lncpint long non-protein coding RNA, Trp53 induced transcript multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LNCPINT mRNA CTD PMID:21641980 NCBI chr 6:31,070,498...31,195,409
Ensembl chr 6:31,059,500...31,197,423 		JBrowse link
G Lnpep leucyl/cystinyl aminopeptidase multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of LNPEP mRNA CTD PMID:26378955 NCBI chr17:17,747,985...17,846,303
Ensembl chr17:17,741,672...17,845,312 		JBrowse link
G Lpar1 lysophosphatidic acid receptor 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of LPAR1 mRNA CTD PMID:21641980 NCBI chr 4:58,435,252...58,554,601
Ensembl chr 4:58,435,255...58,553,898 		JBrowse link
G Lrp1 low density lipoprotein receptor-related protein 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LRP1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of LRP1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr10:127,374,026...127,457,158
Ensembl chr10:127,374,030...127,457,017 		JBrowse link
G Lrrc8c leucine rich repeat containing 8 family, member C multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LRRC8C mRNA CTD PMID:21641980 NCBI chr 5:105,666,850...105,760,884
Ensembl chr 5:105,667,254...105,760,884 		JBrowse link
G Lsm1 LSM1 homolog, mRNA degradation associated multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LSM1 mRNA CTD PMID:21641980 NCBI chr 8:26,275,326...26,294,003
Ensembl chr 8:26,275,316...26,294,003 		JBrowse link
G Lsm8 LSM8 homolog, U6 small nuclear RNA associated multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LSM8 mRNA CTD PMID:21641980 NCBI chr 6:18,848,634...18,854,051
Ensembl chr 6:18,848,578...18,855,750 		JBrowse link
G Lsp1 lymphocyte specific 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LSP1 mRNA CTD PMID:21641980 NCBI chr 7:142,014,583...142,048,605
Ensembl chr 7:142,014,546...142,048,604 		JBrowse link
G Lss lanosterol synthase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LSS mRNA CTD PMID:21641980 NCBI chr10:76,367,303...76,392,973
Ensembl chr10:76,367,422...76,392,972 		JBrowse link
G Ltb lymphotoxin B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of LTB mRNA CTD PMID:21641980 NCBI chr17:35,413,483...35,415,281
Ensembl chr17:35,413,415...35,415,296 		JBrowse link
G Luc7l2 LUC7-like 2 (S. cerevisiae) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LUC7L2 mRNA CTD PMID:21641980 NCBI chr 6:38,522,996...38,586,888
Ensembl chr 6:38,528,269...38,586,405 		JBrowse link
G Luc7l3 LUC7-like 3 (S. cerevisiae) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of LUC7L3 mRNA CTD PMID:21641980 NCBI chr11:94,181,899...94,213,196
Ensembl chr11:94,178,716...94,212,814 		JBrowse link
G Ly96 lymphocyte antigen 96 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of LY96 mRNA CTD PMID:26378955 NCBI chr 1:16,758,680...16,779,829
Ensembl chr 1:16,758,275...16,779,835 		JBrowse link
G Mafb MAF bZIP transcription factor B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MAFB mRNA CTD PMID:21641980 NCBI chr 2:160,205,597...160,208,985
Ensembl chr 2:160,205,623...160,208,985 		JBrowse link
G Magi2 membrane associated guanylate kinase, WW and PDZ domain containing 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MAGI2 mRNA CTD PMID:21641980 NCBI chr 5:19,431,787...20,909,790
Ensembl chr 5:19,432,034...20,909,790 		JBrowse link
G Malat1 metastasis associated lung adenocarcinoma transcript 1 (non-coding RNA) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MALAT1 mRNA CTD PMID:21641980 NCBI chr19:5,845,718...5,852,700
Ensembl chr19:5,845,717...5,852,706 		JBrowse link
G Malt1 MALT1 paracaspase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MALT1 mRNA; [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MALT1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of MALT1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr18:65,564,010...65,612,138
Ensembl chr18:65,564,009...65,612,138 		JBrowse link
G Map3k2 mitogen-activated protein kinase kinase kinase 2 multiple interactions ISO
EXP		 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MAP3K2 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MAP3K2 mRNA		 CTD PMID:26378955 NCBI chr18:32,296,142...32,369,804
Ensembl chr18:32,296,142...32,369,804 		JBrowse link
G Map3k5 mitogen-activated protein kinase kinase kinase 5 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MAP3K5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MAP3K5 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr10:19,809,847...20,018,496
Ensembl chr10:19,810,218...20,018,499 		JBrowse link
G Mapk1ip1l mitogen-activated protein kinase 1 interacting protein 1-like multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MAPK1IP1L mRNA CTD PMID:21641980 NCBI chr14:47,535,731...47,560,663
Ensembl chr14:47,535,723...47,560,661 		JBrowse link
G Mapk8 mitogen-activated protein kinase 8 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MAPK8 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MAPK8 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115 		JBrowse link
G Mapre2 microtubule-associated protein, RP/EB family, member 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MAPRE2 mRNA CTD PMID:21641980 NCBI chr18:23,885,390...24,026,918
Ensembl chr18:23,885,390...24,026,918 		JBrowse link
G Marcks myristoylated alanine rich protein kinase C substrate multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MARCKS mRNA CTD PMID:21641980 NCBI chr10:37,009,239...37,014,922
Ensembl chr10:37,009,371...37,014,916 		JBrowse link
G Marcksl1 MARCKS-like 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MARCKSL1 mRNA CTD PMID:21641980 NCBI chr 4:129,407,374...129,409,774
Ensembl chr 4:129,407,374...129,409,778 		JBrowse link
G Marveld1 MARVEL (membrane-associating) domain containing 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MARVELD1 mRNA CTD PMID:21641980 NCBI chr19:42,135,879...42,140,137
Ensembl chr19:42,135,839...42,140,142 		JBrowse link
G Matr3 matrin 3 multiple interactions ISO
EXP		 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MATR3 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MATR3 mRNA		 CTD PMID:26378955 NCBI chr18:35,686,462...35,724,526
Ensembl chr18:35,695,191...35,726,888 		JBrowse link
G Mbnl2 muscleblind like splicing factor 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MBNL2 mRNA CTD PMID:26378955 NCBI chr14:120,513,077...120,669,110
Ensembl chr14:120,513,081...120,669,109 		JBrowse link
G Mbnl3 muscleblind like splicing factor 3 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MBNL3 mRNA CTD PMID:26378955 NCBI chr  X:50,202,371...50,294,867
Ensembl chr  X:50,206,146...50,295,409 		JBrowse link
G Mbtd1 mbt domain containing 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MBTD1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of MBTD1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:93,776,635...93,837,815
Ensembl chr11:93,776,678...93,837,811 		JBrowse link
G Mchr1 melanin-concentrating hormone receptor 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MCHR1 mRNA CTD PMID:21641980 NCBI chr15:81,119,700...81,123,165
Ensembl chr15:81,119,700...81,123,165 		JBrowse link
G Mcoln2 mucolipin 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MCOLN2 mRNA CTD PMID:21641980 NCBI chr 3:145,855,552...145,901,269
Ensembl chr 3:145,855,588...145,901,268 		JBrowse link
G Mdm2 transformed mouse 3T3 cell double minute 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MDM2 mRNA CTD PMID:26378955 NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663 		JBrowse link
G Mecom MDS1 and EVI1 complex locus multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MECOM mRNA CTD PMID:26378955 NCBI chr 3:30,005,445...30,563,937
Ensembl chr 3:30,005,445...30,602,157 		JBrowse link
G Mecp2 methyl CpG binding protein 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MECP2 mRNA CTD PMID:21641980 NCBI chr  X:73,070,198...73,129,296
Ensembl chr  X:73,070,198...73,129,296 		JBrowse link
G Med13 mediator complex subunit 13 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MED13 mRNA CTD PMID:21641980 NCBI chr11:86,157,859...86,248,422
Ensembl chr11:86,157,859...86,248,428 		JBrowse link
G Mef2a myocyte enhancer factor 2A multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MEF2A mRNA CTD PMID:21641980 NCBI chr 7:66,880,911...67,026,435
Ensembl chr 7:66,880,911...67,022,606 		JBrowse link
G Mef2c myocyte enhancer factor 2C multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MEF2C mRNA CTD PMID:21641980 NCBI chr13:83,652,136...83,815,197
Ensembl chr13:83,652,153...83,815,199 		JBrowse link
G Mesp2 mesoderm posterior 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MESP2 mRNA CTD PMID:21641980 NCBI chr 7:79,460,475...79,463,179
Ensembl chr 7:79,460,475...79,463,187 		JBrowse link
G Mfap3l microfibrillar-associated protein 3-like multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MFAP3L mRNA CTD PMID:21641980 NCBI chr 8:61,085,859...61,129,765
Ensembl chr 8:61,085,861...61,129,763 		JBrowse link
G Mfsd11 major facilitator superfamily domain containing 11 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MFSD11 mRNA CTD PMID:21641980 NCBI chr11:116,743,037...116,766,486
Ensembl chr11:116,743,266...116,766,461 		JBrowse link
G Mfsd2a MFSD2 lysolipid transporter A, lysophospholipid multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MFSD2 mRNA CTD PMID:21641980 NCBI chr 4:122,840,643...122,855,844
Ensembl chr 4:122,840,643...122,854,981 		JBrowse link
G Mga MAX gene associated multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MGA mRNA CTD PMID:21641980 NCBI chr 2:119,702,974...119,800,610
Ensembl chr 2:119,727,709...119,800,062 		JBrowse link
G Mgat4a mannoside acetylglucosaminyltransferase 4, isoenzyme A multiple interactions EXP
ISO		 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MGAT4A mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MGAT4A mRNA		 CTD PMID:26378955 NCBI chr 1:37,478,421...37,580,599
Ensembl chr 1:37,478,421...37,580,097 		JBrowse link
G Mgat5b mannoside acetylglucosaminyltransferase 5, isoenzyme B multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MGAT5B mRNA CTD PMID:26378955 NCBI chr11:116,809,629...116,877,770
Ensembl chr11:116,809,689...116,877,774 		JBrowse link
G Mgst2 microsomal glutathione S-transferase 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MGST2 mRNA CTD PMID:21641980 NCBI chr 3:51,544,179...51,590,096
Ensembl chr 3:51,567,781...51,590,098 		JBrowse link
G Mia3 MIA SH3 domain ER export factor 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MIA3 mRNA CTD PMID:21641980 NCBI chr 1:183,107,091...183,151,091
Ensembl chr 1:183,107,682...183,150,894 		JBrowse link
G Mical2 microtubule associated monooxygenase, calponin and LIM domain containing 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MICAL2 mRNA CTD PMID:26378955 NCBI chr 7:111,825,032...112,012,311
Ensembl chr 7:111,825,063...112,012,313 		JBrowse link
G Micall2 MICAL-like 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MICALL2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of MICALL2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 5:139,692,447...139,722,088
Ensembl chr 5:139,692,451...139,722,091 		JBrowse link
G Mid1 midline 1 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MID1 mRNA CTD PMID:26378955 NCBI chr  X:168,468,178...168,773,692
Ensembl chr  X:168,468,195...168,773,794 		JBrowse link
G Mindy2 MINDY lysine 48 deubiquitinase 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MINDY2 mRNA CTD PMID:21641980 NCBI chr 9:70,506,296...70,566,429
Ensembl chr 9:70,506,296...70,564,456 		JBrowse link
G Mir17hg Mir17 host gene (non-protein coding) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MIR17HG mRNA CTD PMID:21641980 NCBI chr14:115,281,822...115,284,160
Ensembl chr14:115,280,311...115,284,159 		JBrowse link
G Mix23 mitochondrial matrix import factor 23 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MIX23 mRNA CTD PMID:21641980 NCBI chr16:35,892,030...35,912,488
Ensembl chr16:35,892,055...35,912,490 		JBrowse link
G Mki67 antigen identified by monoclonal antibody Ki 67 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MKI67 mRNA CTD PMID:21641980 NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090 		JBrowse link
G Mllt10 myeloid/lymphoid or mixed-lineage leukemia; translocated to, 10 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MLLT10 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MLLT10 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 2:18,059,971...18,217,201
Ensembl chr 2:18,060,048...18,217,199 		JBrowse link
G Mmp10 matrix metallopeptidase 10 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MMP10 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MMP10 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 9:7,502,343...7,510,243
Ensembl chr 9:7,502,353...7,510,241 		JBrowse link
G Mmp11 matrix metallopeptidase 11 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MMP11 mRNA CTD PMID:26378955 NCBI chr10:75,759,056...75,768,336
Ensembl chr10:75,759,056...75,772,330 		JBrowse link
G Mmp12 matrix metallopeptidase 12 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MMP12 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MMP12 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 9:7,344,397...7,360,461
Ensembl chr 9:7,344,381...7,369,499 		JBrowse link
G Mmp9 matrix metallopeptidase 9 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MMP9 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MMP9 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770 		JBrowse link
G Mocos molybdenum cofactor sulfurase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MOCOS mRNA CTD PMID:21641980 NCBI chr18:24,786,538...24,834,634
Ensembl chr18:24,786,748...24,834,632 		JBrowse link
G Mospd2 motile sperm domain containing 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MOSPD2 mRNA CTD PMID:21641980 NCBI chr  X:163,719,165...163,763,501
Ensembl chr  X:163,719,165...163,763,371 		JBrowse link
G Mov10 Mov10 RISC complex RNA helicase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MOV10 mRNA CTD PMID:21641980 NCBI chr 3:104,702,144...104,725,935
Ensembl chr 3:104,702,152...104,725,879 		JBrowse link
G Mrpl50 mitochondrial ribosomal protein L50 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MRPL50 mRNA CTD PMID:21641980 NCBI chr 4:49,512,597...49,521,083
Ensembl chr 4:49,512,596...49,521,093 		JBrowse link
G Mrps6 mitochondrial ribosomal protein S6 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MRPS6 mRNA CTD PMID:21641980 NCBI chr16:91,855,224...91,909,115
Ensembl chr16:91,855,158...91,909,115 		JBrowse link
G Ms4a6b membrane-spanning 4-domains, subfamily A, member 6B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MS4A6B mRNA CTD PMID:21641980 NCBI chr19:11,495,923...11,507,767
Ensembl chr19:11,493,876...11,508,620 		JBrowse link
G Msgn1 mesogenin 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MSGN1 mRNA CTD PMID:21641980 NCBI chr12:11,258,383...11,258,949
Ensembl chr12:11,258,361...11,258,973 		JBrowse link
G Msh2 mutS homolog 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MSH2 mRNA CTD PMID:21641980 NCBI chr17:87,979,960...88,031,141
Ensembl chr17:87,979,758...88,031,141 		JBrowse link
G Msh5 mutS homolog 5 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MSH5 mRNA CTD PMID:21641980 NCBI chr17:35,247,581...35,267,842
Ensembl chr17:35,247,581...35,265,721 		JBrowse link
G Mt1 metallothionein 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MT1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MT1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MT1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 8:94,905,214...94,906,955
Ensembl chr 8:94,905,710...94,906,955 		JBrowse link
G Mt2 metallothionein 2 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MT2A mRNA CTD PMID:26378955 NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196 		JBrowse link
G Mtf1 metal response element binding transcription factor 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MTF1 mRNA CTD PMID:26378955 NCBI chr 4:124,696,342...124,743,593
Ensembl chr 4:124,695,897...124,743,593 		JBrowse link
G Mtf2 metal response element binding transcription factor 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of MTF2 mRNA CTD PMID:26378955 NCBI chr 5:108,213,518...108,257,085
Ensembl chr 5:108,213,540...108,256,870 		JBrowse link
G Mtrex Mtr4 exosome RNA helicase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MTREX mRNA CTD PMID:21641980 NCBI chr13:113,004,306...113,063,914
Ensembl chr13:113,003,952...113,063,932 		JBrowse link
G Mtss1 MTSS I-BAR domain containing 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MTSS1 mRNA CTD PMID:21641980 NCBI chr15:58,813,083...58,955,805
Ensembl chr15:58,813,083...58,953,854 		JBrowse link
G Mtx3 metaxin 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MTX3 mRNA CTD PMID:21641980 NCBI chr13:92,981,251...92,994,738
Ensembl chr13:92,981,268...92,994,738 		JBrowse link
G Muc20 mucin 20 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MUC20 mRNA CTD PMID:21641980 NCBI chr16:32,597,793...32,617,805
Ensembl chr16:32,597,793...32,617,805 		JBrowse link
G Mustn1 musculoskeletal, embryonic nuclear protein 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MUSTN1 mRNA CTD PMID:21641980 NCBI chr14:30,601,214...30,603,567
Ensembl chr14:30,601,157...30,603,567 		JBrowse link
G Mvd mevalonate (diphospho) decarboxylase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MVD mRNA CTD PMID:21641980 NCBI chr 8:123,160,335...123,170,161
Ensembl chr 8:123,160,340...123,170,161 		JBrowse link
G Mxd4 Max dimerization protein 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of MXD4 mRNA CTD PMID:21641980 NCBI chr 5:34,331,231...34,345,076
Ensembl chr 5:34,331,227...34,345,064 		JBrowse link
G Myb myeloblastosis oncogene multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MYB mRNA CTD PMID:26378955 NCBI chr10:21,000,829...21,036,883
Ensembl chr10:21,000,834...21,036,883 		JBrowse link
G Myc myelocytomatosis oncogene multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MYC mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of MYC mRNA CTD PMID:21641980 PMID:26378955 NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223 		JBrowse link
G Myh14 myosin, heavy polypeptide 14 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of MYH14 mRNA CTD PMID:21641980 NCBI chr 7:44,255,227...44,320,296
Ensembl chr 7:44,255,227...44,320,267 		JBrowse link
G Mylk myosin, light polypeptide kinase multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of MYLK mRNA CTD PMID:26378955 NCBI chr16:34,565,569...34,822,806
Ensembl chr16:34,565,580...34,822,790 		JBrowse link
G N4bp2 NEDD4 binding protein 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of N4BP2 mRNA CTD PMID:21641980 NCBI chr 5:65,909,462...65,987,450
Ensembl chr 5:65,920,864...65,987,451 		JBrowse link
G N4bp2l1 NEDD4 binding protein 2-like 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of N4BP2L1 mRNA CTD PMID:21641980 NCBI chr 5:150,495,108...150,518,288
Ensembl chr 5:150,495,109...150,520,653 		JBrowse link
G Naa50 N(alpha)-acetyltransferase 50, NatE catalytic subunit multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NAA50 mRNA CTD PMID:21641980 NCBI chr16:43,960,154...43,983,825
Ensembl chr16:43,960,193...43,983,729 		JBrowse link
G Nabp1 nucleic acid binding protein 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of NABP1 mRNA CTD PMID:21641980 NCBI chr 1:51,504,127...51,517,634
Ensembl chr 1:51,505,021...51,517,584 		JBrowse link
G Naip2 NLR family, apoptosis inhibitory protein 2 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NAIP mRNA CTD PMID:26378955 NCBI chr13:100,280,571...100,338,630
Ensembl chr13:100,280,571...100,338,600 		JBrowse link
G Nav1 neuron navigator 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NAV1 mRNA CTD PMID:21641980 NCBI chr 1:135,362,318...135,616,082
Ensembl chr 1:135,362,318...135,615,843 		JBrowse link
G Nav2 neuron navigator 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NAV2 mRNA CTD PMID:21641980 NCBI chr 7:48,608,796...49,259,838
Ensembl chr 7:48,558,464...49,259,838 		JBrowse link
G Nbeal1 neurobeachin like 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NBEAL1 mRNA CTD PMID:21641980 NCBI chr 1:60,217,910...60,377,487
Ensembl chr 1:60,219,758...60,377,487 		JBrowse link
G Ncapg2 non-SMC condensin II complex, subunit G2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NCAPG2 mRNA CTD PMID:21641980 NCBI chr12:116,368,969...116,427,152
Ensembl chr12:116,369,022...116,427,351 		JBrowse link
G Ncf1 neutrophil cytosolic factor 1 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NCF1 mRNA CTD PMID:26378955 NCBI chr 5:134,248,907...134,258,479
Ensembl chr 5:134,248,907...134,258,479 		JBrowse link
G Nckap1 NCK-associated protein 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of NCKAP1 mRNA CTD PMID:21641980 NCBI chr 2:80,330,856...80,411,526
Ensembl chr 2:80,330,856...80,411,724 		JBrowse link
G Ncl nucleolin multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NCL mRNA CTD PMID:21641980 NCBI chr 1:86,272,441...86,287,177
Ensembl chr 1:86,272,441...86,287,122 		JBrowse link
G Ncoa2 nuclear receptor coactivator 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NCOA2 mRNA CTD PMID:21641980 NCBI chr 1:13,209,329...13,444,451
Ensembl chr 1:13,209,329...13,444,307 		JBrowse link
G Ndc1 NDC1 transmembrane nucleoporin multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NDC1 mRNA CTD PMID:21641980 NCBI chr 4:107,225,244...107,273,543
Ensembl chr 4:107,224,981...107,273,543 		JBrowse link
G Ndrg1 N-myc downstream regulated gene 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NDRG1 mRNA CTD PMID:21641980 NCBI chr15:66,801,167...66,841,490
Ensembl chr15:66,801,167...66,841,489 		JBrowse link
G Ndrg2 N-myc downstream regulated gene 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NDRG2 mRNA CTD PMID:21641980 NCBI chr14:52,142,738...52,151,463
Ensembl chr14:52,142,728...52,151,615 		JBrowse link
G Ndufa10 NADH:ubiquinone oxidoreductase subunit A10 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NDUFA10 mRNA CTD PMID:21641980 NCBI chr 1:92,367,208...92,401,547
Ensembl chr 1:92,366,732...92,401,582 		JBrowse link
G Ndufab1 NADH:ubiquinone oxidoreductase subunit AB1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NDUFAB1 mRNA CTD PMID:21641980 NCBI chr 7:121,686,038...121,701,071
Ensembl chr 7:121,684,626...121,701,109 		JBrowse link
G Neat1 nuclear paraspeckle assembly transcript 1 (non-protein coding) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NEAT1 mRNA CTD PMID:21641980 NCBI chr19:5,874,736...5,895,508
Ensembl chr19:5,874,736...5,895,898 		JBrowse link
G Nectin2 nectin cell adhesion molecule 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of NECTIN2 mRNA CTD PMID:21641980 NCBI chr 7:19,450,569...19,483,498
Ensembl chr 7:19,450,569...19,484,408 		JBrowse link
G Nectin3 nectin cell adhesion molecule 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NECTIN3 mRNA CTD PMID:21641980 NCBI chr16:46,208,028...46,318,898
Ensembl chr16:46,208,069...46,318,888 		JBrowse link
G Nek2 NIMA (never in mitosis gene a)-related expressed kinase 2 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NEK2 mRNA CTD PMID:26378955 NCBI chr 1:191,553,622...191,565,161
Ensembl chr 1:191,553,556...191,565,162 		JBrowse link
G Nek3 NIMA (never in mitosis gene a)-related expressed kinase 3 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NEK3 mRNA CTD PMID:26378955 NCBI chr 8:22,618,299...22,657,009
Ensembl chr 8:22,618,299...22,656,451 		JBrowse link
G Nemf nuclear export mediator factor multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NEMF mRNA CTD PMID:21641980 NCBI chr12:69,358,315...69,403,975
Ensembl chr12:69,357,296...69,403,939 		JBrowse link
G Nfat5 nuclear factor of activated T cells 5 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NFAT5 mRNA CTD PMID:21641980 NCBI chr 8:108,020,072...108,106,149
Ensembl chr 8:108,020,102...108,106,149 		JBrowse link
G Nfatc3 nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NFATC3 mRNA CTD PMID:21641980 NCBI chr 8:106,785,450...106,857,169
Ensembl chr 8:106,785,472...106,857,169 		JBrowse link
G Nfe2l2 nuclear factor, erythroid derived 2, like 2 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NFE2L2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NFE2L2 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NFE2L2 mRNA		 CTD PMID:21641980 PMID:26378955 NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985 		JBrowse link
G Nfix nuclear factor I/X multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NFIX mRNA CTD PMID:21641980 NCBI chr 8:85,431,341...85,527,086
Ensembl chr 8:85,426,505...85,526,973 		JBrowse link
G Nfkb1 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of NFKB1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NFKB1 mRNA
Succimer inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of NFKB1 mRNA]; Succimer inhibits the reaction [sodium arsenite results in increased expression of NFKB1 mRNA]		 CTD PMID:21641980 PMID:26378955 PMID:31163222 PMID:32402895 NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308 		JBrowse link
G Nfkb2 nuclear factor of kappa light polypeptide gene enhancer in B cells 2, p49/p100 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of NFKB2 mRNA CTD PMID:21641980 NCBI chr19:46,285,478...46,300,839
Ensembl chr19:46,292,759...46,300,824 		JBrowse link
G Nfkbia nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of NFKBIA mRNA CTD PMID:21641980 NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432 		JBrowse link
G Nfkbie nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, epsilon multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of NFKBIE mRNA CTD PMID:21641980 NCBI chr17:45,866,626...45,874,095
Ensembl chr17:45,866,629...45,874,095 		JBrowse link
G Nfkbiz nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, zeta multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of NFKBIZ mRNA CTD PMID:21641980 NCBI chr16:55,631,740...55,659,018
Ensembl chr16:55,631,738...55,659,262 		JBrowse link
G Nfx1 nuclear transcription factor, X-box binding 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NFX1 mRNA CTD PMID:26378955 NCBI chr 4:40,970,906...41,025,992
Ensembl chr 4:40,970,906...41,025,993 		JBrowse link
G Ninj1 ninjurin 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of NINJ1 mRNA CTD PMID:21641980 NCBI chr13:49,341,005...49,349,727
Ensembl chr13:49,340,961...49,349,720 		JBrowse link
G Nkd1 naked cuticle 1 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NKD1 mRNA CTD PMID:26378955 NCBI chr 8:89,247,961...89,321,515
Ensembl chr 8:89,247,982...89,321,512 		JBrowse link
G Nktr natural killer tumor recognition sequence multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NKTR mRNA CTD PMID:21641980 NCBI chr 9:121,542,244...121,585,908
Ensembl chr 9:121,548,235...121,585,909 		JBrowse link
G Nlk nemo like kinase multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NLK mRNA CTD PMID:26378955 NCBI chr11:78,457,994...78,588,848
Ensembl chr11:78,457,994...78,588,199 		JBrowse link
G Nln neurolysin (metallopeptidase M3 family) multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NLN mRNA CTD PMID:26378955 NCBI chr13:104,159,558...104,246,170
Ensembl chr13:104,159,565...104,246,122 		JBrowse link
G Nlrc4 NLR family, CARD domain containing 4 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NLRC4 mRNA CTD PMID:26378955 NCBI chr17:74,733,254...74,766,140
Ensembl chr17:74,732,433...74,766,137 		JBrowse link
G Nlrp10 NLR family, pyrin domain containing 10 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NLRP10 mRNA CTD PMID:21641980 NCBI chr 7:108,521,060...108,529,365
Ensembl chr 7:108,521,059...108,529,385 		JBrowse link
G Nlrp3 NLR family, pyrin domain containing 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of NLRP3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NLRP3 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:59,432,395...59,457,781
Ensembl chr11:59,432,394...59,457,782 		JBrowse link
G Nnmt nicotinamide N-methyltransferase multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NNMT mRNA CTD PMID:26378955 NCBI chr 9:48,448,905...48,518,958
Ensembl chr 9:48,503,177...48,516,453 		JBrowse link
G Npas2 neuronal PAS domain protein 2 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NPAS2 mRNA CTD PMID:26378955 NCBI chr 1:39,233,013...39,402,321
Ensembl chr 1:39,232,812...39,402,317 		JBrowse link
G Nptx1 neuronal pentraxin 1 multiple interactions ISO
EXP		 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NPTX1 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NPTX1 mRNA		 CTD PMID:26378955 NCBI chr11:119,429,545...119,438,646
Ensembl chr11:119,429,545...119,438,579 		JBrowse link
G Npy neuropeptide Y multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of NPY mRNA CTD PMID:21641980 NCBI chr 6:49,799,690...49,806,487
Ensembl chr 6:49,799,690...49,806,487 		JBrowse link
G Nqo1 NAD(P)H dehydrogenase, quinone 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NQO1 mRNA CTD PMID:26378955 NCBI chr 8:108,114,856...108,139,012
Ensembl chr 8:108,114,857...108,129,838 		JBrowse link
G Nr1d2 nuclear receptor subfamily 1, group D, member 2 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NR1D2 mRNA CTD PMID:26378955 NCBI chr14:4,230,549...4,265,639
Ensembl chr14:4,230,569...4,265,642 		JBrowse link
G Nr2c2 nuclear receptor subfamily 2, group C, member 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NR2C2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of NR2C2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 6:92,068,426...92,150,039
Ensembl chr 6:92,068,371...92,151,275 		JBrowse link
G Nr2f2 nuclear receptor subfamily 2, group F, member 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NR2F2 mRNA CTD PMID:26378955 NCBI chr 7:70,001,694...70,016,494
Ensembl chr 7:70,001,692...70,016,483 		JBrowse link
G Nr3c1 nuclear receptor subfamily 3, group C, member 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NR3C1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NR3C1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr18:39,543,598...39,652,485
Ensembl chr18:39,543,598...39,652,474 		JBrowse link
G Nr5a2 nuclear receptor subfamily 5, group A, member 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NR5A2 mRNA CTD PMID:26378955 NCBI chr 1:136,770,300...136,888,186
Ensembl chr 1:136,770,309...136,888,186 		JBrowse link
G Nrip1 nuclear receptor interacting protein 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NRIP1 mRNA CTD PMID:21641980 NCBI chr16:76,084,291...76,170,930
Ensembl chr16:76,084,288...76,170,715 		JBrowse link
G Nrp1 neuropilin 1 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NRP1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NRP1 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NRP1 mRNA		 CTD PMID:21641980 PMID:26378955 NCBI chr 8:129,085,553...129,231,957
Ensembl chr 8:129,085,085...129,229,844 		JBrowse link
G Nrp2 neuropilin 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NRP2 mRNA CTD PMID:26378955 NCBI chr 1:62,742,476...62,857,851
Ensembl chr 1:62,742,444...62,857,854 		JBrowse link
G Nrxn3 neurexin III multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NRXN3 mRNA CTD PMID:26378955 NCBI chr12:88,689,454...90,301,709
Ensembl chr12:88,689,646...90,301,709 		JBrowse link
G Nsd1 nuclear receptor-binding SET-domain protein 1 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NSD1 mRNA CTD PMID:26378955 NCBI chr13:55,357,595...55,466,138
Ensembl chr13:55,357,595...55,466,138 		JBrowse link
G Nuak2 NUAK family, SNF1-like kinase, 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NUAK2 mRNA CTD PMID:26378955 NCBI chr 1:132,243,827...132,261,233
Ensembl chr 1:132,243,864...132,261,226 		JBrowse link
G Nudt10 nudix hydrolase 10 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NUDT11 mRNA CTD PMID:26378955 NCBI chr  X:6,080,750...6,085,321
Ensembl chr  X:6,080,750...6,085,069 		JBrowse link
G Nudt5 nudix hydrolase 5 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NUDT5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of NUDT5 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 2:5,849,839...5,875,631
Ensembl chr 2:5,849,830...5,876,706 		JBrowse link
G Nupr1 nuclear protein transcription regulator 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of NUPR1 mRNA CTD PMID:21641980 NCBI chr 7:126,222,418...126,224,642
Ensembl chr 7:126,222,421...126,230,033 		JBrowse link
G Oas1a 2'-5' oligoadenylate synthetase 1A multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of OAS1A mRNA CTD PMID:21641980 NCBI chr 5:121,034,319...121,045,588
Ensembl chr 5:121,034,319...121,045,584 		JBrowse link
G Oas1g 2'-5' oligoadenylate synthetase 1G multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of OAS1 mRNA CTD PMID:26378955 NCBI chr 5:121,014,205...121,025,676
Ensembl chr 5:121,014,205...121,025,676 		JBrowse link
G Oas2 2'-5' oligoadenylate synthetase 2 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of OAS2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of OAS2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 5:120,868,398...120,887,949
Ensembl chr 5:120,868,398...120,887,918 		JBrowse link
G Oas3 2'-5' oligoadenylate synthetase 3 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of OAS3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of OAS3 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 5:120,891,163...120,915,755
Ensembl chr 5:120,891,163...120,915,726 		JBrowse link
G Oasl1 2'-5' oligoadenylate synthetase-like 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of OASL1 mRNA CTD PMID:21641980 NCBI chr 5:115,061,236...115,075,970
Ensembl chr 5:115,061,299...115,075,974 		JBrowse link
G Oasl2 2'-5' oligoadenylate synthetase-like 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of OASL2 mRNA CTD PMID:26378955 NCBI chr 5:115,034,995...115,050,306
Ensembl chr 5:115,034,997...115,050,295 		JBrowse link
G Ocstamp osteoclast stimulatory transmembrane protein multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of OCSTAMP mRNA CTD PMID:21641980 NCBI chr 2:165,237,370...165,242,314
Ensembl chr 2:165,235,680...165,242,325 		JBrowse link
G Odc1 ornithine decarboxylase, structural 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ODC1 mRNA CTD PMID:21641980 NCBI chr12:17,594,906...17,601,503
Ensembl chr12:17,594,795...17,601,506 		JBrowse link
G Ogfrl1 opioid growth factor receptor-like 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of OGFRL1 mRNA CTD PMID:21641980 NCBI chr 1:23,405,505...23,422,282
Ensembl chr 1:23,405,505...23,436,853 		JBrowse link
G Oit3 oncoprotein induced transcript 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of OIT3 mRNA CTD PMID:21641980 NCBI chr10:59,258,782...59,277,601
Ensembl chr10:59,258,780...59,277,600 		JBrowse link
G Orc3 origin recognition complex, subunit 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ORC3 mRNA CTD PMID:21641980 NCBI chr 4:34,566,781...34,614,942
Ensembl chr 4:34,570,796...34,614,944 		JBrowse link
G Osgin2 oxidative stress induced growth inhibitor family member 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of OSGIN2 mRNA CTD PMID:21641980 NCBI chr 4:15,996,354...16,015,266
Ensembl chr 4:15,997,121...16,013,888 		JBrowse link
G Otud4 OTU domain containing 4 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of OTUD4 mRNA CTD PMID:26378955 NCBI chr 8:80,366,305...80,404,384
Ensembl chr 8:80,366,247...80,404,353 		JBrowse link
G Ovol2 ovo like zinc finger 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of OVOL2 mRNA CTD PMID:26378955 NCBI chr 2:144,147,095...144,174,000
Ensembl chr 2:144,147,095...144,174,066 		JBrowse link
G Pacrg PARK2 co-regulated multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PACRG mRNA CTD PMID:21641980 NCBI chr17:10,621,938...11,059,078
Ensembl chr17:10,621,941...11,059,198 		JBrowse link
G Padi2 peptidyl arginine deiminase, type II multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PADI2 mRNA CTD PMID:21641980 NCBI chr 4:140,633,685...140,679,897
Ensembl chr 4:140,633,655...140,679,897 		JBrowse link
G Pafah1b1 platelet-activating factor acetylhydrolase, isoform 1b, subunit 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PAFAH1B1 mRNA CTD PMID:21641980 NCBI chr11:74,564,775...74,615,210
Ensembl chr11:74,564,775...74,615,496 		JBrowse link
G Pald1 phosphatase domain containing, paladin 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PALD1 mRNA CTD PMID:21641980 NCBI chr10:61,155,435...61,219,325
Ensembl chr10:61,155,435...61,219,309 		JBrowse link
G Pals2 protein associated with LIN7 2, MAGUK family member multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PALS2 mRNA CTD PMID:21641980 NCBI chr 6:50,087,206...50,176,134
Ensembl chr 6:50,087,221...50,175,919 		JBrowse link
G Pank1 pantothenate kinase 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PANK1 mRNA CTD PMID:21641980 NCBI chr19:34,784,335...34,862,420
Ensembl chr19:34,784,340...34,856,855 		JBrowse link
G Pappa pregnancy-associated plasma protein A multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PAPPA mRNA CTD PMID:26378955 NCBI chr 4:65,041,993...65,276,776
Ensembl chr 4:65,042,411...65,275,746 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase family, member 1 multiple interactions ISO Succimer inhibits the reaction [sodium arsenite results in increased expression of PARP1 protein] CTD PMID:31163222 NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819 		JBrowse link
G Parp12 poly (ADP-ribose) polymerase family, member 12 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PARP12 mRNA CTD PMID:26378955 NCBI chr 6:39,063,346...39,095,283
Ensembl chr 6:39,063,344...39,095,283 		JBrowse link
G Parp3 poly (ADP-ribose) polymerase family, member 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PARP3 mRNA CTD PMID:21641980 NCBI chr 9:106,347,521...106,354,148
Ensembl chr 9:106,347,521...106,354,148 		JBrowse link
G Patz1 POZ (BTB) and AT hook containing zinc finger 1 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PATZ1 mRNA CTD PMID:26378955 NCBI chr11:3,239,131...3,259,083
Ensembl chr11:3,238,874...3,259,083 		JBrowse link
G Pcbp2 poly(rC) binding protein 2 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PCBP2 mRNA CTD PMID:26378955 NCBI chr15:102,378,974...102,408,503
Ensembl chr15:102,378,974...102,408,496 		JBrowse link
G Pcgf2 polycomb group ring finger 2 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PCGF2 mRNA CTD PMID:26378955 NCBI chr11:97,579,647...97,593,260
Ensembl chr11:97,579,649...97,591,323 		JBrowse link
G Pcgf5 polycomb group ring finger 5 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PCGF5 mRNA CTD PMID:26378955 NCBI chr19:36,325,729...36,438,370
Ensembl chr19:36,325,709...36,438,370 		JBrowse link
G Pcm1 pericentriolar material 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PCM1 mRNA CTD PMID:21641980 NCBI chr 8:41,692,521...41,787,125
Ensembl chr 8:41,692,789...41,785,381 		JBrowse link
G Pcmtd1 protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PCMTD1 mRNA CTD PMID:21641980 NCBI chr 1:7,157,301...7,243,852
Ensembl chr 1:7,159,144...7,243,852 		JBrowse link
G Pdcd1 programmed cell death 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PDCD1 mRNA CTD PMID:21641980 NCBI chr 1:93,966,027...93,980,278
Ensembl chr 1:93,966,027...93,980,278 		JBrowse link
G Pdcd4 programmed cell death 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PDCD4 mRNA CTD PMID:21641980 NCBI chr19:53,880,662...53,926,024
Ensembl chr19:53,880,662...53,918,291 		JBrowse link
G Pdcd6 programmed cell death 6 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PDCD6 mRNA CTD PMID:26378955 NCBI chr13:74,451,240...74,465,445
Ensembl chr13:74,451,628...74,465,699 		JBrowse link
G Pdcd6ip programmed cell death 6 interacting protein multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PDCD6IP mRNA CTD PMID:21641980 NCBI chr 9:113,480,812...113,537,457
Ensembl chr 9:113,480,812...113,537,327 		JBrowse link
G Pde1a phosphodiesterase 1A, calmodulin-dependent multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PDE1A mRNA CTD PMID:26378955 NCBI chr 2:79,664,797...80,026,862
Ensembl chr 2:79,664,797...79,959,802 		JBrowse link
G Pde4b phosphodiesterase 4B, cAMP specific multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PDE4B mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PDE4B mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 4:101,944,529...102,464,459
Ensembl chr 4:101,944,740...102,464,456 		JBrowse link
G Pde4dip phosphodiesterase 4D interacting protein (myomegalin) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PDE4DIP mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PDE4DIP mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 3:97,597,144...97,796,023
Ensembl chr 3:97,597,140...97,796,023 		JBrowse link
G Pde7a phosphodiesterase 7A multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PDE7A mRNA CTD PMID:26378955 NCBI chr 3:19,277,272...19,365,486
Ensembl chr 3:19,277,272...19,365,486 		JBrowse link
G Pde8b phosphodiesterase 8B multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PDE8B mRNA CTD PMID:26378955 NCBI chr13:95,160,962...95,386,904
Ensembl chr13:95,160,962...95,386,844 		JBrowse link
G Pdlim5 PDZ and LIM domain 5 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PDLIM5 mRNA CTD PMID:26378955 NCBI chr 3:141,945,346...142,101,480
Ensembl chr 3:141,945,351...142,101,454 		JBrowse link
G Pdlim7 PDZ and LIM domain 7 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PDLIM7 mRNA CTD PMID:26378955 NCBI chr13:55,645,300...55,661,281
Ensembl chr13:55,643,608...55,661,489 		JBrowse link
G Pdpn podoplanin multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PDPN mRNA CTD PMID:21641980 NCBI chr 4:142,993,979...143,026,134
Ensembl chr 4:142,994,001...143,026,134 		JBrowse link
G Pdss1 prenyl (solanesyl) diphosphate synthase, subunit 1 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PDSS1 mRNA CTD PMID:26378955 NCBI chr 2:22,784,393...22,830,273
Ensembl chr 2:22,785,534...22,830,278 		JBrowse link
G Pf4 platelet factor 4 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PF4 mRNA CTD PMID:26378955 NCBI chr 5:90,920,362...90,921,242
Ensembl chr 5:90,920,294...90,921,242 		JBrowse link
G Pggt1b protein geranylgeranyltransferase type I, beta subunit multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PGGT1B mRNA CTD PMID:26378955 NCBI chr18:46,368,411...46,414,173
Ensembl chr18:46,368,418...46,414,060 		JBrowse link
G Pgm2l1 phosphoglucomutase 2-like 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PGM2L1 mRNA CTD PMID:21641980 NCBI chr 7:99,876,471...99,928,079
Ensembl chr 7:99,876,601...99,928,075 		JBrowse link
G Pgm5 phosphoglucomutase 5 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PGM5 mRNA CTD PMID:21641980 NCBI chr19:24,655,625...24,839,206
Ensembl chr19:24,660,380...24,839,219 		JBrowse link
G Phb2 prohibitin 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PHB2 mRNA CTD PMID:21641980 NCBI chr 6:124,689,252...124,693,908
Ensembl chr 6:124,689,299...124,693,913 		JBrowse link
G Phc3 polyhomeotic 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PHC3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PHC3 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 3:30,953,444...31,023,628
Ensembl chr 3:30,953,520...31,023,564 		JBrowse link
G Phf20l1 PHD finger protein 20-like 1 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PHF20L1 mRNA CTD PMID:26378955 NCBI chr15:66,449,354...66,519,821
Ensembl chr15:66,449,409...66,519,825 		JBrowse link
G Phf3 PHD finger protein 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PHF3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PHF3 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 1:30,841,417...30,912,989
Ensembl chr 1:30,841,420...30,913,002 		JBrowse link
G Phf6 PHD finger protein 6 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PHF6 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PHF6 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr  X:52,001,091...52,045,838
Ensembl chr  X:52,001,143...52,045,820 		JBrowse link
G Phip pleckstrin homology domain interacting protein multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PHIP mRNA CTD PMID:21641980 NCBI chr 9:82,748,212...82,857,776
Ensembl chr 9:82,748,212...82,857,569 		JBrowse link
G Phlda1 pleckstrin homology like domain, family A, member 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PHLDA1 mRNA CTD PMID:21641980 NCBI chr10:111,342,147...111,344,510
Ensembl chr10:111,342,147...111,344,506 		JBrowse link
G Pias2 protein inhibitor of activated STAT 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PIAS2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PIAS2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr18:77,152,883...77,243,406
Ensembl chr18:77,152,904...77,241,496 		JBrowse link
G Piezo2 piezo-type mechanosensitive ion channel component 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PIEZO2 mRNA CTD PMID:21641980 NCBI chr18:63,143,284...63,520,787
Ensembl chr18:63,143,284...63,520,254 		JBrowse link
G Pik3ca phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PIK3CA mRNA CTD PMID:21641980 NCBI chr 3:32,451,203...32,520,256
Ensembl chr 3:32,451,820...32,522,635 		JBrowse link
G Pik3r1 phosphoinositide-3-kinase regulatory subunit 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PIK3R1 mRNA CTD PMID:21641980 NCBI chr13:101,817,269...101,904,725
Ensembl chr13:101,817,071...101,904,725 		JBrowse link
G Pilra paired immunoglobin-like type 2 receptor alpha multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PILRA mRNA CTD PMID:21641980 NCBI chr 5:137,820,214...137,834,540
Ensembl chr 5:137,820,214...137,834,543 		JBrowse link
G Pim1 proviral integration site 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PIM1 mRNA CTD PMID:21641980 NCBI chr17:29,709,759...29,715,085
Ensembl chr17:29,709,727...29,715,086 		JBrowse link
G Pink1 PTEN induced putative kinase 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PINK1 mRNA CTD PMID:26378955 NCBI chr 4:138,040,718...138,053,631
Ensembl chr 4:138,040,720...138,053,618 		JBrowse link
G Pip4k2a phosphatidylinositol-5-phosphate 4-kinase, type II, alpha multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PIP4K2A mRNA CTD PMID:21641980 NCBI chr 2:18,847,066...19,003,101
Ensembl chr 2:18,847,066...19,002,937 		JBrowse link
G Pip5k1b phosphatidylinositol-4-phosphate 5-kinase, type 1 beta multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PIP5K1B mRNA CTD PMID:21641980 NCBI chr19:24,272,158...24,533,236
Ensembl chr19:24,272,158...24,533,236 		JBrowse link
G Pir pirin multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PIR mRNA CTD PMID:26378955 NCBI chr  X:163,052,427...163,156,009
Ensembl chr  X:163,052,367...163,156,007 		JBrowse link
G Pira2 paired-Ig-like receptor A2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PIRA2 mRNA; [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PIRA2 mRNA CTD PMID:21641980 NCBI chr 7:3,839,807...3,848,102
Ensembl chr 7:3,839,811...3,848,050 		JBrowse link
G Pira6 paired-Ig-like receptor A6 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PIRA6 mRNA CTD PMID:21641980
G Pitpnm1 phosphatidylinositol transfer protein, membrane-associated 1 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PITPNM1 mRNA CTD PMID:26378955 NCBI chr19:4,150,012...4,163,966
Ensembl chr19:4,149,998...4,163,965 		JBrowse link
G Pja2 praja ring finger ubiquitin ligase 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PJA2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PJA2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr17:64,588,001...64,638,878
Ensembl chr17:64,588,000...64,638,911 		JBrowse link
G Pkd2 polycystin 2, transient receptor potential cation channel multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PKD2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PKD2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 5:104,599,379...104,653,685
Ensembl chr 5:104,607,316...104,653,685 		JBrowse link
G Pklr pyruvate kinase liver and red blood cell multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PKLR mRNA CTD PMID:26378955 NCBI chr 3:89,043,429...89,054,122
Ensembl chr 3:89,043,449...89,054,091 		JBrowse link
G Plagl2 pleiomorphic adenoma gene-like 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PLAGL2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PLAGL2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 2:153,069,689...153,083,278
Ensembl chr 2:153,069,679...153,083,346 		JBrowse link
G Plau plasminogen activator, urokinase multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PLAU mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PLAU mRNA		 CTD PMID:21641980 PMID:26378955 NCBI chr14:20,886,730...20,893,456
Ensembl chr14:20,886,728...20,893,453 		JBrowse link
G Plaur plasminogen activator, urokinase receptor multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PLAUR mRNA CTD PMID:21641980 NCBI chr 7:24,161,857...24,175,393
Ensembl chr 7:24,161,909...24,175,393 		JBrowse link
G Plcb4 phospholipase C, beta 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PLCB4 mRNA CTD PMID:21641980 NCBI chr 2:135,500,523...135,856,522
Ensembl chr 2:135,500,931...135,856,513 		JBrowse link
G Pld3 phospholipase D family member 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PLD3 mRNA CTD PMID:21641980 NCBI chr 7:27,231,090...27,252,511
Ensembl chr 7:27,231,425...27,252,643 		JBrowse link
G Plk2 polo like kinase 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PLK2 mRNA CTD PMID:21641980 NCBI chr13:110,531,578...110,537,378
Ensembl chr13:110,531,580...110,537,378 		JBrowse link
G Plk4 polo like kinase 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PLK4 mRNA CTD PMID:21641980 NCBI chr 3:40,754,463...40,771,318
Ensembl chr 3:40,754,454...40,771,318 		JBrowse link
G Plpp3 phospholipid phosphatase 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PLPP3 mRNA CTD PMID:21641980 NCBI chr 4:105,014,544...105,089,964
Ensembl chr 4:105,014,544...105,089,961 		JBrowse link
G Plscr2 phospholipid scramblase 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PLSCR2 mRNA CTD PMID:26378955 NCBI chr 9:92,157,655...92,179,805
Ensembl chr 9:92,157,655...92,179,805 		JBrowse link
G Plxdc1 plexin domain containing 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PLXDC1 mRNA CTD PMID:21641980 NCBI chr11:97,814,063...97,879,393
Ensembl chr11:97,814,064...97,877,270 		JBrowse link
G Pmepa1 prostate transmembrane protein, androgen induced 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PMEPA1 mRNA CTD PMID:21641980 NCBI chr 2:173,066,251...173,118,329
Ensembl chr 2:173,066,251...173,118,326 		JBrowse link
G Pms1 PMS1 homolog 1, mismatch repair system component multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PMS1 mRNA CTD PMID:21641980 NCBI chr 1:53,225,794...53,336,190
Ensembl chr 1:53,228,346...53,336,177 		JBrowse link
G Pnisr PNN interacting serine/arginine-rich multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PNISR mRNA CTD PMID:21641980 NCBI chr 4:21,846,621...21,876,475
Ensembl chr 4:21,847,583...21,876,475 		JBrowse link
G Pnn pinin multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PNN mRNA CTD PMID:21641980 NCBI chr12:59,113,705...59,120,803
Ensembl chr12:59,113,670...59,120,784 		JBrowse link
G Pnpla6 patatin-like phospholipase domain containing 6 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PNPLA6 mRNA CTD PMID:26378955 NCBI chr 8:3,565,341...3,594,267
Ensembl chr 8:3,565,384...3,594,267 		JBrowse link
G Poglut3 protein O-glucosyltransferase 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of POGLUT3 mRNA CTD PMID:21641980 NCBI chr 9:53,294,217...53,313,167
Ensembl chr 9:53,295,325...53,313,167 		JBrowse link
G Pola1 polymerase (DNA directed), alpha 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of POLA1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of POLA1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr  X:92,348,372...92,675,993
Ensembl chr  X:92,348,373...92,675,761 		JBrowse link
G Polr1a polymerase (RNA) I polypeptide A multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of POLR1A mRNA CTD PMID:26378955 NCBI chr 6:71,886,037...71,956,419
Ensembl chr 6:71,886,037...71,961,919 		JBrowse link
G Pou2f2 POU domain, class 2, transcription factor 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of POU2F2 mRNA CTD PMID:21641980 NCBI chr 7:24,790,111...24,879,292
Ensembl chr 7:24,786,769...24,879,151 		JBrowse link
G Pparg peroxisome proliferator activated receptor gamma multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PPARG mRNA CTD PMID:26378955 NCBI chr 6:115,337,828...115,467,365
Ensembl chr 6:115,337,912...115,467,360 		JBrowse link
G Ppfia3 protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PPFIA3 mRNA CTD PMID:21641980 NCBI chr 7:44,988,550...45,016,443
Ensembl chr 7:44,988,546...45,016,443 		JBrowse link
G Ppfibp2 PTPRF interacting protein, binding protein 2 (liprin beta 2) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PPFIBP2 mRNA CTD PMID:21641980 NCBI chr 7:107,192,608...107,347,790
Ensembl chr 7:107,194,414...107,347,790 		JBrowse link
G Ppwd1 peptidylprolyl isomerase domain and WD repeat containing 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PPWD1 mRNA CTD PMID:21641980 NCBI chr13:104,340,102...104,365,378
Ensembl chr13:104,341,632...104,365,351 		JBrowse link
G Pram1 PML-RAR alpha-regulated adaptor molecule 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PRAM1 mRNA CTD PMID:21641980 NCBI chr17:33,857,030...33,864,680
Ensembl chr17:33,857,030...33,864,680 		JBrowse link
G Prdm1 PR domain containing 1, with ZNF domain multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PRDM1 mRNA CTD PMID:26378955 NCBI chr10:44,313,170...44,404,579
Ensembl chr10:44,313,173...44,404,497 		JBrowse link
G Prdm2 PR domain containing 2, with ZNF domain multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PRDM2 mRNA CTD PMID:26378955 NCBI chr 4:142,833,961...142,939,560
Ensembl chr 4:142,833,961...142,939,565 		JBrowse link
G Prim2 DNA primase, p58 subunit multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PRIM2 mRNA CTD PMID:26378955 NCBI chr 1:33,492,889...33,708,867
Ensembl chr 1:33,492,891...33,708,876 		JBrowse link
G Prkaa2 protein kinase, AMP-activated, alpha 2 catalytic subunit multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PRKAA2 mRNA CTD PMID:26378955 NCBI chr 4:104,886,846...104,967,095
Ensembl chr 4:104,887,071...104,967,087 		JBrowse link
G Prkar2b protein kinase, cAMP dependent regulatory, type II beta multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PRKAR2B mRNA CTD PMID:26378955 NCBI chr12:32,008,468...32,111,639
Ensembl chr12:32,008,475...32,111,295 		JBrowse link
G Prkcb protein kinase C, beta multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PRKCB mRNA CTD PMID:26378955 NCBI chr 7:121,888,327...122,233,625
Ensembl chr 7:121,887,974...122,233,625 		JBrowse link
G Procr protein C receptor, endothelial multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PROCR mRNA CTD PMID:21641980 NCBI chr 2:155,592,159...155,597,391
Ensembl chr 2:155,593,037...155,597,391 		JBrowse link
G Prpf38b PRP38 pre-mRNA processing factor 38 (yeast) domain containing B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PRPF38B mRNA CTD PMID:21641980 NCBI chr 3:108,810,121...108,819,055
Ensembl chr 3:108,810,121...108,819,043 		JBrowse link
G Prpf39 pre-mRNA processing factor 39 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PRPF39 mRNA CTD PMID:21641980 NCBI chr12:65,083,094...65,110,160
Ensembl chr12:65,083,107...65,110,160 		JBrowse link
G Prpf40a pre-mRNA processing factor 40A multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PRPF40A mRNA CTD PMID:21641980 NCBI chr 2:53,024,714...53,081,450
Ensembl chr 2:53,024,716...53,081,714 		JBrowse link
G Prpf4b pre-mRNA processing factor 4B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PRPF4B mRNA CTD PMID:21641980 NCBI chr13:35,058,803...35,090,047
Ensembl chr13:35,059,285...35,090,047 		JBrowse link
G Prrc1 proline-rich coiled-coil 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PRRC1 mRNA CTD PMID:21641980 NCBI chr18:57,487,805...57,526,028
Ensembl chr18:57,487,813...57,526,028 		JBrowse link
G Prrg4 proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PRRG4 mRNA CTD PMID:21641980 NCBI chr 2:104,657,374...104,680,216
Ensembl chr 2:104,661,086...104,680,221 		JBrowse link
G Prrt1 proline-rich transmembrane protein 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PRRT1 mRNA CTD PMID:21641980 NCBI chr17:34,848,396...34,852,108
Ensembl chr17:34,848,507...34,852,100 		JBrowse link
G Prss50 serine protease 50 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PRSS50 mRNA CTD PMID:21641980 NCBI chr 9:110,687,032...110,693,697
Ensembl chr 9:110,687,035...110,693,697 		JBrowse link
G Psma1 proteasome subunit alpha 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PSMA1 mRNA CTD PMID:21641980 NCBI chr 7:113,863,785...113,875,351
Ensembl chr 7:113,863,841...113,875,353 		JBrowse link
G Ptch2 patched 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PTCH2 mRNA CTD PMID:21641980 NCBI chr 4:116,953,253...116,973,298
Ensembl chr 4:116,953,272...116,973,298 		JBrowse link
G Ptgir prostaglandin I receptor (IP) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PTGIR mRNA CTD PMID:21641980 NCBI chr 7:16,640,442...16,644,828
Ensembl chr 7:16,640,415...16,644,830 		JBrowse link
G Ptgs1 prostaglandin-endoperoxide synthase 1 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PTGS1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of PTGS1 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PTGS1 mRNA		 CTD PMID:21641980 PMID:26378955 NCBI chr 2:36,106,758...36,142,287
Ensembl chr 2:36,120,438...36,142,284 		JBrowse link
G Ptgs2 prostaglandin-endoperoxide synthase 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PTGS2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PTGS2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 1:149,975,851...149,983,978
Ensembl chr 1:149,975,782...149,983,978 		JBrowse link
G Ptpn11 protein tyrosine phosphatase, non-receptor type 11 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PTPN11 mRNA CTD PMID:26378955 NCBI chr 5:121,268,596...121,329,460
Ensembl chr 5:121,268,596...121,329,460 		JBrowse link
G Ptpn14 protein tyrosine phosphatase, non-receptor type 14 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PTPN14 mRNA CTD PMID:21641980 NCBI chr 1:189,460,417...189,608,892
Ensembl chr 1:189,460,465...189,608,892 		JBrowse link
G Ptpn2 protein tyrosine phosphatase, non-receptor type 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PTPN2 mRNA CTD PMID:21641980 NCBI chr18:67,798,571...67,857,697
Ensembl chr18:67,798,581...67,857,665 		JBrowse link
G Ptpn22 protein tyrosine phosphatase, non-receptor type 22 (lymphoid) multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PTPN22 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of PTPN22 mRNA		 CTD PMID:21641980 PMID:26378955 NCBI chr 3:103,763,891...103,819,568
Ensembl chr 3:103,767,111...103,819,563 		JBrowse link
G Ptprc protein tyrosine phosphatase receptor type C multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PTPRC mRNA CTD PMID:21641980 NCBI chr 1:137,990,601...138,103,491
Ensembl chr 1:137,990,599...138,103,446 		JBrowse link
G Pus3 pseudouridine synthase 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PUS3 mRNA CTD PMID:21641980 NCBI chr 9:35,469,856...35,478,697
Ensembl chr 9:35,469,891...35,478,697 		JBrowse link
G Pxk PX domain containing serine/threonine kinase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of PXK mRNA CTD PMID:21641980 NCBI chr14:14,304,656...14,371,593
Ensembl chr14:14,304,656...14,371,562 		JBrowse link
G Pxmp4 peroxisomal membrane protein 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of PXMP4 mRNA CTD PMID:21641980 NCBI chr 2:154,427,678...154,445,592
Ensembl chr 2:154,427,678...154,445,628 		JBrowse link
G Qpct glutaminyl-peptide cyclotransferase (glutaminyl cyclase) multiple interactions ISO
EXP		 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of QPCT mRNA CTD PMID:26378955 NCBI chr17:79,359,335...79,397,807
Ensembl chr17:79,359,335...79,397,807 		JBrowse link
G Qser1 glutamine and serine rich 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of QSER1 mRNA CTD PMID:21641980 NCBI chr 2:104,585,140...104,649,028
Ensembl chr 2:104,585,140...104,647,105 		JBrowse link
G Rab14 RAB14, member RAS oncogene family multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RAB14 mRNA CTD PMID:21641980 NCBI chr 2:35,070,217...35,091,132
Ensembl chr 2:35,070,217...35,091,132 		JBrowse link
G Rab6a RAB6A, member RAS oncogene family multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RAB6A mRNA CTD PMID:26378955 NCBI chr 7:100,256,778...100,290,475
Ensembl chr 7:100,256,617...100,290,475 		JBrowse link
G Rad18 RAD18 E3 ubiquitin protein ligase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RAD18 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of RAD18 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 6:112,596,812...112,673,650
Ensembl chr 6:112,596,811...112,673,647 		JBrowse link
G Rad54l RAD54 like (S. cerevisiae) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RAD54L mRNA CTD PMID:21641980 NCBI chr 4:115,951,458...115,980,875
Ensembl chr 4:115,951,461...115,980,887 		JBrowse link
G Rasa2 RAS p21 protein activator 2 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RASA2 mRNA CTD PMID:26378955 NCBI chr 9:96,421,353...96,513,665
Ensembl chr 9:96,421,353...96,513,670 		JBrowse link
G Rasgrp3 RAS, guanyl releasing protein 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RASGRP3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RASGRP3 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr17:75,742,849...75,836,049
Ensembl chr17:75,742,891...75,836,049 		JBrowse link
G Rassf1 Ras association (RalGDS/AF-6) domain family member 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RASSF1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RASSF1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 9:107,428,752...107,439,460
Ensembl chr 9:107,428,754...107,439,466 		JBrowse link
G Rassf2 Ras association (RalGDS/AF-6) domain family member 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RASSF2 mRNA CTD PMID:21641980 NCBI chr 2:131,834,770...131,872,336
Ensembl chr 2:131,831,335...131,872,178 		JBrowse link
G Rassf4 Ras association (RalGDS/AF-6) domain family member 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of RASSF4 mRNA CTD PMID:21641980 NCBI chr 6:116,609,969...116,650,797
Ensembl chr 6:116,609,969...116,650,913 		JBrowse link
G Rassf8 Ras association (RalGDS/AF-6) domain family (N-terminal) member 8 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of RASSF8 mRNA CTD PMID:21641980 NCBI chr 6:145,692,292...145,766,805
Ensembl chr 6:145,692,474...145,766,805 		JBrowse link
G Rbbp4 retinoblastoma binding protein 4, chromatin remodeling factor multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBBP4 mRNA CTD PMID:21641980 NCBI chr 4:129,200,893...129,229,163
Ensembl chr 4:129,200,893...129,229,163 		JBrowse link
G Rbbp6 retinoblastoma binding protein 6, ubiquitin ligase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of RBBP6 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RBBP6 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 7:122,568,980...122,601,780
Ensembl chr 7:122,564,909...122,601,780 		JBrowse link
G Rbbp8 retinoblastoma binding protein 8, endonuclease multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBBP8 mRNA CTD PMID:21641980 NCBI chr18:11,766,333...11,876,264
Ensembl chr18:11,766,333...11,878,278 		JBrowse link
G Rbfox1 RNA binding protein, fox-1 homolog (C. elegans) 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBFOX1 mRNA CTD PMID:21641980 NCBI chr16:5,702,566...7,230,344
Ensembl chr16:5,703,219...7,229,390 		JBrowse link
G Rbl1 RB transcriptional corepressor like 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBL1 mRNA CTD PMID:21641980 NCBI chr 2:156,987,813...157,046,454
Ensembl chr 2:156,987,813...157,046,454 		JBrowse link
G Rbm25 RNA binding motif protein 25 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBM25 mRNA CTD PMID:21641980 NCBI chr12:83,678,990...83,729,901
Ensembl chr12:83,678,010...83,729,897 		JBrowse link
G Rbm26 RNA binding motif protein 26 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBM26 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RBM26 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr14:105,344,187...105,418,475
Ensembl chr14:105,344,187...105,414,763 		JBrowse link
G Rbm3 RNA binding motif (RNP1, RRM) protein 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBM3 mRNA CTD PMID:21641980 NCBI chr  X:8,005,214...8,012,119
Ensembl chr  X:8,005,214...8,012,119 		JBrowse link
G Rbm39 RNA binding motif protein 39 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBM39 mRNA CTD PMID:21641980 NCBI chr 2:155,989,159...156,022,649
Ensembl chr 2:155,989,159...156,022,158 		JBrowse link
G Rbm5 RNA binding motif protein 5 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RBM5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RBM5 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 9:107,617,694...107,648,228
Ensembl chr 9:107,617,570...107,648,195 		JBrowse link
G Rc3h2 ring finger and CCCH-type zinc finger domains 2 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RC3H2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of RC3H2 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RC3H2 mRNA		 CTD PMID:21641980 PMID:26378955 NCBI chr 2:37,260,078...37,313,007
Ensembl chr 2:37,260,081...37,312,915 		JBrowse link
G Rcan1 regulator of calcineurin 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of RCAN1 mRNA CTD PMID:21641980 NCBI chr16:92,188,839...92,263,057
Ensembl chr16:92,188,841...92,267,755 		JBrowse link
G Rcn2 reticulocalbin 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RCN2 mRNA CTD PMID:26378955 NCBI chr 9:55,949,129...55,966,367
Ensembl chr 9:55,949,129...55,969,166 		JBrowse link
G Reep3 receptor accessory protein 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of REEP3 mRNA CTD PMID:21641980 NCBI chr10:66,844,968...66,932,767
Ensembl chr10:66,844,968...66,932,724 		JBrowse link
G Relb avian reticuloendotheliosis viral (v-rel) oncogene related B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of RELB mRNA CTD PMID:21641980 NCBI chr 7:19,340,142...19,363,352
Ensembl chr 7:19,340,142...19,363,363 		JBrowse link
G Rest RE1-silencing transcription factor multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of REST mRNA CTD PMID:26378955 NCBI chr 5:77,413,273...77,434,279
Ensembl chr 5:77,413,338...77,434,279 		JBrowse link
G Rev3l REV3 like, DNA directed polymerase zeta catalytic subunit multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of REV3L mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of REV3L mRNA CTD PMID:21641980 PMID:26378955 NCBI chr10:39,607,557...39,751,207
Ensembl chr10:39,608,114...39,751,207 		JBrowse link
G Rftn2 raftlin family member 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of RFTN2 mRNA CTD PMID:21641980 NCBI chr 1:55,209,318...55,267,128
Ensembl chr 1:55,209,318...55,265,941 		JBrowse link
G Rfx7 regulatory factor X, 7 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RFX7 mRNA CTD PMID:21641980 NCBI chr 9:72,439,346...72,530,231
Ensembl chr 9:72,439,522...72,530,111 		JBrowse link
G Rgs16 regulator of G-protein signaling 16 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of RGS16 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RGS16 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 1:153,616,099...153,621,212
Ensembl chr 1:153,616,095...153,621,214 		JBrowse link
G Rgs18 regulator of G-protein signaling 18 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of RGS18 mRNA CTD PMID:21641980 NCBI chr 1:144,628,430...144,651,165
Ensembl chr 1:144,628,421...144,651,173 		JBrowse link
G Rheb Ras homolog enriched in brain multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] affects the expression of RHEB mRNA CTD PMID:26378955 NCBI chr 5:25,007,821...25,047,359
Ensembl chr 5:25,007,821...25,047,622 		JBrowse link
G Rhoc ras homolog family member C multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of RHOC mRNA CTD PMID:21641980 NCBI chr 3:104,696,350...104,701,775
Ensembl chr 3:104,695,691...104,701,775 		JBrowse link
G Rhof ras homolog family member F (in filopodia) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RHOF mRNA; [Succimer binds to Magnetite Nanoparticles] which results in increased expression of RHOF mRNA CTD PMID:21641980 NCBI chr 5:123,256,243...123,270,692
Ensembl chr 5:123,241,107...123,270,755 		JBrowse link
G Rhoq ras homolog family member Q multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RHOQ mRNA CTD PMID:21641980 NCBI chr17:87,270,539...87,307,497
Ensembl chr17:87,270,510...87,307,497 		JBrowse link
G Rhov ras homolog family member V multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RHOV mRNA CTD PMID:26378955 NCBI chr 2:119,099,682...119,108,489
Ensembl chr 2:119,099,682...119,101,753 		JBrowse link
G Rif1 replication timing regulatory factor 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RIF1 mRNA CTD PMID:21641980 NCBI chr 2:51,962,725...52,016,781
Ensembl chr 2:51,962,844...52,012,395 		JBrowse link
G Rigi RNA sensor RIG-I multiple interactions ISO
EXP		 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RIGI mRNA
[Succimer binds to Magnetite Nanoparticles] which results in increased expression of RIGI mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RIGI mRNA		 CTD PMID:21641980 PMID:26378955 NCBI chr 4:40,203,775...40,239,843
Ensembl chr 4:40,203,773...40,239,828 		JBrowse link
G Rilpl2 Rab interacting lysosomal protein-like 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of RILPL2 mRNA CTD PMID:21641980 NCBI chr 5:124,601,328...124,616,298
Ensembl chr 5:124,601,328...124,616,429 		JBrowse link
G Rimklb ribosomal modification protein rimK-like family member B multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RIMKLB mRNA CTD PMID:26378955 NCBI chr 6:122,424,255...122,464,021
Ensembl chr 6:122,424,255...122,475,720 		JBrowse link
G Rims2 regulating synaptic membrane exocytosis 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of RIMS2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RIMS2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr15:39,061,681...39,547,768
Ensembl chr15:39,061,656...39,547,768 		JBrowse link
G Rin1 Ras and Rab interactor 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RIN1 mRNA CTD PMID:21641980 NCBI chr19:5,100,035...5,107,100
Ensembl chr19:5,100,509...5,107,099 		JBrowse link
G Rmnd1 required for meiotic nuclear division 1 homolog multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RMND1 mRNA CTD PMID:21641980 NCBI chr10:4,353,168...4,382,583
Ensembl chr10:4,351,915...4,382,388 		JBrowse link
G Rmnd5a required for meiotic nuclear division 5 homolog A multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RMND5A mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RMND5A mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 6:71,365,623...71,417,491
Ensembl chr 6:71,365,618...71,417,621 		JBrowse link
G Rnase1 ribonuclease, RNase A family, 1 (pancreatic) multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RNASE1 mRNA CTD PMID:26378955 NCBI chr14:51,382,459...51,384,224
Ensembl chr14:51,382,455...51,384,242 		JBrowse link
G Rnase4 ribonuclease, RNase A family 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RNASE4 mRNA CTD PMID:21641980 NCBI chr14:51,328,534...51,343,608
Ensembl chr14:51,328,534...51,343,608 		JBrowse link
G Rnf122 ring finger protein 122 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RNF122 mRNA CTD PMID:26378955 NCBI chr 8:31,601,855...31,623,346
Ensembl chr 8:31,601,848...31,621,510 		JBrowse link
G Rnf144b ring finger protein 144B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RNF144B mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of RNF144B mRNA CTD PMID:21641980 PMID:26378955 NCBI chr13:47,276,196...47,401,470
Ensembl chr13:47,276,132...47,401,467 		JBrowse link
G Rnf183 ring finger protein 183 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of RNF183 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RNF183 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 4:62,345,777...62,353,487
Ensembl chr 4:62,345,777...62,353,489 		JBrowse link
G Rnf19b ring finger protein 19B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of RNF19B mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RNF19B mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 4:128,951,871...128,978,319
Ensembl chr 4:128,952,064...128,979,679 		JBrowse link
G Rnf213 ring finger protein 213 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RNF213 mRNA CTD PMID:26378955 NCBI chr11:119,280,778...119,378,245
Ensembl chr11:119,283,926...119,378,244 		JBrowse link
G Rnf24 ring finger protein 24 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RNF24 mRNA CTD PMID:26378955 NCBI chr 2:131,139,984...131,194,766
Ensembl chr 2:131,139,984...131,194,812 		JBrowse link
G Rnf38 ring finger protein 38 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RNF38 mRNA CTD PMID:26378955 NCBI chr 4:44,126,210...44,233,929
Ensembl chr 4:44,126,210...44,233,789 		JBrowse link
G Rnf39 ring finger protein 39 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RNF39 mRNA CTD PMID:26378955 NCBI chr17:37,253,943...37,258,878
Ensembl chr17:37,253,810...37,258,878 		JBrowse link
G Rnf44 ring finger protein 44 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RNF44 mRNA CTD PMID:26378955 NCBI chr13:54,827,212...54,841,889
Ensembl chr13:54,827,212...54,841,720 		JBrowse link
G Rnf6 ring finger protein (C3H2C3 type) 6 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RNF6 mRNA CTD PMID:26378955 NCBI chr 5:146,146,003...146,158,267
Ensembl chr 5:146,146,002...146,158,365 		JBrowse link
G Ro60 Ro60, Y RNA binding protein multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] affects the expression of RO60 mRNA CTD PMID:26378955 NCBI chr 1:143,626,528...143,652,794
Ensembl chr 1:143,626,528...143,652,806 		JBrowse link
G Rock1 Rho-associated coiled-coil containing protein kinase 1 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ROCK1 mRNA CTD PMID:26378955 NCBI chr18:10,064,401...10,182,225
Ensembl chr18:10,064,401...10,182,045 		JBrowse link
G Rp2 retinitis pigmentosa 2 homolog multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RP2 mRNA CTD PMID:21641980 NCBI chr  X:20,230,778...20,271,873
Ensembl chr  X:20,230,720...20,271,892 		JBrowse link
G Rpl30 ribosomal protein L30 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RPL30 mRNA CTD PMID:21641980 NCBI chr15:34,440,649...34,443,405
Ensembl chr15:34,440,651...34,443,786 		JBrowse link
G Rpl37 ribosomal protein L37 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RPL37 mRNA CTD PMID:26378955 NCBI chr15:5,146,127...5,148,626
Ensembl chr15:5,146,127...5,148,622 		JBrowse link
G Rpl37a ribosomal protein L37a multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] affects the expression of RPL37A mRNA CTD PMID:26378955 NCBI chr 1:72,750,426...72,752,972
Ensembl chr 1:72,750,449...72,752,972 		JBrowse link
G Rpl5 ribosomal protein L5 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RPL5 mRNA CTD PMID:21641980 NCBI chr 5:108,048,388...108,056,871
Ensembl chr 5:108,048,368...108,056,871 		JBrowse link
G Rps17 ribosomal protein S17 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RPS17 mRNA CTD PMID:21641980 NCBI chr 7:80,992,481...80,994,982
Ensembl chr 7:80,992,480...80,995,002 		JBrowse link
G Rps24 ribosomal protein S24 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RPS24 mRNA CTD PMID:21641980 NCBI chr14:24,540,786...24,545,925
Ensembl chr14:24,537,193...24,547,027 		JBrowse link
G Rps27l ribosomal protein S27-like multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] affects the expression of RPS27L mRNA CTD PMID:26378955 NCBI chr 9:66,851,906...66,856,804
Ensembl chr 9:66,853,368...66,856,798 		JBrowse link
G Rps6ka2 ribosomal protein S6 kinase, polypeptide 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of RPS6KA2 mRNA CTD PMID:21641980 NCBI chr17:7,356,384...7,570,714
Ensembl chr17:7,437,514...7,570,714 		JBrowse link
G Rps6ka5 ribosomal protein S6 kinase, polypeptide 5 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RPS6KA5 mRNA CTD PMID:21641980 NCBI chr12:100,514,692...100,691,693
Ensembl chr12:100,514,698...100,693,242 		JBrowse link
G Rps6kb1 ribosomal protein S6 kinase, polypeptide 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RPS6KB1 mRNA CTD PMID:21641980 NCBI chr11:86,389,695...86,435,711
Ensembl chr11:86,389,697...86,435,631 		JBrowse link
G Rrm2b ribonucleotide reductase M2 B (TP53 inducible) multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RRM2B mRNA CTD PMID:26378955 NCBI chr15:37,924,196...37,961,562
Ensembl chr15:37,924,196...37,961,562 		JBrowse link
G Rsad2 radical S-adenosyl methionine domain containing 2 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of RSAD2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RSAD2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr12:26,492,742...26,506,451
Ensembl chr12:26,492,745...26,506,451 		JBrowse link
G Rsc1a1 regulatory solute carrier protein, family 1, member 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RSC1A1 mRNA CTD PMID:21641980 NCBI chr 4:141,410,874...141,413,027
Ensembl chr 4:141,411,162...141,412,910 		JBrowse link
G Rsf1 remodeling and spacing factor 1 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RSF1 mRNA CTD PMID:26378955 NCBI chr 7:97,229,103...97,341,989
Ensembl chr 7:97,229,096...97,341,985 		JBrowse link
G Rspo3 R-spondin 3 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RSPO3 mRNA CTD PMID:26378955 NCBI chr10:29,329,102...29,411,863
Ensembl chr10:29,328,412...29,411,863 		JBrowse link
G Rsrc2 arginine/serine-rich coiled-coil 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RSRC2 mRNA CTD PMID:21641980 NCBI chr 5:123,866,489...123,887,522
Ensembl chr 5:123,866,489...123,887,477 		JBrowse link
G Rtel1 regulator of telomere elongation helicase 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of RTEL1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RTEL1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 2:180,961,504...180,998,409
Ensembl chr 2:180,961,532...180,998,409 		JBrowse link
G Rtn1 reticulon 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of RTN1 mRNA CTD PMID:26378955 NCBI chr12:72,258,523...72,455,828
Ensembl chr12:72,258,526...72,455,828 		JBrowse link
G Rtn4 reticulon 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RTN4 mRNA CTD PMID:21641980 NCBI chr11:29,642,898...29,694,414
Ensembl chr11:29,642,947...29,694,331 		JBrowse link
G Rtp4 receptor transporter protein 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of RTP4 mRNA CTD PMID:21641980 NCBI chr16:23,338,976...23,432,972
Ensembl chr16:23,339,041...23,432,972 		JBrowse link
G Rufy3 RUN and FYVE domain containing 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RUFY3 mRNA CTD PMID:21641980 NCBI chr 5:88,711,305...88,799,276
Ensembl chr 5:88,712,899...88,799,251 		JBrowse link
G Runx2 runt related transcription factor 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of RUNX2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of RUNX2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr17:44,806,873...45,125,518
Ensembl chr17:44,806,874...45,125,684 		JBrowse link
G S100a10 S100 calcium binding protein A10 (calpactin) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of S100A10 mRNA CTD PMID:21641980 NCBI chr 3:93,462,424...93,471,952
Ensembl chr 3:93,462,387...93,471,950 		JBrowse link
G S100a8 S100 calcium binding protein A8 (calgranulin A) multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of S100A8 mRNA CTD PMID:26378955 NCBI chr 3:90,576,378...90,577,341
Ensembl chr 3:90,576,285...90,577,342 		JBrowse link
G S100a9 S100 calcium binding protein A9 (calgranulin B) multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of S100A9 mRNA CTD PMID:26378955 NCBI chr 3:90,599,937...90,603,028
Ensembl chr 3:90,599,939...90,603,028 		JBrowse link
G Saa3 serum amyloid A 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SAA3 mRNA CTD PMID:21641980 NCBI chr 7:46,361,422...46,365,100
Ensembl chr 7:46,361,422...46,365,124 		JBrowse link
G Sacm1l SAC1 suppressor of actin mutations 1-like (yeast) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SACM1L mRNA CTD PMID:21641980 NCBI chr 9:123,358,818...123,421,665
Ensembl chr 9:123,358,824...123,421,665 		JBrowse link
G Sacs sacsin multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SACS mRNA CTD PMID:21641980 NCBI chr14:61,375,870...61,478,142
Ensembl chr14:61,375,906...61,478,144 		JBrowse link
G Samd9l sterile alpha motif domain containing 9-like multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SAMD9L mRNA CTD PMID:21641980 NCBI chr 6:3,372,257...3,399,458
Ensembl chr 6:3,372,257...3,399,572 		JBrowse link
G Samhd1 SAM domain and HD domain, 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SAMHD1 mRNA CTD PMID:26378955 NCBI chr 2:156,939,454...156,977,016
Ensembl chr 2:156,939,453...156,977,185 		JBrowse link
G Sap18 Sin3-associated polypeptide 18 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SAP18 mRNA CTD PMID:21641980 NCBI chr14:58,035,646...58,042,437
Ensembl chr14:58,035,637...58,044,095 		JBrowse link
G Sap30l SAP30-like multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SAP30L mRNA CTD PMID:26378955 NCBI chr11:57,692,439...57,705,707
Ensembl chr11:57,692,463...57,701,043 		JBrowse link
G Sapcd1 suppressor APC domain containing 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SAPCD1 mRNA CTD PMID:21641980 NCBI chr17:35,244,935...35,247,600
Ensembl chr17:35,244,935...35,246,992 		JBrowse link
G Sash3 SAM and SH3 domain containing 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SASH3 mRNA CTD PMID:21641980 NCBI chr  X:47,235,313...47,250,442
Ensembl chr  X:47,235,313...47,250,442 		JBrowse link
G Sc5d sterol-C5-desaturase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SC5D mRNA CTD PMID:21641980 NCBI chr 9:42,162,888...42,175,607
Ensembl chr 9:42,162,891...42,175,552 		JBrowse link
G Scaper S phase cyclin A-associated protein in the ER multiple interactions ISO
EXP		 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SCAPER mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SCAPER mRNA		 CTD PMID:26378955 NCBI chr 9:55,457,163...55,845,505
Ensembl chr 9:55,457,163...55,845,403 		JBrowse link
G Scd2 stearoyl-Coenzyme A desaturase 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SCD2 mRNA CTD PMID:21641980 NCBI chr19:44,282,115...44,295,303
Ensembl chr19:44,282,113...44,295,303 		JBrowse link
G Scin scinderin multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SCIN mRNA CTD PMID:21641980 NCBI chr12:40,109,768...40,184,227
Ensembl chr12:40,109,768...40,184,227 		JBrowse link
G Scyl3 SCY1-like 3 (S. cerevisiae) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SCYL3 mRNA CTD PMID:21641980 NCBI chr 1:163,756,669...163,782,695
Ensembl chr 1:163,756,669...163,782,695 		JBrowse link
G Sdc3 syndecan 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SDC3 mRNA CTD PMID:21641980 NCBI chr 4:130,519,855...130,553,629
Ensembl chr 4:130,519,848...130,553,630 		JBrowse link
G Sdc4 syndecan 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SDC4 mRNA CTD PMID:21641980 NCBI chr 2:164,266,167...164,285,512
Ensembl chr 2:164,266,167...164,285,807 		JBrowse link
G Selenbp1 selenium binding protein 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SELENBP1 mRNA CTD PMID:21641980 NCBI chr 3:94,840,394...94,852,069
Ensembl chr 3:94,840,367...94,852,069 		JBrowse link
G Selenow selenoprotein W multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SELENOW mRNA CTD PMID:21641980 NCBI chr 7:15,651,133...15,656,296
Ensembl chr 7:15,651,133...15,656,327 		JBrowse link
G Sema3e sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SEMA3E mRNA CTD PMID:21641980 NCBI chr 5:14,075,290...14,306,703
Ensembl chr 5:14,075,290...14,306,703 		JBrowse link
G Sema4a sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SEMA4A mRNA CTD PMID:21641980 NCBI chr 3:88,343,266...88,368,500
Ensembl chr 3:88,343,266...88,368,489 		JBrowse link
G Sema4c sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4C multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SEMA4C mRNA CTD PMID:21641980 NCBI chr 1:36,587,720...36,599,780
Ensembl chr 1:36,587,720...36,597,430 		JBrowse link
G Sema4g sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SEMA4G mRNA CTD PMID:21641980 NCBI chr19:44,976,838...44,991,836
Ensembl chr19:44,977,540...44,991,836 		JBrowse link
G Sema5a sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5A multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SEMA5A mRNA CTD PMID:21641980 NCBI chr15:32,244,959...32,696,487
Ensembl chr15:32,244,956...32,696,487 		JBrowse link
G Sema7a sema domain, immunoglobulin domain (Ig), and GPI membrane anchor, (semaphorin) 7A multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SEMA7A mRNA CTD PMID:21641980 NCBI chr 9:57,846,879...57,870,148
Ensembl chr 9:57,847,395...57,870,148 		JBrowse link
G Senp7 SUMO1/sentrin specific peptidase 7 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SENP7 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SENP7 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr16:55,869,306...56,010,394
Ensembl chr16:55,868,701...56,010,375 		JBrowse link
G Serbp1 serpine1 mRNA binding protein 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SERBP1 mRNA CTD PMID:21641980 NCBI chr 6:67,243,963...67,266,286
Ensembl chr 6:67,215,160...67,274,720 		JBrowse link
G Serinc2 serine incorporator 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SERINC2 mRNA CTD PMID:21641980 NCBI chr 4:130,147,289...130,172,993
Ensembl chr 4:130,147,288...130,172,998 		JBrowse link
G Serinc3 serine incorporator 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SERINC3 mRNA CTD PMID:21641980 NCBI chr 2:163,466,577...163,487,767
Ensembl chr 2:163,465,192...163,487,051 		JBrowse link
G Serpina7 serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SERPINA7 mRNA CTD PMID:26378955 NCBI chr  X:137,979,998...137,985,985
Ensembl chr  X:137,980,006...137,985,985 		JBrowse link
G Serpinb12 serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 12 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SERPINB12 mRNA CTD PMID:26378955 NCBI chr 1:106,862,179...106,884,810
Ensembl chr 1:106,862,179...106,884,810 		JBrowse link
G Serpinb1b serine (or cysteine) peptidase inhibitor, clade B, member 1b multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SERPINB1B mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SERPINB1B mRNA CTD PMID:21641980 PMID:26378955 NCBI chr13:33,262,478...33,278,363
Ensembl chr13:33,262,558...33,278,363 		JBrowse link
G Serpinb5 serine (or cysteine) peptidase inhibitor, clade B, member 5 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SERPINB5 mRNA CTD PMID:26378955 NCBI chr 1:106,788,905...106,811,078
Ensembl chr 1:106,788,903...106,811,078 		JBrowse link
G Serpinb6b serine (or cysteine) peptidase inhibitor, clade B, member 6b multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SERPINB6B mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SERPINB6B mRNA CTD PMID:21641980 PMID:26378955 NCBI chr13:33,140,797...33,163,050
Ensembl chr13:33,149,192...33,163,050 		JBrowse link
G Serpinb8 serine (or cysteine) peptidase inhibitor, clade B, member 8 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SERPINB8 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SERPINB8 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 1:107,517,668...107,536,708
Ensembl chr 1:107,517,736...107,538,214 		JBrowse link
G Serpinb9 serine (or cysteine) peptidase inhibitor, clade B, member 9 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SERPINB9 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SERPINB9 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr13:33,181,044...33,201,938
Ensembl chr13:33,187,233...33,201,940 		JBrowse link
G Serpinb9b serine (or cysteine) peptidase inhibitor, clade B, member 9b multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SERPINB9B mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SERPINB9B mRNA CTD PMID:21641980 PMID:26378955 NCBI chr13:33,211,397...33,224,571
Ensembl chr13:33,211,399...33,225,867 		JBrowse link
G Serpind1 serine (or cysteine) peptidase inhibitor, clade D, member 1 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SERPIND1 mRNA CTD PMID:26378955 NCBI chr16:17,149,235...17,161,438
Ensembl chr16:17,149,235...17,161,439 		JBrowse link
G Serpine1 serine (or cysteine) peptidase inhibitor, clade E, member 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SERPINE1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SERPINE1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 5:137,090,358...137,101,126
Ensembl chr 5:137,090,358...137,101,122 		JBrowse link
G Serpini1 serine (or cysteine) peptidase inhibitor, clade I, member 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SERPINI1 mRNA CTD PMID:26378955 NCBI chr 3:75,464,800...75,549,830
Ensembl chr 3:75,464,854...75,550,802 		JBrowse link
G Sesn1 sestrin 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SESN1 mRNA CTD PMID:21641980 NCBI chr10:41,686,570...41,784,432
Ensembl chr10:41,685,931...41,784,420 		JBrowse link
G Setd4 SET domain containing 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SETD4 mRNA CTD PMID:21641980 NCBI chr16:93,380,345...93,401,693
Ensembl chr16:93,380,345...93,400,951 		JBrowse link
G Sfi1 Sfi1 homolog, spindle assembly associated (yeast) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SFI1 mRNA CTD PMID:21641980 NCBI chr11:3,081,850...3,153,344
Ensembl chr11:3,081,850...3,143,463 		JBrowse link
G Sfpq splicing factor proline/glutamine rich (polypyrimidine tract binding protein associated) multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SFPQ mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SFPQ mRNA		 CTD PMID:21641980 PMID:26378955 NCBI chr 4:126,914,504...126,944,894
Ensembl chr 4:126,915,117...126,930,806 		JBrowse link
G Sh3glb1 SH3-domain GRB2-like B1 (endophilin) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SH3GLB1 mRNA CTD PMID:21641980 NCBI chr 3:144,389,426...144,426,186
Ensembl chr 3:144,389,439...144,426,096 		JBrowse link
G Sik3 SIK family kinase 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SIK3 mRNA CTD PMID:21641980 NCBI chr 9:45,924,099...46,135,492
Ensembl chr 9:45,924,118...46,135,492 		JBrowse link
G Skil SKI-like multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SKIL mRNA CTD PMID:21641980 NCBI chr 3:31,149,259...31,176,741
Ensembl chr 3:31,149,207...31,176,726 		JBrowse link
G Slc11a1 solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC11A1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SLC11A1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 1:74,414,318...74,429,974
Ensembl chr 1:74,414,354...74,425,221 		JBrowse link
G Slc11a2 solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC11A2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SLC11A2 mRNA CTD PMID:21641980 PMID:23086747 PMID:26378955 NCBI chr15:100,285,779...100,322,090
Ensembl chr15:100,285,779...100,322,953 		JBrowse link
G Slc12a3 solute carrier family 12, member 3 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SLC12A3 mRNA CTD PMID:26378955 NCBI chr 8:95,055,737...95,092,850
Ensembl chr 8:95,055,829...95,092,842 		JBrowse link
G Slc15a3 solute carrier family 15, member 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC15A3 mRNA CTD PMID:21641980 NCBI chr19:10,819,908...10,835,279
Ensembl chr19:10,817,091...10,836,726 		JBrowse link
G Slc16a12 solute carrier family 16 (monocarboxylic acid transporters), member 12 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC16A12 mRNA CTD PMID:23086747 NCBI chr19:34,645,801...34,725,223
Ensembl chr19:34,645,803...34,724,689 		JBrowse link
G Slc16a4 solute carrier family 16 (monocarboxylic acid transporters), member 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC16A4 mRNA CTD PMID:21641980 NCBI chr 3:107,198,543...107,219,437
Ensembl chr 3:107,198,546...107,219,431 		JBrowse link
G Slc1a4 solute carrier family 1 (glutamate/neutral amino acid transporter), member 4 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SLC1A4 mRNA CTD PMID:26378955 NCBI chr11:20,252,180...20,282,713
Ensembl chr11:20,252,180...20,282,713 		JBrowse link
G Slc20a2 solute carrier family 20, member 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC20A2 mRNA CTD PMID:21641980 NCBI chr 8:22,966,771...23,059,632
Ensembl chr 8:22,966,804...23,059,628 		JBrowse link
G Slc22a4 solute carrier family 22 (organic cation transporter), member 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC22A4 mRNA CTD PMID:21641980 NCBI chr11:53,873,941...53,920,866
Ensembl chr11:53,873,949...53,918,916 		JBrowse link
G Slc25a23 solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC25A23 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SLC25A23 mRNA CTD PMID:21641980 PMID:23086747 PMID:26378955 NCBI chr17:57,350,711...57,366,863
Ensembl chr17:57,350,711...57,366,863 		JBrowse link
G Slc25a26 solute carrier family 25 (mitochondrial carrier, phosphate carrier), member 26 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC25A26 mRNA CTD PMID:23086747 NCBI chr 6:94,477,272...94,581,636
Ensembl chr 6:94,477,312...94,581,653 		JBrowse link
G Slc28a2 solute carrier family 28 (sodium-coupled nucleoside transporter), member 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC28A2 mRNA CTD PMID:21641980 NCBI chr 2:122,256,836...122,291,633
Ensembl chr 2:122,256,958...122,291,618 		JBrowse link
G Slc31a2 solute carrier family 31, member 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC31A2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SLC31A2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 4:62,198,630...62,216,649
Ensembl chr 4:62,180,799...62,216,648 		JBrowse link
G Slc38a2 solute carrier family 38, member 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC38A2 mRNA CTD PMID:21641980 PMID:23086747 NCBI chr15:96,585,267...96,597,609
Ensembl chr15:96,585,273...96,597,611 		JBrowse link
G Slc40a1 solute carrier family 40 (iron-regulated transporter), member 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC40A1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SLC40A1 mRNA CTD PMID:21641980 PMID:23086747 PMID:26378955 NCBI chr 1:45,947,230...45,965,690
Ensembl chr 1:45,947,228...45,965,683 		JBrowse link
G Slc44a1 solute carrier family 44, member 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC44A1 mRNA CTD PMID:21641980 PMID:23086747 NCBI chr 4:53,440,387...53,622,478
Ensembl chr 4:53,440,413...53,622,478 		JBrowse link
G Slc48a1 solute carrier family 48 (heme transporter), member 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC48A1 mRNA CTD PMID:21641980 PMID:23086747 NCBI chr15:97,682,246...97,690,573
Ensembl chr15:97,676,401...97,690,573 		JBrowse link
G Slc4a7 solute carrier family 4, sodium bicarbonate cotransporter, member 7 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC4A7 mRNA CTD PMID:21641980 NCBI chr14:7,669,819...7,766,808
Ensembl chr14:7,669,823...7,767,484 		JBrowse link
G Slc5a3 solute carrier family 5 (inositol transporters), member 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC5A3 mRNA CTD PMID:21641980 PMID:23086747 NCBI chr16:91,855,210...91,884,361
Ensembl chr16:91,855,210...91,884,361 		JBrowse link
G Slc6a12 solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC6A12 mRNA CTD PMID:21641980 PMID:23086747 NCBI chr 6:121,319,533...121,342,732
Ensembl chr 6:121,320,035...121,342,734 		JBrowse link
G Slc6a13 solute carrier family 6 (neurotransmitter transporter, GABA), member 13 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLC6A13 mRNA CTD PMID:21641980 PMID:23086747 NCBI chr 6:121,277,247...121,314,680
Ensembl chr 6:121,277,186...121,314,692 		JBrowse link
G Slc7a11 solute carrier family 7 (cationic amino acid transporter, y+ system), member 11 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC7A11 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SLC7A11 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 3:50,319,385...50,403,947
Ensembl chr 3:49,846,975...50,398,063 		JBrowse link
G Slc8a1 solute carrier family 8 (sodium/calcium exchanger), member 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SLC8A1 mRNA CTD PMID:26378955 NCBI chr17:81,680,534...82,045,816
Ensembl chr17:81,680,534...82,045,806 		JBrowse link
G Slc9b2 solute carrier family 9, subfamily B (NHA2, cation proton antiporter 2), member 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLC9B2 mRNA CTD PMID:21641980 NCBI chr 3:135,013,083...135,048,606
Ensembl chr 3:135,013,461...135,051,148 		JBrowse link
G Slco4a1 solute carrier organic anion transporter family, member 4a1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLCO4A1 mRNA CTD PMID:21641980 PMID:23086747 NCBI chr 2:180,098,019...180,116,646
Ensembl chr 2:180,098,038...180,116,660 		JBrowse link
G Slf1 SMC5-SMC6 complex localization factor 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLF1 mRNA CTD PMID:21641980 NCBI chr13:77,191,207...77,283,632
Ensembl chr13:77,191,207...77,283,592 		JBrowse link
G Slfn2 schlafen 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLFN2 mRNA CTD PMID:21641980 NCBI chr11:82,955,938...82,961,504
Ensembl chr11:82,955,938...82,961,504 		JBrowse link
G Slfn9 schlafen 9 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLFN9 mRNA CTD PMID:21641980 NCBI chr11:82,865,142...82,883,041
Ensembl chr11:82,869,216...82,882,656 		JBrowse link
G Slpi secretory leukocyte peptidase inhibitor multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SLPI mRNA CTD PMID:21641980 NCBI chr 2:164,195,990...164,231,086
Ensembl chr 2:164,195,990...164,231,015 		JBrowse link
G Sltm SAFB-like, transcription modulator multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SLTM mRNA CTD PMID:21641980 NCBI chr 9:70,449,717...70,499,519
Ensembl chr 9:70,450,036...70,499,516 		JBrowse link
G Smad6 SMAD family member 6 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SMAD6 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SMAD6 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 9:63,860,358...63,929,374
Ensembl chr 9:63,860,358...63,929,341 		JBrowse link
G Smad7 SMAD family member 7 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SMAD7 mRNA CTD PMID:26378955 NCBI chr18:75,500,436...75,529,006
Ensembl chr18:75,500,600...75,529,006 		JBrowse link
G Smad9 SMAD family member 9 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SMAD9 mRNA CTD PMID:26378955 NCBI chr 3:54,662,873...54,709,162
Ensembl chr 3:54,663,003...54,708,678 		JBrowse link
G Smc2 structural maintenance of chromosomes 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SMC2 mRNA CTD PMID:21641980 NCBI chr 4:52,438,966...52,488,365
Ensembl chr 4:52,439,243...52,488,260 		JBrowse link
G Smc6 structural maintenance of chromosomes 6 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SMC6 mRNA CTD PMID:21641980 NCBI chr12:11,315,887...11,369,786
Ensembl chr12:11,315,887...11,369,786 		JBrowse link
G Smg1 SMG1 nonsense mediated mRNA decay associated PI3K related kinase multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SMG1 mRNA CTD PMID:26378955 NCBI chr 7:117,730,531...117,843,026
Ensembl chr 7:117,730,531...117,842,893 		JBrowse link
G Smoc1 SPARC related modular calcium binding 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SMOC1 mRNA CTD PMID:26378955 NCBI chr12:81,073,582...81,233,188
Ensembl chr12:81,073,582...81,233,188 		JBrowse link
G Smpd4 sphingomyelin phosphodiesterase 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SMPD4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SMPD4 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr16:17,437,218...17,462,694
Ensembl chr16:17,437,218...17,462,692 		JBrowse link
G Smyd4 SET and MYND domain containing 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SMYD4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SMYD4 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:75,239,259...75,296,533
Ensembl chr11:75,239,259...75,296,531 		JBrowse link
G Snai2 snail family zinc finger 2 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SNAI2 mRNA CTD PMID:26378955 NCBI chr16:14,523,716...14,527,259
Ensembl chr16:14,523,716...14,527,249 		JBrowse link
G Snap23 synaptosomal-associated protein 23 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SNAP23 mRNA CTD PMID:26378955 NCBI chr 2:120,398,137...120,436,829
Ensembl chr 2:120,398,152...120,431,736 		JBrowse link
G Snord123 small nucleolar RNA, C/D box 123 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SNORD123 mRNA CTD PMID:21641980 NCBI chr15:32,241,991...32,242,078
Ensembl chr15:32,241,999...32,242,069 		JBrowse link
G Snta1 syntrophin, acidic 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SNTA1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SNTA1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 2:154,218,234...154,250,004
Ensembl chr 2:154,218,233...154,250,019 		JBrowse link
G Snx24 sorting nexing 24 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SNX24 mRNA CTD PMID:21641980 NCBI chr18:53,376,877...53,523,994
Ensembl chr18:53,378,734...53,523,992 		JBrowse link
G Soat1 sterol O-acyltransferase 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SOAT1 mRNA CTD PMID:21641980 NCBI chr 1:156,255,678...156,301,898
Ensembl chr 1:156,252,095...156,301,901 		JBrowse link
G Socs3 suppressor of cytokine signaling 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SOCS3 mRNA CTD PMID:21641980 NCBI chr11:117,856,905...117,860,192
Ensembl chr11:117,856,905...117,860,873 		JBrowse link
G Sod2 superoxide dismutase 2, mitochondrial multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SOD2 mRNA CTD PMID:26378955 NCBI chr17:13,226,726...13,237,006
Ensembl chr17:13,225,733...13,258,950 		JBrowse link
G Sorbs2 sorbin and SH3 domain containing 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SORBS2 mRNA CTD PMID:26378955 NCBI chr 8:45,960,470...46,280,943
Ensembl chr 8:45,960,825...46,280,943 		JBrowse link
G Sord sorbitol dehydrogenase multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SORD mRNA CTD PMID:26378955 NCBI chr 2:122,065,320...122,095,818
Ensembl chr 2:122,065,230...122,095,821 		JBrowse link
G Sorl1 sortilin-related receptor, LDLR class A repeats-containing multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SORL1 mRNA CTD PMID:26378955 NCBI chr 9:41,876,005...42,035,593
Ensembl chr 9:41,876,016...42,035,593 		JBrowse link
G Spag9 sperm associated antigen 9 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SPAG9 mRNA CTD PMID:21641980 NCBI chr11:93,886,794...94,016,919
Ensembl chr11:93,886,917...94,016,911 		JBrowse link
G Spata13 spermatogenesis associated 13 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SPATA13 mRNA CTD PMID:21641980 NCBI chr14:60,722,617...61,002,005
Ensembl chr14:60,871,450...61,002,005 		JBrowse link
G Spdl1 spindle apparatus coiled-coil protein 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SPDL1 mRNA CTD PMID:21641980 NCBI chr11:34,700,012...34,724,492
Ensembl chr11:34,700,017...34,724,468 		JBrowse link
G Spp1 secreted phosphoprotein 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SPP1 mRNA CTD PMID:26378955 NCBI chr 5:104,582,977...104,588,919
Ensembl chr 5:104,582,984...104,588,916 		JBrowse link
G Spry2 sprouty RTK signaling antagonist 2 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SPRY2 mRNA CTD PMID:26378955 NCBI chr14:106,129,381...106,134,559
Ensembl chr14:106,129,381...106,134,253 		JBrowse link
G Sqor sulfide quinone oxidoreductase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SQOR mRNA CTD PMID:21641980 NCBI chr 2:122,607,249...122,651,473
Ensembl chr 2:122,607,157...122,651,489 		JBrowse link
G Sqstm1 sequestosome 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SQSTM1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SQSTM1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:50,090,979...50,105,303
Ensembl chr11:50,090,193...50,101,654 		JBrowse link
G Src Rous sarcoma oncogene multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SRC mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of SRC mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 2:157,265,828...157,313,758
Ensembl chr 2:157,260,364...157,313,782 		JBrowse link
G Srek1 splicing regulatory glutamine/lysine-rich protein 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SREK1 mRNA CTD PMID:21641980 NCBI chr13:103,873,291...103,911,379
Ensembl chr13:103,875,856...103,911,116 		JBrowse link
G Srpk2 serine/arginine-rich protein specific kinase 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SRPK2 mRNA CTD PMID:21641980 NCBI chr 5:23,708,262...23,889,639
Ensembl chr 5:23,708,262...23,889,615 		JBrowse link
G Srsf10 serine and arginine-rich splicing factor 10 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SRSF10 mRNA CTD PMID:21641980 NCBI chr 4:135,582,454...135,597,219
Ensembl chr 4:135,583,058...135,597,219 		JBrowse link
G Srsf3 serine and arginine-rich splicing factor 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SFRS3 mRNA CTD PMID:21641980 NCBI chr17:29,251,634...29,262,346
Ensembl chr17:29,251,602...29,262,347 		JBrowse link
G Srsf7 serine and arginine-rich splicing factor 7 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SRSF7 mRNA CTD PMID:21641980 NCBI chr17:80,507,509...80,514,734
Ensembl chr17:80,507,509...80,514,736 		JBrowse link
G Srxn1 sulfiredoxin 1 homolog (S. cerevisiae) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SRXN1 mRNA CTD PMID:21641980 NCBI chr 2:151,946,738...151,953,296
Ensembl chr 2:151,947,436...151,953,296 		JBrowse link
G Ssb small RNA binding exonuclease protection factor La multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SSB mRNA CTD PMID:21641980 NCBI chr 2:69,691,963...69,702,185
Ensembl chr 2:69,691,906...69,702,190 		JBrowse link
G Ssr1 signal sequence receptor, alpha multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SSR1 mRNA CTD PMID:21641980 NCBI chr13:38,155,377...38,178,184
Ensembl chr13:38,150,581...38,178,193 		JBrowse link
G St18 suppression of tumorigenicity 18 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ST18 mRNA CTD PMID:26378955 NCBI chr 1:6,557,455...6,931,164
Ensembl chr 1:6,557,455...6,931,164 		JBrowse link
G St3gal1 ST3 beta-galactoside alpha-2,3-sialyltransferase 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ST3GAL1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ST3GAL1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr15:66,974,724...67,048,575
Ensembl chr15:66,974,724...67,048,679 		JBrowse link
G St3gal6 ST3 beta-galactoside alpha-2,3-sialyltransferase 6 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ST3GAL6 mRNA CTD PMID:21641980 NCBI chr16:58,290,105...58,344,614
Ensembl chr16:58,288,488...58,344,606 		JBrowse link
G St6gal1 beta galactoside alpha 2,6 sialyltransferase 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ST6GAL1 mRNA CTD PMID:21641980 NCBI chr16:23,043,478...23,179,100
Ensembl chr16:23,043,490...23,179,100 		JBrowse link
G St8sia4 ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ST8SIA4 mRNA CTD PMID:21641980 NCBI chr 1:95,515,407...95,595,473
Ensembl chr 1:95,515,407...95,595,296 		JBrowse link
G Stac2 SH3 and cysteine rich domain 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of STAC2 mRNA CTD PMID:26378955 NCBI chr11:97,927,449...97,944,288
Ensembl chr11:97,927,449...97,944,288 		JBrowse link
G Stard4 StAR related lipid transfer domain containing 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of STARD4 mRNA CTD PMID:21641980 NCBI chr18:33,332,191...33,346,937
Ensembl chr18:33,332,408...33,346,915 		JBrowse link
G Stard9 StAR related lipid transfer domain containing 9 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of STARD9 mRNA CTD PMID:21641980 NCBI chr 2:120,459,567...120,562,371
Ensembl chr 2:120,459,602...120,562,376 		JBrowse link
G Stat2 signal transducer and activator of transcription 2 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of STAT2 mRNA CTD PMID:26378955 NCBI chr10:128,106,367...128,128,722
Ensembl chr10:128,106,428...128,128,718 		JBrowse link
G Stc2 stanniocalcin 2 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of STC2 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of STC2 mRNA		 CTD PMID:21641980 PMID:26378955 NCBI chr11:31,309,441...31,320,061
Ensembl chr11:31,307,307...31,320,074 		JBrowse link
G Steap4 STEAP family member 4 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of STEAP4 mRNA CTD PMID:26378955 NCBI chr 5:8,010,472...8,032,213
Ensembl chr 5:8,010,457...8,032,213 		JBrowse link
G Stk26 serine/threonine kinase 26 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of STK26 mRNA CTD PMID:26378955 NCBI chr  X:49,930,052...49,981,980
Ensembl chr  X:49,929,924...49,981,974 		JBrowse link
G Strn3 striatin, calmodulin binding protein 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of STRN3 mRNA CTD PMID:21641980 NCBI chr12:51,655,324...51,743,942
Ensembl chr12:51,656,415...51,738,680 		JBrowse link
G Stx11 syntaxin 11 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of STX11 mRNA CTD PMID:21641980 NCBI chr10:12,813,961...12,840,242
Ensembl chr10:12,813,953...12,840,042 		JBrowse link
G Stxbp4 syntaxin binding protein 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of STXBP4 mRNA CTD PMID:21641980 NCBI chr11:90,367,318...90,528,962
Ensembl chr11:90,367,318...90,528,910 		JBrowse link
G Stxbp5 syntaxin binding protein 5 (tomosyn) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of STXBP5 mRNA CTD PMID:21641980 NCBI chr10:9,631,285...9,776,987
Ensembl chr10:9,631,291...9,776,823 		JBrowse link
G Sulf2 sulfatase 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SULF2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SULF2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 2:165,915,819...165,997,603
Ensembl chr 2:165,915,009...165,997,583 		JBrowse link
G Suv39h2 suppressor of variegation 3-9 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SUV39H2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SUV39H2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 2:3,456,852...3,476,085
Ensembl chr 2:3,456,852...3,476,068 		JBrowse link
G Suz12 SUZ12 polycomb repressive complex 2 subunit multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SUZ12 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SUZ12 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:79,883,932...79,924,949
Ensembl chr11:79,883,932...79,924,949 		JBrowse link
G Syn1 synapsin I multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of SYN1 mRNA CTD PMID:21641980 NCBI chr  X:20,726,750...20,787,157
Ensembl chr  X:20,726,750...20,787,243 		JBrowse link
G Syncrip synaptotagmin binding, cytoplasmic RNA interacting protein multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of SYNCRIP mRNA CTD PMID:21641980 NCBI chr 9:88,331,417...88,364,645
Ensembl chr 9:88,329,062...88,364,627 		JBrowse link
G Sytl4 synaptotagmin-like 4 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of SYTL4 mRNA CTD PMID:26378955 NCBI chr  X:132,837,134...132,882,569
Ensembl chr  X:132,837,134...132,882,561 		JBrowse link
G Taf15 TATA-box binding protein associated factor 15 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TAF15 mRNA CTD PMID:21641980 NCBI chr11:83,363,897...83,397,569
Ensembl chr11:83,363,912...83,397,569 		JBrowse link
G Taf1d TATA-box binding protein associated factor, RNA polymerase I, D multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TAF1D mRNA CTD PMID:21641980 NCBI chr 9:15,217,485...15,228,293
Ensembl chr 9:15,217,510...15,228,287 		JBrowse link
G Tafa3 TAFA chemokine like family member 3 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TAFA3 mRNA CTD PMID:26378955 NCBI chr 3:104,674,721...104,686,854
Ensembl chr 3:104,674,722...104,689,156 		JBrowse link
G Tank TRAF family member-associated Nf-kappa B activator multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TANK mRNA CTD PMID:26378955 NCBI chr 2:61,408,901...61,484,515
Ensembl chr 2:61,408,929...61,484,515 		JBrowse link
G Tap1 transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TAP1 mRNA CTD PMID:21641980 NCBI chr17:34,406,530...34,416,199
Ensembl chr17:34,406,527...34,416,199 		JBrowse link
G Tardbp TAR DNA binding protein multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TARDBP mRNA CTD PMID:21641980 NCBI chr 4:148,696,839...148,711,672
Ensembl chr 4:148,696,839...148,711,476 		JBrowse link
G Tatdn3 TatD DNase domain containing 3 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TATDN3 mRNA CTD PMID:26378955 NCBI chr 1:190,778,023...190,795,373
Ensembl chr 1:190,778,023...190,795,129 		JBrowse link
G Tbc1d4 TBC1 domain family, member 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TBC1D4 mRNA CTD PMID:21641980 NCBI chr14:101,679,800...101,846,717
Ensembl chr14:101,679,796...101,846,627 		JBrowse link
G Tbc1d5 TBC1 domain family, member 5 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TBC1D5 mRNA CTD PMID:21641980 NCBI chr17:51,040,155...51,488,228
Ensembl chr17:51,040,152...51,486,380 		JBrowse link
G Tbc1d8b TBC1 domain family, member 8B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TBC1D8B mRNA CTD PMID:21641980 NCBI chr  X:138,585,730...138,654,970
Ensembl chr  X:138,585,745...138,654,154 		JBrowse link
G Tbxas1 thromboxane A synthase 1, platelet multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TBXAS1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TBXAS1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 6:38,817,897...39,061,524
Ensembl chr 6:38,852,338...39,061,519 		JBrowse link
G Tcam1 testicular cell adhesion molecule 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TCAM1 mRNA CTD PMID:21641980 NCBI chr11:106,163,856...106,179,563
Ensembl chr11:106,167,498...106,179,571 		JBrowse link
G Tcf12 transcription factor 12 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TCF12 mRNA CTD PMID:21641980 NCBI chr 9:71,751,534...72,019,611
Ensembl chr 9:71,749,970...72,019,153 		JBrowse link
G Tcf4 transcription factor 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TCF4 mRNA CTD PMID:21641980 NCBI chr18:69,476,500...69,821,038
Ensembl chr18:69,476,427...69,822,150 		JBrowse link
G Tcn2 transcobalamin 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TCN2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TCN2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:3,867,077...3,882,078
Ensembl chr11:3,867,192...3,882,159 		JBrowse link
G Tdo2 tryptophan 2,3-dioxygenase multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TDO2 mRNA CTD PMID:26378955 NCBI chr 3:81,865,719...81,883,035
Ensembl chr 3:81,864,397...81,883,509 		JBrowse link
G Tert telomerase reverse transcriptase multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TERT mRNA CTD PMID:26378955 NCBI chr13:73,775,030...73,797,962
Ensembl chr13:73,775,030...73,797,962 		JBrowse link
G Tet2 tet methylcytosine dioxygenase 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TET2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of TET2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 3:133,169,438...133,250,882
Ensembl chr 3:133,169,440...133,250,900 		JBrowse link
G Tfdp2 transcription factor Dp 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TFDP2 mRNA CTD PMID:21641980 NCBI chr 9:96,078,348...96,205,699
Ensembl chr 9:96,078,328...96,205,699 		JBrowse link
G Tfec transcription factor EC multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TFEC mRNA CTD PMID:21641980 NCBI chr 6:16,830,926...16,898,463
Ensembl chr 6:16,833,372...16,898,440 		JBrowse link
G Tfrc transferrin receptor multiple interactions EXP [Magnetite Nanoparticles co-treated with Succimer] results in decreased expression of TFRC mRNA; [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TFRC mRNA CTD PMID:21641980 PMID:23086747 PMID:25522732 NCBI chr16:32,427,714...32,451,612
Ensembl chr16:32,427,738...32,451,612 		JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TGFB1 mRNA CTD PMID:26378955 NCBI chr 7:25,386,406...25,404,503
Ensembl chr 7:25,386,427...25,404,502 		JBrowse link
G Tgfbr1 transforming growth factor, beta receptor I multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TGFBR1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TGFBR1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 4:47,353,258...47,414,926
Ensembl chr 4:47,353,222...47,414,931 		JBrowse link
G Tgfbr2 transforming growth factor, beta receptor II multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TGFBR2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TGFBR2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 9:115,916,763...116,004,431
Ensembl chr 9:115,913,361...116,004,428 		JBrowse link
G Tgm2 transglutaminase 2, C polypeptide multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TGM2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TGM2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 2:157,958,325...157,988,312
Ensembl chr 2:157,958,322...157,988,356 		JBrowse link
G Tgm5 transglutaminase 5 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TGM5 mRNA CTD PMID:26378955 NCBI chr 2:120,876,591...120,916,322
Ensembl chr 2:120,876,592...120,916,322 		JBrowse link
G Thap2 THAP domain containing, apoptosis associated protein 2 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of THAP2 mRNA CTD PMID:26378955 NCBI chr10:115,204,303...115,220,340
Ensembl chr10:115,204,309...115,220,348 		JBrowse link
G Thbs1 thrombospondin 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of THBS1 mRNA CTD PMID:26378955 NCBI chr 2:117,942,357...117,957,614
Ensembl chr 2:117,942,357...117,957,614 		JBrowse link
G Thoc1 THO complex 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of THOC1 mRNA CTD PMID:21641980 NCBI chr18:9,958,176...9,995,486
Ensembl chr18:9,957,906...9,995,489 		JBrowse link
G Thoc2 THO complex 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of THOC2 mRNA CTD PMID:21641980 NCBI chr  X:40,883,869...41,000,878
Ensembl chr  X:40,883,868...41,009,551 		JBrowse link
G Tial1 Tia1 cytotoxic granule-associated RNA binding protein-like 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TIAL1 mRNA CTD PMID:21641980 NCBI chr 7:128,041,496...128,063,450
Ensembl chr 7:128,041,501...128,063,441 		JBrowse link
G Tifa TRAF-interacting protein with forkhead-associated domain multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TIFA mRNA CTD PMID:21641980 NCBI chr 3:127,582,524...127,592,043
Ensembl chr 3:127,583,454...127,625,813 		JBrowse link
G Tifab TRAF-interacting protein with forkhead-associated domain, family member B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TIFAB mRNA CTD PMID:21641980 NCBI chr13:56,318,917...56,326,816
Ensembl chr13:56,321,517...56,326,698 		JBrowse link
G Timm9 translocase of inner mitochondrial membrane 9 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TIMM9 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TIMM9 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr12:71,169,946...71,183,476
Ensembl chr12:71,169,947...71,183,458 		JBrowse link
G Timp3 tissue inhibitor of metalloproteinase 3 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TIMP3 mRNA CTD PMID:26378955 NCBI chr10:86,136,276...86,185,369
Ensembl chr10:86,136,236...86,185,370 		JBrowse link
G Tiparp TCDD-inducible poly(ADP-ribose) polymerase multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TIPARP mRNA CTD PMID:26378955 NCBI chr 3:65,435,868...65,462,939
Ensembl chr 3:65,435,831...65,462,939 		JBrowse link
G Tlcd2 TLC domain containing 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TLCD2 mRNA CTD PMID:21641980 NCBI chr11:75,358,771...75,361,725
Ensembl chr11:75,352,541...75,361,725 		JBrowse link
G Tlr4 toll-like receptor 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TLR4 mRNA CTD PMID:21641980 NCBI chr 4:66,745,788...66,765,338
Ensembl chr 4:66,745,821...66,848,521 		JBrowse link
G Tlr7 toll-like receptor 7 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TLR7 mRNA CTD PMID:21641980 NCBI chr  X:166,086,376...166,113,570
Ensembl chr  X:166,087,925...166,113,554 		JBrowse link
G Tm9sf3 transmembrane 9 superfamily member 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TM9SF3 mRNA CTD PMID:21641980 NCBI chr19:41,199,281...41,252,443
Ensembl chr19:41,199,283...41,252,436 		JBrowse link
G Tmed10 transmembrane p24 trafficking protein 10 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TMED10 mRNA CTD PMID:21641980 NCBI chr12:85,387,388...85,421,491
Ensembl chr12:85,387,388...85,421,621 		JBrowse link
G Tmem140 transmembrane protein 140 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TMEM140 mRNA CTD PMID:21641980 NCBI chr 6:34,840,081...34,851,881
Ensembl chr 6:34,840,081...34,851,881 		JBrowse link
G Tmem170b transmembrane protein 170B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TMEM170B mRNA CTD PMID:21641980 NCBI chr13:41,759,358...41,794,830
Ensembl chr13:41,759,383...41,794,831 		JBrowse link
G Tmem171 transmembrane protein 171 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TMEM171 mRNA CTD PMID:21641980 NCBI chr13:98,822,744...98,832,142
Ensembl chr13:98,822,743...98,831,342 		JBrowse link
G Tmem202 transmembrane protein 202 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TMEM202 mRNA CTD PMID:21641980 NCBI chr 9:59,425,954...59,447,134
Ensembl chr 9:59,425,968...59,447,130 		JBrowse link
G Tmem38b transmembrane protein 38B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TMEM38B mRNA CTD PMID:21641980 NCBI chr 4:53,825,988...53,862,019
Ensembl chr 4:53,826,045...53,862,019 		JBrowse link
G Tmem41b transmembrane protein 41B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TMEM41B mRNA CTD PMID:21641980 NCBI chr 7:109,570,422...109,586,011
Ensembl chr 7:109,571,394...109,586,136 		JBrowse link
G Tmem51 transmembrane protein 51 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TMEM51 mRNA CTD PMID:21641980 NCBI chr 4:141,758,301...141,811,985
Ensembl chr 4:141,758,303...141,811,615 		JBrowse link
G Tmem86a transmembrane protein 86A multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TMEM86A mRNA CTD PMID:21641980 NCBI chr 7:46,700,388...46,704,524
Ensembl chr 7:46,700,349...46,704,525 		JBrowse link
G Tmpo thymopoietin multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TMPO mRNA CTD PMID:21641980 NCBI chr10:90,983,433...91,017,614
Ensembl chr10:90,983,433...91,017,177 		JBrowse link
G Tmprss4 transmembrane protease, serine 4 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TMPRSS4 mRNA CTD PMID:26378955 NCBI chr 9:45,084,024...45,115,417
Ensembl chr 9:45,084,024...45,115,390 		JBrowse link
G Tnf tumor necrosis factor multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TNF mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TNF mRNA
Succimer inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TNF protein]; Succimer inhibits the reaction [sodium arsenite results in increased expression of TNF mRNA]; Succimer inhibits the reaction [sodium arsenite results in increased secretion of TNF protein]		 CTD PMID:21641980 PMID:26378955 PMID:31163222 PMID:32402895 NCBI chr17:35,418,343...35,420,983
Ensembl chr17:35,418,357...35,420,983 		JBrowse link
G Tnfaip2 tumor necrosis factor, alpha-induced protein 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TNFAIP2 mRNA CTD PMID:21641980 NCBI chr12:111,408,898...111,421,452
Ensembl chr12:111,408,903...111,421,452 		JBrowse link
G Tnfaip3 tumor necrosis factor, alpha-induced protein 3 multiple interactions EXP
ISO		 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TNFAIP3 mRNA CTD PMID:26378955 NCBI chr10:18,876,658...18,891,158
Ensembl chr10:18,876,658...18,891,405 		JBrowse link
G Tnfaip8 tumor necrosis factor, alpha-induced protein 8 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TNFAIP8 mRNA CTD PMID:26378955 NCBI chr18:50,112,494...50,226,296
Ensembl chr18:50,112,494...50,240,240 		JBrowse link
G Tnfrsf12a tumor necrosis factor receptor superfamily, member 12a multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TNFRSF12A mRNA CTD PMID:26378955 NCBI chr17:23,894,419...23,896,423
Ensembl chr17:23,894,419...23,896,442 		JBrowse link
G Tnfrsf1b tumor necrosis factor receptor superfamily, member 1b multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TNFRSF1B mRNA CTD PMID:21641980 NCBI chr 4:144,938,938...144,973,453
Ensembl chr 4:144,940,033...144,973,440 		JBrowse link
G Tnfsf10 tumor necrosis factor (ligand) superfamily, member 10 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TNFSF10 mRNA CTD PMID:26378955 NCBI chr 3:27,371,226...27,393,814
Ensembl chr 3:27,371,177...27,396,576 		JBrowse link
G Tnfsf12 tumor necrosis factor (ligand) superfamily, member 12 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TNFSF12 mRNA CTD PMID:21641980 NCBI chr11:69,577,066...69,586,924
Ensembl chr11:69,577,076...69,586,675 		JBrowse link
G Tnfsf13b tumor necrosis factor (ligand) superfamily, member 13b multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TNFSF13B mRNA CTD PMID:26378955 NCBI chr 8:10,056,637...10,086,000
Ensembl chr 8:10,056,467...10,089,072 		JBrowse link
G Tnip1 TNFAIP3 interacting protein 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TNIP1 mRNA CTD PMID:21641980 NCBI chr11:54,801,613...54,853,766
Ensembl chr11:54,801,611...54,853,743 		JBrowse link
G Tnks2 tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase 2 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TNKS2 mRNA CTD PMID:26378955 NCBI chr19:36,811,583...36,870,877
Ensembl chr19:36,811,632...36,870,877 		JBrowse link
G Tnnc1 troponin C, cardiac/slow skeletal multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TNNC1 mRNA CTD PMID:26378955 NCBI chr14:30,930,274...30,933,671
Ensembl chr14:30,930,269...30,933,686 		JBrowse link
G Tnrc6b trinucleotide repeat containing 6b multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TNRC6B mRNA CTD PMID:21641980 NCBI chr15:80,595,514...80,825,287
Ensembl chr15:80,595,514...80,825,286 		JBrowse link
G Top2a topoisomerase (DNA) II alpha multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TOP2A mRNA CTD PMID:26378955 NCBI chr11:98,883,773...98,915,037
Ensembl chr11:98,883,769...98,915,015 		JBrowse link
G Topbp1 topoisomerase (DNA) II binding protein 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TOPBP1 mRNA CTD PMID:21641980 NCBI chr 9:103,182,351...103,227,627
Ensembl chr 9:103,182,414...103,227,627 		JBrowse link
G Tox2 TOX high mobility group box family member 2 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TOX2 mRNA CTD PMID:26378955 NCBI chr 2:163,045,047...163,166,092
Ensembl chr 2:163,045,045...163,166,090 		JBrowse link
G Tpbg trophoblast glycoprotein multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TPBG mRNA CTD PMID:21641980 NCBI chr 9:85,724,433...85,729,110
Ensembl chr 9:85,724,433...85,729,093 		JBrowse link
G Tpd52l1 tumor protein D52-like 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TPD52L1 mRNA CTD PMID:26378955 NCBI chr10:31,208,369...31,321,989
Ensembl chr10:31,208,372...31,321,954 		JBrowse link
G Traf1 TNF receptor-associated factor 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TRAF1 mRNA CTD PMID:21641980 NCBI chr 2:34,831,762...34,851,784
Ensembl chr 2:34,831,762...34,851,784 		JBrowse link
G Traf3ip1 TRAF3 interacting protein 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRAF3IP1 mRNA CTD PMID:21641980 NCBI chr 1:91,422,311...91,457,029
Ensembl chr 1:91,422,369...91,457,029 		JBrowse link
G Traf5 TNF receptor-associated factor 5 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TRAF5 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TRAF5 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 1:191,729,164...191,776,899
Ensembl chr 1:191,729,166...191,776,868 		JBrowse link
G Trex1 three prime repair exonuclease 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TREX1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TREX1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 9:108,887,000...108,888,791
Ensembl chr 9:108,887,001...108,888,802 		JBrowse link
G Trf transferrin multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRF mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TRF mRNA CTD PMID:21641980 PMID:23086747 PMID:26378955 NCBI chr 9:103,086,075...103,107,485
Ensembl chr 9:103,081,200...103,107,643 		JBrowse link
G Trim16 tripartite motif-containing 16 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TRIM16 mRNA CTD PMID:26378955 NCBI chr11:62,711,034...62,733,774
Ensembl chr11:62,711,057...62,741,634 		JBrowse link
G Trim2 tripartite motif-containing 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TRIM2 mRNA CTD PMID:26378955 NCBI chr 3:84,067,746...84,215,659
Ensembl chr 3:84,067,746...84,214,184 		JBrowse link
G Trim29 tripartite motif-containing 29 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TRIM29 mRNA CTD PMID:26378955 NCBI chr 9:43,222,012...43,247,422
Ensembl chr 9:43,222,145...43,247,412 		JBrowse link
G Trim30a tripartite motif-containing 30A multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TRIM30A mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TRIM22 mRNA		 CTD PMID:21641980 PMID:26378955 NCBI chr 7:104,058,232...104,114,400
Ensembl chr 7:104,058,232...104,114,400 		JBrowse link
G Trim37 tripartite motif-containing 37 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRIM37 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TRIM37 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:87,017,675...87,141,700
Ensembl chr11:87,017,903...87,111,509 		JBrowse link
G Trim44 tripartite motif-containing 44 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRIM44 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TRIM44 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 2:102,130,464...102,231,541
Ensembl chr 2:102,130,464...102,238,173 		JBrowse link
G Trim5 tripartite motif-containing 5 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TRIM5 mRNA CTD PMID:26378955 NCBI chr 7:103,912,593...103,937,448
Ensembl chr 7:103,912,593...103,937,301 		JBrowse link
G Trim59 tripartite motif-containing 59 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TRIM59 mRNA CTD PMID:26378955 NCBI chr 3:68,942,625...68,952,075
Ensembl chr 3:68,942,621...68,952,088 		JBrowse link
G Trim6 tripartite motif-containing 6 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TRIM6 mRNA CTD PMID:26378955 NCBI chr 7:103,868,002...103,884,359
Ensembl chr 7:103,868,000...103,884,359 		JBrowse link
G Trip11 thyroid hormone receptor interactor 11 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRIP11 mRNA CTD PMID:21641980 NCBI chr12:101,800,304...101,879,463
Ensembl chr12:101,800,302...101,879,526 		JBrowse link
G Trmt6 tRNA methyltransferase 6 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRMT6 mRNA CTD PMID:21641980 NCBI chr 2:132,646,127...132,658,127
Ensembl chr 2:132,646,127...132,657,975 		JBrowse link
G Trp53 transformation related protein 53 multiple interactions ISO Succimer inhibits the reaction [[sodium arsenite results in increased abundance of Arsenic] which results in increased expression of TP53 mRNA]; Succimer inhibits the reaction [sodium arsenite results in increased expression of TP53 mRNA]; Succimer inhibits the reaction [sodium arsenite results in increased phosphorylation of TP53 protein] CTD PMID:31163222 PMID:32402895 NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699 		JBrowse link
G Trp53inp1 transformation related protein 53 inducible nuclear protein 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRP53INP1 mRNA CTD PMID:21641980 NCBI chr 4:11,156,441...11,174,379
Ensembl chr 4:11,156,431...11,174,379 		JBrowse link
G Trpc2 transient receptor potential cation channel, subfamily C, member 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRPC2 mRNA CTD PMID:21641980 NCBI chr 7:101,732,323...101,746,071
Ensembl chr 7:101,732,323...101,745,603 		JBrowse link
G Trpc5 transient receptor potential cation channel, subfamily C, member 5 increases activity ISO Succimer results in increased activity of TRPC5 protein CTD PMID:21984481 NCBI chr  X:143,160,323...143,471,176
Ensembl chr  X:143,164,667...143,471,176 		JBrowse link
G Trpm7 transient receptor potential cation channel, subfamily M, member 7 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TRPM7 mRNA CTD PMID:26378955 NCBI chr 2:126,633,478...126,718,181
Ensembl chr 2:126,633,485...126,718,150 		JBrowse link
G Trps1 transcriptional repressor GATA binding 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TRPS1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TRPS1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr15:50,518,149...50,754,027
Ensembl chr15:50,518,148...50,753,859 		JBrowse link
G Tsc22d1 TSC22 domain family, member 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TSC22D1 mRNA CTD PMID:21641980 NCBI chr14:76,652,401...76,745,205
Ensembl chr14:76,652,401...76,745,205 		JBrowse link
G Tsc22d3 TSC22 domain family, member 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TSC22D3 mRNA CTD PMID:21641980 NCBI chr  X:139,440,277...139,501,257
Ensembl chr  X:139,440,277...139,501,408 		JBrowse link
G Tshz3 teashirt zinc finger family member 3 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of TSHZ3 mRNA CTD PMID:26378955 NCBI chr 7:36,397,543...36,472,978
Ensembl chr 7:36,397,543...36,472,978 		JBrowse link
G Tspan14 tetraspanin 14 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TSPAN14 mRNA CTD PMID:21641980 NCBI chr14:40,628,384...40,688,835
Ensembl chr14:40,628,402...40,688,764 		JBrowse link
G Tspoap1 TSPO associated protein 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TSPOAP1 mRNA CTD PMID:21641980 NCBI chr11:87,649,022...87,676,754
Ensembl chr11:87,651,367...87,676,754 		JBrowse link
G Ttc14 tetratricopeptide repeat domain 14 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TTC14 mRNA CTD PMID:21641980 NCBI chr 3:33,853,923...33,869,009
Ensembl chr 3:33,853,981...33,869,009 		JBrowse link
G Ttc3 tetratricopeptide repeat domain 3 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TTC3 mRNA CTD PMID:26378955 NCBI chr16:94,171,479...94,270,081
Ensembl chr16:94,171,477...94,270,202 		JBrowse link
G Ttc7 tetratricopeptide repeat domain 7 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TTC7 mRNA CTD PMID:21641980 NCBI chr17:87,590,328...87,689,197
Ensembl chr17:87,590,314...87,689,197 		JBrowse link
G Ttll11 tubulin tyrosine ligase-like family, member 11 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TTLL11 mRNA; [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TTLL11 mRNA CTD PMID:21641980 NCBI chr 2:35,641,250...35,870,250
Ensembl chr 2:35,641,253...35,869,925 		JBrowse link
G Tug1 taurine upregulated gene 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of TUG1 mRNA CTD PMID:21641980 NCBI chr11:3,589,313...3,599,021
Ensembl chr11:3,589,785...3,599,673 		JBrowse link
G Txn1 thioredoxin 1 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TXN1 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of TXN mRNA		 CTD PMID:21641980 PMID:26378955 NCBI chr 4:57,943,373...57,956,411
Ensembl chr 4:57,943,373...57,956,411 		JBrowse link
G Txndc15 thioredoxin domain containing 15 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of TXNDC15 mRNA CTD PMID:21641980 NCBI chr13:55,862,463...55,874,040
Ensembl chr13:55,862,463...55,874,040 		JBrowse link
G Uba3 ubiquitin-like modifier activating enzyme 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of UBA3 mRNA CTD PMID:21641980 NCBI chr 6:97,160,593...97,182,608
Ensembl chr 6:97,160,631...97,182,608 		JBrowse link
G Uba7 ubiquitin-like modifier activating enzyme 7 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of UBA7 mRNA CTD PMID:21641980 NCBI chr 9:107,852,766...107,861,255
Ensembl chr 9:107,852,704...107,861,259 		JBrowse link
G Ubap2l ubiquitin-associated protein 2-like multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of UBAP2L mRNA CTD PMID:21641980 NCBI chr 3:89,906,896...89,959,867
Ensembl chr 3:89,907,447...89,959,935 		JBrowse link
G Ube2i ubiquitin-conjugating enzyme E2I multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of UBE2I mRNA CTD PMID:26378955 NCBI chr17:25,479,484...25,494,965
Ensembl chr17:25,479,482...25,493,856 		JBrowse link
G Ube2l6 ubiquitin-conjugating enzyme E2L 6 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of UBE2L6 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of UBE2L6 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 2:84,629,172...84,640,347
Ensembl chr 2:84,629,172...84,640,679 		JBrowse link
G Ubr3 ubiquitin protein ligase E3 component n-recognin 3 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of UBR3 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of UBR3 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 2:69,727,276...69,854,354
Ensembl chr 2:69,727,590...69,854,357 		JBrowse link
G Ubxn2b UBX domain protein 2B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of UBXN2B mRNA CTD PMID:21641980 NCBI chr 4:6,191,105...6,219,788
Ensembl chr 4:6,191,098...6,221,688 		JBrowse link
G Ucp2 uncoupling protein 2 (mitochondrial, proton carrier) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of UCP2 mRNA CTD PMID:21641980 NCBI chr 7:100,142,565...100,148,832
Ensembl chr 7:100,142,544...100,151,227 		JBrowse link
G Unc13a unc-13 homolog A multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of UNC13A mRNA CTD PMID:26378955 NCBI chr 8:72,079,356...72,124,418
Ensembl chr 8:72,077,061...72,124,401 		JBrowse link
G Ung uracil DNA glycosylase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of UNG mRNA CTD PMID:21641980 NCBI chr 5:114,268,427...114,277,382
Ensembl chr 5:114,268,447...114,277,384 		JBrowse link
G Upf2 UPF2 regulator of nonsense transcripts homolog (yeast) multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of UPF2 mRNA CTD PMID:21641980 NCBI chr 2:5,956,218...6,061,514
Ensembl chr 2:5,956,280...6,061,514 		JBrowse link
G Upp1 uridine phosphorylase 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of UPP1 mRNA CTD PMID:21641980 NCBI chr11:9,068,008...9,086,170
Ensembl chr11:9,068,103...9,086,170 		JBrowse link
G Usp1 ubiquitin specific peptidase 1 multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of USP1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of USP1 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of USP1 mRNA		 CTD PMID:21641980 PMID:26378955 NCBI chr 4:98,812,047...98,823,780
Ensembl chr 4:98,812,047...98,823,780 		JBrowse link
G Usp16 ubiquitin specific peptidase 16 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of USP16 mRNA CTD PMID:26378955 NCBI chr16:87,251,833...87,280,403
Ensembl chr16:87,251,591...87,280,405 		JBrowse link
G Usp18 ubiquitin specific peptidase 18 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of USP18 mRNA CTD PMID:21641980 NCBI chr 6:121,222,865...121,247,876
Ensembl chr 6:121,222,865...121,247,876 		JBrowse link
G Usp2 ubiquitin specific peptidase 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of USP2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of USP2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 9:43,978,318...44,006,924
Ensembl chr 9:43,978,318...44,006,924 		JBrowse link
G Usp34 ubiquitin specific peptidase 34 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of USP34 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of USP34 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:23,256,433...23,440,560
Ensembl chr11:23,256,895...23,440,560 		JBrowse link
G Usp37 ubiquitin specific peptidase 37 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of USP37 mRNA CTD PMID:26378955 NCBI chr 1:74,474,669...74,583,447
Ensembl chr 1:74,474,670...74,583,443 		JBrowse link
G Usp47 ubiquitin specific peptidase 47 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of USP47 mRNA CTD PMID:26378955 NCBI chr 7:111,622,692...111,710,591
Ensembl chr 7:111,622,711...111,710,868 		JBrowse link
G Usp9x ubiquitin specific peptidase 9, X chromosome multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of USP9X mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of USP9X mRNA CTD PMID:21641980 PMID:26378955 NCBI chr  X:12,937,221...13,039,567
Ensembl chr  X:12,937,737...13,039,567 		JBrowse link
G Utrn utrophin multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of UTRN mRNA CTD PMID:26378955 NCBI chr10:12,257,931...12,745,632
Ensembl chr10:12,257,932...12,745,109 		JBrowse link
G Uty ubiquitously transcribed tetratricopeptide repeat containing, Y-linked multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of UTY mRNA CTD PMID:26378955 NCBI chr  Y:1,085,187...1,245,787
Ensembl chr  Y:1,096,861...1,245,759 		JBrowse link
G Vav3 vav 3 oncogene multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of VAV3 mRNA CTD PMID:26378955 NCBI chr 3:109,247,757...109,593,010
Ensembl chr 3:109,247,969...109,593,014 		JBrowse link
G Vcf1 VCP nuclear cofactor family member 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of VCF2 mRNA CTD PMID:21641980 NCBI chr11:113,552,145...113,574,988
Ensembl chr11:113,552,145...113,574,981 		JBrowse link
G Vcpip1 valosin containing protein (p97)/p47 complex interacting protein 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of VCPIP1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of VCPIP1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 1:9,788,847...9,818,607
Ensembl chr 1:9,788,847...9,818,607 		JBrowse link
G Vegfa vascular endothelial growth factor A multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of VEGFA mRNA CTD PMID:26378955 NCBI chr17:46,327,919...46,343,303
Ensembl chr17:46,327,919...46,343,295 		JBrowse link
G Vegfc vascular endothelial growth factor C multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of VEGFC mRNA CTD PMID:21641980 NCBI chr 8:54,530,567...54,639,489
Ensembl chr 8:54,530,641...54,640,131 		JBrowse link
G Vldlr very low density lipoprotein receptor multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of VLDLR mRNA CTD PMID:26378955 NCBI chr19:27,190,070...27,231,631
Ensembl chr19:27,193,884...27,231,631 		JBrowse link
G Vps18 VPS18 CORVET/HOPS core subunit multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of VPS18 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of VPS18 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 2:119,119,220...119,128,934
Ensembl chr 2:119,119,221...119,128,934 		JBrowse link
G Vps41 VPS41 HOPS complex subunit multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of VPS41 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of VPS41 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr13:18,901,462...19,050,981
Ensembl chr13:18,901,456...19,050,981 		JBrowse link
G Vps50 VPS50 EARP/GARPII complex subunit multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of VPS50 mRNA CTD PMID:21641980 NCBI chr 6:3,498,393...3,603,531
Ensembl chr 6:3,498,382...3,603,531 		JBrowse link
G Vtn vitronectin multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of VTN mRNA CTD PMID:26378955 NCBI chr11:78,389,946...78,393,151
Ensembl chr11:78,389,917...78,393,150 		JBrowse link
G Vwf Von Willebrand factor multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of VWF mRNA CTD PMID:26378955 NCBI chr 6:125,529,911...125,663,642
Ensembl chr 6:125,523,737...125,663,642 		JBrowse link
G Wbp4 WW domain binding protein 4 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of WBP4 mRNA CTD PMID:26378955 NCBI chr14:79,697,377...79,718,708
Ensembl chr14:79,697,377...79,718,960 		JBrowse link
G Wdhd1 WD repeat and HMG-box DNA binding protein 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of WDHD1 mRNA CTD PMID:21641980 NCBI chr14:47,478,401...47,514,352
Ensembl chr14:47,478,401...47,514,314 		JBrowse link
G Wdpcp WD repeat containing planar cell polarity effector multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of WDPCP mRNA CTD PMID:21641980 NCBI chr11:21,521,969...21,848,686
Ensembl chr11:21,522,235...21,848,989 		JBrowse link
G Wdr12 WD repeat domain 12 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of WDR12 mRNA CTD PMID:21641980 NCBI chr 1:60,110,520...60,137,659
Ensembl chr 1:60,108,944...60,137,804 		JBrowse link
G Wdr26 WD repeat domain 26 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of WDR26 mRNA CTD PMID:21641980 NCBI chr 1:181,000,791...181,046,211
Ensembl chr 1:181,000,793...181,039,566 		JBrowse link
G Wipf1 WAS/WASL interacting protein family, member 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of WIPF1 mRNA CTD PMID:21641980 NCBI chr 2:73,259,954...73,359,831
Ensembl chr 2:73,259,954...73,360,078 		JBrowse link
G Wwox WW domain-containing oxidoreductase multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of WWOX mRNA CTD PMID:21641980 NCBI chr 8:115,166,377...116,079,451
Ensembl chr 8:115,166,395...116,079,447 		JBrowse link
G Wwp1 WW domain containing E3 ubiquitin protein ligase 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of WWP1 mRNA CTD PMID:21641980 NCBI chr 4:19,608,296...19,709,004
Ensembl chr 4:19,608,303...19,708,993 		JBrowse link
G Xaf1 XIAP associated factor 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of XAF1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of XAF1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:72,192,229...72,204,560
Ensembl chr11:72,192,455...72,204,559 		JBrowse link
G Xrn2 5'-3' exoribonuclease 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of XRN2 mRNA CTD PMID:26378955 NCBI chr 2:146,854,672...146,919,922
Ensembl chr 2:146,854,916...146,919,920 		JBrowse link
G Xylt2 xylosyltransferase II multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of XYLT2 mRNA CTD PMID:21641980 NCBI chr11:94,554,671...94,568,341
Ensembl chr11:94,554,677...94,568,341 		JBrowse link
G Zbp1 Z-DNA binding protein 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZBP1 mRNA CTD PMID:21641980 NCBI chr 2:173,048,405...173,060,715
Ensembl chr 2:173,048,405...173,060,716 		JBrowse link
G Zbtb20 zinc finger and BTB domain containing 20 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZBTB20 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of ZBTB20 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr16:42,728,008...43,462,981
Ensembl chr16:42,696,244...43,462,965 		JBrowse link
G Zbtb32 zinc finger and BTB domain containing 32 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZBTB32 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZBTB32 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 7:30,289,105...30,302,244
Ensembl chr 7:30,289,106...30,298,334 		JBrowse link
G Zbtb4 zinc finger and BTB domain containing 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZBTB4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZBTB4 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:69,656,738...69,674,852
Ensembl chr11:69,656,738...69,674,849 		JBrowse link
G Zbtb43 zinc finger and BTB domain containing 43 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZBTB43 mRNA CTD PMID:26378955 NCBI chr 2:33,340,299...33,358,592
Ensembl chr 2:33,340,299...33,358,571 		JBrowse link
G Zbtb7a zinc finger and BTB domain containing 7a multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZBTB7A mRNA CTD PMID:26378955 NCBI chr10:80,971,113...80,988,056
Ensembl chr10:80,971,054...80,988,829 		JBrowse link
G Zbtb8a zinc finger and BTB domain containing 8a multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZBTB8A mRNA CTD PMID:26378955 NCBI chr 4:129,247,425...129,271,821
Ensembl chr 4:129,247,421...129,271,909 		JBrowse link
G Zc3h11a zinc finger CCCH type containing 11A multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZC3H11A mRNA CTD PMID:26378955 NCBI chr 1:133,547,600...133,589,137
Ensembl chr 1:133,547,600...133,589,118 		JBrowse link
G Zc3h12a zinc finger CCCH type containing 12A multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZC3H12A mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZC3H12A mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 4:125,012,207...125,021,674
Ensembl chr 4:125,012,216...125,021,633 		JBrowse link
G Zc3h12c zinc finger CCCH type containing 12C multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZC3H12C mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZC3H12C mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 9:52,020,869...52,080,028
Ensembl chr 9:52,022,644...52,079,872 		JBrowse link
G Zc3h13 zinc finger CCCH type containing 13 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] affects the expression of ZC3H13 mRNA CTD PMID:26378955 NCBI chr14:75,521,746...75,581,873
Ensembl chr14:75,521,813...75,581,866 		JBrowse link
G Zc3h15 zinc finger CCCH-type containing 15 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZC3H15 mRNA CTD PMID:26378955 NCBI chr 2:83,474,922...83,494,961
Ensembl chr 2:83,474,779...83,494,966 		JBrowse link
G Zcchc2 zinc finger, CCHC domain containing 2 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZCCHC2 mRNA CTD PMID:26378955 NCBI chr 1:105,916,929...105,961,807
Ensembl chr 1:105,918,136...105,961,804 		JBrowse link
G Zcchc7 zinc finger, CCHC domain containing 7 multiple interactions ISO
EXP		 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZCCHC7 mRNA CTD PMID:26378955 NCBI chr 4:44,756,556...44,932,215
Ensembl chr 4:44,755,877...44,932,215 		JBrowse link
G Zdhhc14 zinc finger, DHHC domain containing 14 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZDHHC14 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZDHHC14 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr17:5,542,220...5,810,517
Ensembl chr17:5,542,832...5,804,086 		JBrowse link
G Zdhhc2 zinc finger, DHHC domain containing 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] affects the expression of ZDHHC2 mRNA CTD PMID:26378955 NCBI chr 8:40,876,526...40,946,178
Ensembl chr 8:40,876,856...40,963,309 		JBrowse link
G Zdhhc21 zinc finger, DHHC domain containing 21 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZDHHC21 mRNA CTD PMID:26378955 NCBI chr 4:82,716,975...82,778,892
Ensembl chr 4:82,716,975...82,778,195 		JBrowse link
G Zeb2 zinc finger E-box binding homeobox 2 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZEB2 mRNA CTD PMID:26378955 NCBI chr 2:44,873,523...45,007,378
Ensembl chr 2:44,873,644...45,007,407 		JBrowse link
G Zfc3h1 zinc finger, C3H1-type containing multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFC3H1 mRNA CTD PMID:26378955 NCBI chr10:115,220,691...115,268,677
Ensembl chr10:115,220,864...115,268,677 		JBrowse link
G Zfhx4 zinc finger homeodomain 4 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFHX4 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFHX4 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 3:5,276,268...5,480,921
Ensembl chr 3:5,283,586...5,480,917 		JBrowse link
G Zfp101 zinc finger protein 101 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP101 mRNA CTD PMID:26378955 NCBI chr17:33,599,148...33,613,593
Ensembl chr17:33,579,481...33,613,615 		JBrowse link
G Zfp146 zinc finger protein 146 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF146 mRNA CTD PMID:26378955 NCBI chr 7:29,859,912...29,869,225
Ensembl chr 7:29,860,694...29,869,175 		JBrowse link
G Zfp148 zinc finger protein 148 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP148 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP148 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr16:33,201,145...33,324,273
Ensembl chr16:33,201,206...33,324,733 		JBrowse link
G Zfp185 zinc finger protein 185 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFP185 mRNA CTD PMID:26378955 NCBI chr  X:72,030,860...72,075,149
Ensembl chr  X:72,030,945...72,075,149 		JBrowse link
G Zfp207 zinc finger protein 207 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP207 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP207 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:80,274,105...80,299,387
Ensembl chr11:80,274,105...80,296,559 		JBrowse link
G Zfp266 zinc finger protein 266 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP266 mRNA CTD PMID:21641980 NCBI chr 9:20,406,364...20,432,715
Ensembl chr 9:20,406,364...20,432,713 		JBrowse link
G Zfp267 zinc finger protein 267 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP267 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP267 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 3:36,205,233...36,224,491
Ensembl chr 3:36,205,166...36,224,491 		JBrowse link
G Zfp280d zinc finger protein 280D multiple interactions EXP
ISO		 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP280D mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF280D mRNA		 CTD PMID:21641980 PMID:26378955 NCBI chr 9:72,181,900...72,271,061
Ensembl chr 9:72,182,142...72,271,059 		JBrowse link
G Zfp292 zinc finger protein 292 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP292 mRNA CTD PMID:26378955 NCBI chr 4:34,803,110...34,882,982
Ensembl chr 4:34,803,113...34,882,960 		JBrowse link
G Zfp296 zinc finger protein 296 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP296 mRNA CTD PMID:26378955 NCBI chr 7:19,311,212...19,314,581
Ensembl chr 7:19,311,212...19,314,581 		JBrowse link
G Zfp329 zinc finger protein 329 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP329 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of ZFP329 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 7:12,537,705...12,552,844
Ensembl chr 7:12,538,904...12,552,785 		JBrowse link
G Zfp36 zinc finger protein 36 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZFP36 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFP36 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 7:28,076,208...28,078,680
Ensembl chr 7:28,076,209...28,079,678 		JBrowse link
G Zfp367 zinc finger protein 367 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP367 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP367 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr13:64,280,836...64,301,013
Ensembl chr13:64,280,832...64,301,016 		JBrowse link
G Zfp36l1 zinc finger protein 36, C3H type-like 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFP36L1 mRNA CTD PMID:26378955 NCBI chr12:80,154,534...80,159,787
Ensembl chr12:80,154,528...80,159,787 		JBrowse link
G Zfp386 zinc finger protein 386 (Kruppel-like) multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF519 mRNA CTD PMID:26378955 NCBI chr12:116,011,334...116,026,851
Ensembl chr12:116,011,344...116,026,980 		JBrowse link
G Zfp420 zinc finger protein 420 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZNF420 mRNA CTD PMID:26378955 NCBI chr 7:29,559,392...29,576,727
Ensembl chr 7:29,559,404...29,576,717 		JBrowse link
G Zfp422-ps zinc finger protein 422, pseudogene multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP422-PS mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP422-PS mRNA CTD PMID:21641980 PMID:26378955 NCBI chr17:33,522,623...33,524,837
Ensembl chr17:33,524,013...33,524,719 		JBrowse link
G Zfp444 zinc finger protein 444 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZFP444 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFP444 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 7:6,175,429...6,196,103
Ensembl chr 7:6,175,225...6,196,810 		JBrowse link
G Zfp445 zinc finger protein 445 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP445 mRNA CTD PMID:26378955 NCBI chr 9:122,677,988...122,715,916
Ensembl chr 9:122,673,594...122,695,071 		JBrowse link
G Zfp457 zinc finger protein 457 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF93 mRNA CTD PMID:26378955 NCBI chr13:67,440,514...67,454,476
Ensembl chr13:67,436,202...67,454,549 		JBrowse link
G Zfp458 zinc finger protein 458 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP458 mRNA CTD PMID:26378955 NCBI chr13:67,350,853...67,417,844
Ensembl chr13:67,402,982...67,426,530 		JBrowse link
G Zfp503 zinc finger protein 503 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP503 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP503 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr14:22,034,030...22,039,669
Ensembl chr14:22,034,027...22,039,669 		JBrowse link
G Zfp518a zinc finger protein 518A multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF518A mRNA CTD PMID:26378955 NCBI chr19:40,882,472...40,906,391
Ensembl chr19:40,883,149...40,906,391 		JBrowse link
G Zfp605 zinc finger protein 605 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF605 mRNA CTD PMID:26378955 NCBI chr 5:110,257,898...110,279,402
Ensembl chr 5:110,257,958...110,277,660 		JBrowse link
G Zfp638 zinc finger protein 638 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP638 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP638 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 6:83,844,050...83,963,855
Ensembl chr 6:83,844,091...83,966,532 		JBrowse link
G Zfp644 zinc finger protein 644 multiple interactions EXP
ISO		 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP644 mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF644 mRNA		 CTD PMID:26378955 NCBI chr 5:106,764,605...106,844,696
Ensembl chr 5:106,764,605...106,845,153 		JBrowse link
G Zfp68 zinc finger protein 68 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP68 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP68 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 5:138,601,914...138,618,005
Ensembl chr 5:138,601,914...138,618,023 		JBrowse link
G Zfp729a zinc finger protein 729a multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFP729A mRNA CTD PMID:26378955 NCBI chr13:67,760,879...67,785,925
Ensembl chr13:67,760,882...67,785,910 		JBrowse link
G Zfp799 zinc finger protein 799 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZFP799 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFP799 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr17:33,031,125...33,049,235
Ensembl chr17:33,034,423...33,049,235 		JBrowse link
G Zfp800 zinc finger protein 800 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP800 mRNA CTD PMID:26378955 NCBI chr 6:28,210,543...28,398,010
Ensembl chr 6:28,239,926...28,398,004 		JBrowse link
G Zfp804a zinc finger protein 804A multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNF804A mRNA CTD PMID:26378955 NCBI chr 2:81,880,473...82,090,223
Ensembl chr 2:81,883,566...82,090,223 		JBrowse link
G Zfp811 zinc finger protein 811 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZFP811 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFP811 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr17:33,014,650...33,029,033
Ensembl chr17:33,014,650...33,028,905 		JBrowse link
G Zfp831 zinc finger protein 831 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZNF831 mRNA CTD PMID:26378955 NCBI chr 2:174,440,453...174,552,625
Ensembl chr 2:174,485,327...174,552,625 		JBrowse link
G Zfp871 zinc finger protein 871 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFP871 mRNA CTD PMID:26378955 NCBI chr17:32,984,470...33,007,261
Ensembl chr17:32,984,470...33,007,261 		JBrowse link
G Zfp91 zinc finger protein 91 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFP91 mRNA CTD PMID:26378955 NCBI chr19:12,744,303...12,773,487
Ensembl chr19:12,744,384...12,773,490 		JBrowse link
G Zfp930 zinc finger protein 930 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP930 mRNA CTD PMID:21641980 NCBI chr 8:69,661,701...69,683,188
Ensembl chr 8:69,661,690...69,683,188 		JBrowse link
G Zfp932 zinc finger protein 932 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP932 mRNA CTD PMID:21641980 NCBI chr 5:110,144,334...110,160,132
Ensembl chr 5:110,144,387...110,158,277 		JBrowse link
G Zfp946 zinc finger protein 946 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP946 mRNA CTD PMID:21641980 NCBI chr17:22,643,102...22,675,670
Ensembl chr17:22,643,203...22,675,670 		JBrowse link
G Zfp955b zinc finger protein 955B multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFP955B mRNA CTD PMID:21641980 NCBI chr17:33,508,495...33,526,213
Ensembl chr17:33,508,518...33,526,215 		JBrowse link
G Zfr zinc finger RNA binding protein multiple interactions EXP
ISO		 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFR mRNA
[Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZFR mRNA		 CTD PMID:26378955 NCBI chr15:12,117,649...12,185,535
Ensembl chr15:12,117,917...12,185,769 		JBrowse link
G Zfyve16 zinc finger, FYVE domain containing 16 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFYVE16 mRNA CTD PMID:26378955 NCBI chr13:92,624,257...92,667,318
Ensembl chr13:92,623,616...92,667,376 		JBrowse link
G Zfyve21 zinc finger, FYVE domain containing 21 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZFYVE21 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZFYVE21 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr12:111,780,600...111,794,822
Ensembl chr12:111,780,604...111,798,626 		JBrowse link
G Zik1 zinc finger protein interacting with K protein 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZIK1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] affects the expression of ZIK1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 7:10,221,151...10,229,308
Ensembl chr 7:10,221,156...10,229,321 		JBrowse link
G Zkscan1 zinc finger with KRAB and SCAN domains 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZKSCAN1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZKSCAN1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 5:138,083,312...138,106,084
Ensembl chr 5:138,083,346...138,106,084 		JBrowse link
G Zkscan14 zinc finger with KRAB and SCAN domains 14 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZKSCAN14 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZKSCAN14 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 5:145,131,756...145,140,972
Ensembl chr 5:145,131,756...145,138,678 		JBrowse link
G Zmym3 zinc finger, MYM-type 3 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZMYM3 mRNA CTD PMID:26378955 NCBI chr  X:100,447,990...100,464,986
Ensembl chr  X:100,447,990...100,464,455 		JBrowse link
G Zmynd15 zinc finger, MYND-type containing 15 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZMYND15 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZMYND15 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr11:70,350,259...70,357,028
Ensembl chr11:70,350,259...70,357,028 		JBrowse link
G Zmynd19 zinc finger, MYND domain containing 19 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZMYND19 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZMYND19 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 2:24,839,789...24,850,882
Ensembl chr 2:24,839,804...24,852,087 		JBrowse link
G Zmynd8 zinc finger, MYND-type containing 8 multiple interactions EXP [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZMYND8 mRNA CTD PMID:26378955 NCBI chr 2:165,626,072...165,740,896
Ensembl chr 2:165,626,072...165,740,936 		JBrowse link
G Znrf1 zinc and ring finger 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in increased expression of ZNRF1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZNRF1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 8:112,262,652...112,352,352
Ensembl chr 8:112,262,729...112,352,662 		JBrowse link
G Znrf2 zinc and ring finger 2 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZNRF2 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZNRF2 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 6:54,793,901...54,867,209
Ensembl chr 6:54,793,901...54,870,485 		JBrowse link
G Zranb1 zinc finger, RAN-binding domain containing 1 multiple interactions EXP [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ZRANB1 mRNA; [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ZRANB1 mRNA CTD PMID:21641980 PMID:26378955 NCBI chr 7:132,532,905...132,588,127
Ensembl chr 7:132,532,871...132,588,120 		JBrowse link
G Zup1 zinc finger containing ubiquitin peptidase 1 multiple interactions ISO [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of ZUP1 mRNA CTD PMID:26378955 NCBI chr10:33,795,138...33,827,316
Ensembl chr10:33,795,138...33,827,265 		JBrowse link
Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 22194
    chemical entity 22193
      group 22088
        inorganic group 21043
          thiol group 1996
            thiol 1996
              dithiol 1409
                1,4-dithiothreitol + 99
                2,3-disulfanylpropane-1-sulfonic acid 0
                3-mercapto-2-mercaptomethylpropanoic acid 0
                biphenyl-4,4'-dithiol 0
                dihydrolipoamide + 1
                dimercaprol + 40
                iminodimethanethiol 0
                propane-1,3-dithiol 0
                rostratin D 0
                succimer 1320
Path 2
Term Annotations click to browse term
  CHEBI ontology 22194
    subatomic particle 22186
      composite particle 22186
        hadron 22186
          baryon 22186
            nucleon 22186
              atomic nucleus 22186
                atom 22186
                  main group element atom 22120
                    main group molecular entity 22120
                      s-block molecular entity 21717
                        hydrogen molecular entity 21634
                          hydrides 20777
                            inorganic hydride 18692
                              chalcogen hydride 2619
                                sulfur hydride 2117
                                  hydrogen sulfide 2117
                                    thiol group 1996
                                      thiol 1996
                                        dithiol 1409
                                          1,4-dithiothreitol + 99
                                          2,3-disulfanylpropane-1-sulfonic acid 0
                                          3-mercapto-2-mercaptomethylpropanoic acid 0
                                          biphenyl-4,4'-dithiol 0
                                          dihydrolipoamide + 1
                                          dimercaprol + 40
                                          iminodimethanethiol 0
                                          propane-1,3-dithiol 0
                                          rostratin D 0
                                          succimer 1320
paths to the root